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“Life is what happens to you while you’re busy making other plans.” 
– John Lennon 
When I look back at my life’s journey so far, this quote from John Lennon hits close 
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the many people who played an important role in helping me stand where I am now.  
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been possible without their unconditional love and support. I would also like to thank my 
brothers Sachin and Manish, sister-in-law Shweta, and niece Grisha for their love and 
support throughout the years, and my in-laws, Mr. William Perry and Mrs. Gina Perry, for 
welcoming me into their family.  
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master’s student at New York University. It is most certainly an understatement to say 
that my time at NYU made me the person I am today, both on a personal and professional 
level. It started with Lionel Christiaen giving me, someone with no molecular biology 
experience whatsoever, the opportunity to conduct my master’s thesis research in his lab. 
There, then-postdoctoral researcher (and now professor!) Alberto Stolfi took me on as his 
young padawan and taught me the technical skills I needed to succeed as a scientist. His 
training continues to help me even today, and I am most grateful for his mentorship both 
inside and outside the lab. I would be remiss not to mention members of the Christiaen 




I came to Caltech with a different career path in mind, but unfortunate 
circumstances surrounding my last rotation left me battered. My confidence was at an all-
time low, and I briefly considered dropping out of grad school, naively thinking that not 
having a lab to join after being tricked into doing a second rotation in the same lab (and 
a fourth rotation overall) was an ominous sign that I was not meant to become a scientist 
after all. That incident later on proved to be both a blessing in disguise and a critical 
turning point in my PhD. A senior graduate student at the time, Ravi Nath, advised me to 
talk to a professor who he said had a track record of being an excellent mentor. He 
suggested I meet with her before making any rash decisions, as she was sure to 
empathize with my situation. That professor was none other than my thesis advisor, 
Marianne Bronner, who ended up offering me a position in her lab without asking me to 
do a formal rotation. I came in with no external funding and was ineligible to apply for 
federal grants or fellowships as an international student, and yet, she showed faith in me 
and took me on as one of her graduate students. Over the years, Marianne instilled in me 
the confidence I needed to come up with my own ideas to work on in the lab. At the same 
time, she helped me realize the importance of maintaining a healthy work-life balance. I 
often found myself being sent back home to sleep if she discovered me in the lab early in 
the morning wearing the same clothes as the previous day. She was always eager to 
make hands-on contributions to experiments in the lab, and to this day, members of the 
lab, including myself, continue to rely on her expertise when a project requires tricky 
injections in an embryo. Even during the pandemic, between her endless Zoom meetings, 
Marianne always made time to meet with me, sometimes on just a few minutes’ notice. 
In fact, Marianne has often pointed out how spoiled I have become after years of receiving 
her edits and comments on my manuscripts within a matter of days, sometimes overnight! 
If I can manage to be only half as efficient as she has been, I would consider myself a 
successful scientist. I have cherished every single one of my interactions with Marianne 
over the course of my PhD. I look up to her in many ways, and she will continue to be a 
role model throughout my career. 
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While I have been very fortunate to collaborate with several current and former 
members of the Bronner lab, there are a few people whom I would like to particularly 
mention for their contributions to my professional and personal development: Max Ezin—
my mentor, friend, and closest collaborator. I have learned so much from Max, and her 
unique storytelling style and sense of humor made every interaction enjoyable. Max was 
not afraid to call me out on my actions and life choices, especially when I failed to take 
care of my injuries. Je voudrais remercier vous pour votre support, Max! Felipe Vieceli, 
who trained me in chick embryology techniques when I first joined the lab and eventually 
became a close collaborator and friend. Erica Hutchins, who was always willing to nerd 
out with me about everything Star Wars, and often treated the lab with her delicious baked 
goods. I especially appreciated Erica’s honesty and the scientific rigor with which she 
approached her work. Erica is also the individual who shared with me the best joke I have 
ever heard: “What’s the internal temperature of a Tauntaun? Lukewarm.” Megan Martik, 
who thinks about science in a way similar to how I have approached my graduate work. 
She was always happy to provide feedback on my manuscripts and fellowship 
applications, which as it turns out, I will continue to seek at UC Berkeley where she’s 
starting her own lab! Meyer Barembaum—senior scientist in the lab who was always 
willing to share his experience and wisdom with me, including his in situ probes on several 
occasions. And finally, a big shout out to Johanna Tan-Cabugao, Constanza Gonzalez, 
and David Mayorga. Because of their hard work, I never had to worry about ordering 
reagents, making plates and solutions, or dealing with bureaucracy surrounding travel 
reimbursements, leaving me with more time to focus on doing the best science I possibly 
could. 
 I would also like to express my gratitude towards the faculty members who 
supported me at Caltech. In particular, my thesis advisory committee members, Ellen 
Rothenberg, Matt Thomson, Joe Parker, and Magdalena Zernicka-Goetz, provided 
valuable insights and feedback on my work and wrote letters of recommendation to 
support my various fellowship applications. I would especially like to thank Ellen, who 
served as the chair of my thesis committee. Even short conversations with Ellen always 
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left me energized. Most importantly, Ellen helped me to better appreciate my 
accomplishments with her infectious enthusiasm every time I shared a piece of good 
news. I would also like to acknowledge Matt Thomson for his guidance and support while 
I was preparing my fellowship applications. Finally, although she was not officially a 
member of my thesis advisory committee, Dianne Newman provided invaluable advice 
and support during my time at Caltech. 
I would also like to thank the undergraduate students I had the privilege to mentor 
over the course of my PhD—Alexa Lauinger, Krystyna Maruszko, Donald Siu, Ciannah 
Correa, and Jens Bager Christensen. Not only did they make valuable hands-on 
contributions to several of my published works, but their patience and honesty also 
enabled me to become a better teacher and mentor.  
Most of my graduate work would not have been possible without the help and 
technical support from the Caltech and Beckman Institute core facilities. I would especially 
like to thank Rochelle Diamond, Jamie Tijeria, and Diana Perez with the Fluorescence-
Activated Cell Sorting facility, Igor Antoshechkin with the Millard and Muriel Jacobs 
Genetics and Genomics Laboratory, Sisi Chen and Jong Park with the Single Cell 
Profiling and Engineering Center of the Beckman Institute, Grace Shin and Maayan 
Schwarzkopf with Molecular Technologies, and Giada Spigolon and Andres Collazo with 
the Biological Imaging Facility of the Beckman Institute for their expertise and 
contributions to my projects. In the last few years of my PhD, I was fortunate to interact 
with Fan Gao, Director of the Bioinformatics Resource Center of the Beckman Institute. 
Fan has continued to play an instrumental role in several of my projects, and I have 
tremendously benefitted from my conversations with him.  
No one’s graduate school experience in Caltech’s Biology and Biological 
Engineering division is complete without the administrative support from Liz Ayala and 
Raina Beaven. From as early as planning my travel for the in-person interview at Caltech 
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playing professional cricket in the US, and Shahid Jalil, who backed me up as a player 
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I will continue to cherish the relationships I have established with several members of 
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Finally, I am ever so grateful for my wife, Dr. Elena Perry. I met Elena at graduate 
student orientation back in Fall 2015. Not many people know this, but Elena took a year 
off from her undergrad to study abroad in Korea. When she was interviewing for grad 
school at one of her top choices, there was a big storm in Boston that weekend, which 
swayed her away from going to grad school on the east coast. On the other hand, while I 
had a productive time during my master’s at NYU, I was not very fond of New York City 
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back then, and desperately wanted to leave. So deciding where to get my PhD, at NYU 
or Caltech, was not a difficult choice. The reason why I am mentioning this is because all 
these things had to happen exactly like they did for Elena and me to come to Caltech and 
sit next to each other in Justin Bois’ Python bootcamp. A few weeks later, we would find 
ourselves taking Justin’s Data Analysis class together, working on assignments in the 
same group. To a certain degree, we do owe our relationship to Justin. If it weren’t for his 
hard assignments on Bayesian statistics, we wouldn’t have spent as much time around 
each other, all the while getting to know and appreciate one another. Elena, I am really 
fortunate to have met you. We have had quite a few adventures around the world, from 
drinking champagne on top of the Eiffel Tower to sleeping in a hammock in the middle of 
the Amazon Rainforest. And there’s no other person I can imagine with whom I’d rather 
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flaws in my personality that have affected my professional and personal relationships. It 
was your support that carried me during the turbulent time I had in my first year. The 
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your ggplot expertise. Traveling with you to New York even made me fall in love with the 
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you’re in it. I can probably go on and on, but I will just say this – Elena, you are my pillar 
of strength. Every day spent with you is a blessing, and I am eagerly looking forward to 










The neural crest is a multipotent, vertebrate-specific stem cell population that gives 
rise to diverse cell types in the developing embryo, including craniofacial cartilage, enteric 
ganglia, and cardiac septa. Neural crest cells that originate from a given axial level in the 
embryo give rise to a characteristic array of progeny and follow distinct pathways from those 
arising at other levels. One of these subpopulations, called the cardiac neural crest, 
originates in the dorsal hindbrain and migrates into the developing heart, where it forms the 
aorticopulmonary septum, cardiac ganglion, and part of the interventricular septum. 
Mutations in or loss of these cells causes heart defects that are among the most common 
birth defects in the general population. For my thesis, I sought to identify the mechanisms 
that underlie the formation of neural crest cells, and confer cardiac neural crest cells with 
their unique developmental potential.  
To enable interrogation of epistatic relationships between key neural crest genes 
during neural crest induction and crest specification, I first optimized the CRISPR-Cas9 
system for genome editing in gastrula and neurula-stage chicken embryos. I then further 
improved the CRISPR toolbox by devising an all-in-one single-plasmid strategy that 
harnesses the self-cleavage properties of ribozymes for the simultaneous delivery of Cas9, 
gRNAs, and fluorescent reporters in transfected cells. This has enabled live tracking of 
wildtype and mutant neural crest cells as they migrate to their terminal locations. 
Prior to their induction at the neural plate border, precursors in the neural plate 
border are transcriptionally primed toward multiple cell fates, including neural tube, neural 
crest, epidermis, and placode. While this priming has been thought to involve epigenetic 
regulation, chromatin remodeler genes have been overlooked in the context of neural crest 
formation given their concomitant expression in surrounding cell types. By combining 
single-cell transcriptional profiling of the early chick embryonic hindbrain with temporally-




remodeler gene Hmga1 first regulates Pax7-dependent neural crest induction at the neural 
plate border, and later modulates Wnt signaling in the dorsal neural tube to control neural 
crest delamination. These results established Hmga1 as a direct regulator of neural crest 
induction and emigration.  
Finally, given that amongst distinct neural crest subpopulations designated as 
cranial, cardiac/vagal, and trunk, only cardiac crest has the ability to contribute to heart 
development, and that neither trunk nor cranial neural crest subpopulations can rescue the 
loss of cardiac crest, I investigated the genetic logic that imbues cardiac crest with its unique 
ability to form cardiovascular derivatives. To this end, I combined surgical ablations, bulk 
and single-cell transcriptional profiling, RNA labeling, CRISPR-Cas9-mediated gene 
editing, transcription factor binding motif mutation analysis, and transgenic tissue grafting 
approaches to uncover and characterize a cardiac-neural-crest-specific subcircuit 
comprised of the transcription factors Sox8, Tgif1, and Ets1. I demonstrated that ectopic 
expression of this subcircuit in trunk neural crest cells reprogrammed them towards a 
cardiac-crest-like fate, and transplanting these reprogrammed cells in place of ablated 
cardiac crest restored cardiac-crest-like migration patterns and rescued outflow tract 
septation defects.  
Taken together, my thesis work has not only built a genome engineering toolbox for 
a key model system in developmental biology, but has also expanded our understanding 
of the genetic circuits that govern the formation of the cardiac neural crest and underlie its 
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1.1 A brief history of the neural crest 
The neural crest is a transient, multipotent stem cell population unique to 
vertebrates. The history of neural crest research dates back 150 years, when the Swiss 
anatomist, Wilhelm His, Sr., identified a region at the border of the neural tube and the 
non-ectoderm in early stage chick embryos that differentiated into the cranial and spinal 
ganglia (His W., 1868; Trainor et al., 2003). This cell population, which he named 
Zwischenstrang (the intermediate cord) was later referred to as the neural crest. Early 
grafting experiments in amphibians gave the first insights into the developmental potential 
of these cells. Subsequently, lineage tracing experiments in avian embryos using various 
methods of marking the neural crest greatly enhanced our understanding of the pathways 
of migration and derivatives they formed. These initially involved radioactive labeling 
(Chibon, 1967; Weston, 1963), but were revolutionized by the advent of the quail-chick 
chimeric grafts (Le Douarin, 1980) which allowed Le Douarin and colleagues to map 
neural crest migratory pathways, derivatives, and their axial level of origin (Le Douarin, 
1973; Le Douarin and Teillet, 1973, 1974). As an amniotic system, the chick embryo has 
been a particularly valuable organism for understanding these questions, sharing 
similarities with humans both at the morphological and nucleotide level. Their stem cell-
like regenerative properties, long-range migratory capabilities, and experimental 
malleability have made neural crest cells an excellent model system to study 
developmental potential and cell-fate decisions (Dupin and Sommer, 2012; Smith, 1990; 
Tucker, 2004). Therefore, understanding how the neural crest develops can help us gain 
insights into how cells behave differently depending on their position and function in the 
organism.  
1.2 Thesis overview 
In Chapter 2, I discuss the mechanisms underlying neural crest specification, 
migration, and differentiation in avian embryos, and highlight the genetic tools that were 
available to study these biological processes in chick embryos at the time I began working 




In Chapter 3, in collaboration with postdoctoral researcher Dr. Megan Martik, I 
address the question of how evolution of the neural crest impacted the vertebrate body 
plan. Contribution of the neural crest towards the craniofacial architecture of vertebrates 
led to the genesis of the “new head hypothesis” (Gans and Northcutt, 1983), according to 
which the possession of distinct craniofacial derivatives enabled diversification of the 
brain and acquisition of predatory behavior in vertebrates, as compared to filter feeding 
chordates (Le Douarin, 2004). We examine the molecular circuits that control neural crest 
development along the anteroposterior axis of a jawless vertebrate, the sea lamprey. 
Gene expression analyses show that the lamprey cranial neural crest lacks most 
components of an amniote cranial-specific transcriptional circuit that confers the ability to 
form craniofacial cartilage onto other neural crest populations (Simões-Costa and 
Bronner, 2016). Consistent with this, hierarchical clustering reveals that the transcriptional 
profile of the lamprey cranial crest is more similar to the amniote trunk crest. Intriguingly, 
analysis of the cranial neural crest in little skate and zebrafish embryos demonstrates that 
the cranial-specific transcriptional circuit emerged via gradual addition of network 
components to the neural crest of gnathostomes, which subsequently became restricted 
to the cephalic region. Our results indicate that the ancestral neural crest at the base of 
vertebrates possessed a trunk-like identity, and we propose that the emergence of the 
cranial neural crest, by progressive assembly of a novel axial-level-specific regulatory 
circuit, allowed for the elaboration of the New Head during vertebrate evolution. 
In Chapter 4, I present an optimized CRISPR-Cas9 method for targeted gene 
knockouts in chicken embryos that is reproducible, robust, and specific. By employing a 
three-fold strategy to modify CRISPR reagents, we significantly improve the efficiency of 
gene knockouts when compared to previous iterations of this tool. We start by flanking 
Cas9 protein with two nuclear localization signal sequences to improve its nuclear 
localization. Second, we use a modified guide RNA (gRNA) scaffold that obviates 
premature termination of transcription and unstable Cas9-gRNA interactions. Third, we 
use a chick-specific U6 promoter that yields 4-fold higher gRNA expression than the 




also generate a chicken fibroblast cell line that constitutively expresses Cas9-GFP. As 
proof of principle, we target Pax7 and Sox10 via electroporation in the neural crest. These 
key transcription factors have known functions in neural crest development, and the 
results show that CRISPR/Cas9-mediated deletions cause loss of their respective 
proteins and transcripts, as well as putative downstream targets. CRISPR-Cas9 has 
made genome editing possible in virtually any organism, including those not previously 
amenable to genetic manipulations, and here we implement it for efficient loss-of-function 
experiments in early avian embryos. 
In Chapter 5, I present a combinatorial approach for lineage analysis and CRISPR-
Cas9-mediated genome editing that employs replication-incompetent avian (RIA) 
retroviruses to study experimentally perturbed cells in an otherwise normal environment 
in several tissues of the chick embryo. To achieve this, we have engineered a plasmid 
that encodes Cas9 protein, gene-specific guide RNA (gRNA), and a fluorescent marker 
within the same construct. Using transfection- and electroporation-based approaches, we 
show that this construct can be used to perturb gene function in early embryos as well as 
human cell lines. Importantly, incorporation of this cistronic construct into RIA retroviruses 
enabled long-term lineage analysis of mutant cells. We demonstrate the application of 
our newly-engineered reagents by perturbing b-catenin in vitro and Sox10, Pax6, and 
Pax7 in the neural crest, retina, and neural tube and segmental plate in vivo, respectively. 
This work finally makes it possible to challenge a cell’s developmental potential and 
interrogate the role of particular genes in developmental processes by enabling their 
knockout in permanently-labeled cells in living embryos. 
In Chapter 6, I characterize the chromatin remodeler gene Hmga1 as an important 
regulator of neural crest formation at the neural plate border. We combine single-cell RNA 
sequencing with high resolution in situ hybridization to show that Hmga1 is highly 
expressed prior to neural crest induction and is retained during chick neural crest 
specification, delamination, and migration. Temporally-controlled CRISPR-Cas9-
mediated knockouts uncovered two distinct roles for Hmga1 in neural crest development. 




specification. At premigratory stages, a second role manifests where Hmga1 loss reduces 
cranial crest emigration from the dorsal neural tube independent of Pax7.  Interestingly, 
this is rescued by stabilized ß-catenin, thus implicating Hmga1 as a canonical Wnt 
activator. Together, our results show that Hmga1 functions in a bimodal manner during 
neural crest development to regulate specification at the neural plate border, and 
subsequent emigration from the neural tube via canonical Wnt signaling.  
In Chapter 7, I probe the molecular mechanisms underlying the cardiac neural 
crest’s unique developmental potential. The cardiac neural crest arises in the hindbrain, 
then migrates to the heart and contributes to critical structures, including the outflow tract 
septum. Chick cardiac crest ablation results in failure of this septation, phenocopying the 
human heart defect Persistent Truncus Arteriosus (PTA), which trunk neural crest fails to 
rescue. We first report laterality differences in cardiovascular defects resulting from 
unilateral cardiac neural fold ablations. We resolve the heterogeneity within the migratory 
cardiac neural crest using single-cell RNA sequencing and report the earlier-than-
expected onset of gene expression associated with their ectomesenchymal differentiation 
potential. Using loss-of-function analyses, we establish regulatory relationships of cardiac 
neural crest genes and explore their role in heart development. Accordingly, we find that 
one of these genes, Tgif1, functions in a cardiac neural crest subcircuit important for 
specification and proper outflow tract septation. Finally, we show that ectopic expression 
of a cardiac crest-specific subcircuit, comprised of Sox8, Tgif1, and Ets1, is sufficient to 
reprogram trunk neural crest cells, enabling them to migrate to the heart and rescue the 
effects of a cardiac crest ablation, which they cannot normally do. Taken together, our 
results help elucidate the genetic properties of this unique neural crest lineage in the 
formation and function of the heart, helping uncover potential target genes involved in 
cardiovascular birth defects, and provide a molecular recipe for generating 






Finally, in Chapter 8, I provide concluding remarks on my thesis work and discuss 
how genomic approaches have provided new insights into old questions in neural crest 
biology, especially those that elucidate transcriptional and post-transcriptional 
mechanisms governing neural crest formation and establishment of axial level identity. 
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Neural crest development in avian embryos 
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The neural crest is a multipotent and highly migratory cell type that contributes to 
many of the defining features of vertebrates, including the skeleton of the head and most 
of the peripheral nervous system. Induced at the border of the neural plate and the non-
neural ectoderm, this cell population initially resides in the elevating neural folds as 
neurulation progresses, and then within the dorsal neural tube [Figure 1]. Shortly after 
neural tube closure in avian embryos, neural crest cells undergo an epithelial-to-
mesenchymal transition (EMT), losing their cell-cell contacts and transforming into a 
migratory cell type, distinct from both neural tube and the epidermal cells (Bronner and 
Simões-Costa, 2016; Le Douarin and Kalcheim, 1999; Hall, 2009; Sauka-Spengler and 
Bronner-Fraser, 2008; Steventon et al., 2005). Post EMT, these cells migrate extensively 
throughout the embryo along distinct pathways, exhibiting both collective and individual 
cell migration behavior in response to environmental cues and morphogenetic signals. 
They subsequently give rise to numerous cell types, including melanocytes of the skin, 
craniofacial cartilage and bones, smooth muscle, Schwann cells, and sensory and 
autonomic neurons of the peripheral nervous system (Le Douarin and Kalcheim, 1999; 
Le Douarin and Teillet, 1971; Dupin et al., 2006; Grenier et al., 2009; Hall, 2009; Kirby 
and Hutson, 2010; Minoux and Rijli, 2010; Theveneau and Mayor, 2011). Despite the fact 
that the neural crest is derived from the ectoderm, it has been referred to as the fourth 
germ layer due to its ability to migrate long distances and differentiate into such a plethora 
of derivatives (Le Douarin and Dupin, 2014; Hall, 2000; Shyamala et al., 2015).  
150 years after the discovery of the neural crest, avian embryos have been one of 
the most important model organisms for studying neural crest development. Past and 
emerging technologies continue to improve the resolution with which we can examine 
important questions of neural crest development, with modern avian molecular 
embryology continuing to make important contributions. In this chapter, I describe aspects 
of neural crest induction, migration, and axial level differences, highlighting what is known 




2.2 Induction of the neural crest in avian embryos 
Until the mid-2000s, the prevailing view of neural crest induction was that 
interactions between the non-neural surface ectoderm, neural plate, and/or underlying 
mesoderm resulted in specification of neural crest precursors via signaling interactions 
Figure 1. Illustration demonstrating various stages of neural crest development. A. The neural crest is a 
transient population of multipotent cells found in vertebrates. Neural crest cells are specified at the border between 
the neural plate (blue) and non-neural ectoderm (yellow) at the gastrula stage.  B. During neurulation, the neural plate 
border elevates to form the neural folds containing premigratory neural crest cells. C-D. As the neural folds fuse to 
form the neural tube, neural crest cells undergo an epithelial-to-mesenchymal transition (EMT), delaminate from the 
dorsal neural tube, and migrate extensively to various parts of the developing embryo where they differentiate into a 




between tissues (Basch et al., 2004; Gammill and Bronner-Fraser, 2002; Monsoro-Burq 
et al., 2003; Takahashi et al., 2007). Moreover, multiple juxtaposition studies performed 
in both avian and amphibian embryos highlighted the role of the epidermis in specifying 
neural crest cells. However, most of the early experiments in chick embryos were 
performed after the neural tube had already formed. In 2006, Basch et al. (2006) 
presented a revised view on the specification and induction of the neural crest precursors. 
They hypothesized that regions of the epiblast were already induced to become 
presumptive neural crest during gastrulation, better matching experimental evidence in 
frog and zebrafish. The comparatively slow development of the chick embryo enabled 
more refined analysis of the timing of neural crest induction. By characterizing the 
expression level of the paired box transcription factor Pax7 in gastrulating chick embryos, 
Basch et al. (2006) concluded that the neural plate border region was already fated to 
become neural crest prior to completion of gastrulation, and that cells from this domain 
incorporate into the neural folds, and ultimately, the migratory neural crest. Dissection of 
the Pax7 expressing domain from the epiblast followed by explantation in a neutral 
environment was sufficient to give rise to migratory neural crest, identified by staining for 
the migratory cell-surface antigen HNK1. Finally, using molecular markers for mesoderm, 
they also demonstrated that the neural crest was specified without any interaction 
between the neural plate border region expressing Pax7, and the underlying mesoderm. 
These results not only characterized Pax7 as an early neural plate border marker, but 
also placed the initiation of neural crest specification at or before gastrulation. More 
recently, Roellig et al. (2017) have expanded this viewpoint by resolving the co-
expression pattern of transcription factors including Pax7, Sox2, and Six1 in the neural 
plate border at a single-cell level. 
The specification of neural crest cells has been described as a multistep process 
involving Fibroblast Growth Factor (FGF), Bone Morphogenetic Protein (BMP), and the 
Wnt signaling cascades, with additional contributions by Notch/Delta, Retinoic Acid (RA), 
Hedgehog, and endothelin signaling (Barembaum and Bronner-Fraser, 2005; Basch et 




signaling, which arises from the surrounding mesoderm, acts in conjunction with Wnt 
signaling to repress BMP signaling during the first half of neural crest induction 
(Stuhlmiller and García-Castro, 2012). In the second half, inhibition of FGF signaling 
allows for the activation of BMP signaling, which together with Wnt signaling, activate a 
pool of transcription factors referred to as Neural Plate Border (NPB) specifiers. These 
NPB specifiers, including transcription factors Pax3/7, Msx1/2, Pax7, Zic1, Gbx2, and 
Tfap2, play an important role in establishing the interface between the neuroepithelium 
and the surface ectoderm (Grocott et al., 2012; Khudyakov and Bronner-Fraser, 2009). 
Once the NPB is established, the NPB specifier genes activate another set of transcription 
factors called the Neural Crest Specifier genes such as FoxD3, Sox9, Snail, and Sox10 
(Simões-Costa and Bronner, 2013, 2015; Simões-Costa et al., 2014). Of these, the 
transcription factor Forkhead Box protein D3 (FoxD3) appears to be expressed first, and 
is required for the subsequent onset of other neural crest specifier genes (Labosky and 
Kaestner, 1998; Sasai et al., 2001; Sauka-Spengler and Bronner-Fraser, 2008; Stewart 
et al., 2006). FoxD3 is expressed in both premigratory and some migratory neural crest 
cells, and regulates their epithelial-to-mesenchymal transition, thereby controlling 
emigration (Fairchild et al., 2014; Kos et al., 2001). However, detailed genomic analysis 
has revealed that the expression of FoxD3 in the cranial versus the trunk axial level is 
tightly regulated by direct transcriptional input into two different enhancers, NC1 and NC2, 
from different transcription factors, hence establishing a direct interactional network 
between the neural plate border specifier genes and their downstream neural crest 
specifier target genes (Simões-Costa et al., 2012). Interestingly, the NC1 enhancer 
governs the expression of FoxD3 in the premigratory cranial neural crest, while the NC2 
enhancer is initially active in the trunk neural crest. In contrast, the neural crest specifier 
gene Sox10 is expressed as neural crest cells prepare to emigrate and then maintained 
in the migratory population (Betancur et al., 2010). It also directly or indirectly regulates 
the activity of proteins like Rho GTPases that are actively involved in actin reorganization, 
thus contributing to cell membrane fluidity, and ultimately, cell migration (Liu and Jessell, 




plays an important role in differentiation of neural crest cells into specific neuronal cell 
types (Carney et al., 2006; Kim et al., 2003). 
Contrary to the induction model of neural crest specification, a recent study in 
Xenopus embryos has proposed that neural crest cells retain multipotency from an early 
blastula to the neurula stage (Buitrago-Delgado et al., 2015). Interestingly, this model 
seems consistent with findings in avian embryos, where expression of the earliest neural 
plate border marker Pax7 was observed in distinct regions of epiblast between stages 3 
and 4 (Basch et al., 2006).  
2.3 Neural crest migration pathways along the body axis of the chick embryo 
Following delamination from the dorsolateral part of the neural tube, neural crest 
cells undergo a change in their transcriptional landscape, assuming a state distinct from 
both the neural tube and the epidermis. This migratory state is marked by a reduction in 
cell-cell adhesion and enhanced interactions with the extracellular matrix. In chick 
embryos, the process of delamination overlaps with neural tube closure (Le Douarin and 
Kalcheim, 1999; Duband and Thiery, 1982; Théveneau et al., 2007), and differs along the 
rostral-caudal axis. In the rostral part of the embryo, the cranial neural crest cells undergo 
EMT as a collective event, resulting in the delamination of numerous cells concurrently. 
They then follow distinct streams and migrate extensively with leader cells pioneering the 
pathways followed by closely-associated follower cells. In contrast, trunk neural crest cells 
delaminate by leaving the neural tube one cell at a time in a drip-like fashion and start 
migrating immediately after detaching from the tube. Interestingly, neural crest migration 
in the trunk is tightly linked with differentiation of the somites (Sela-Donenfeld and 
Kalcheim, 1999). As neural crest cells first leave the neural tube, they migrate between 
the neural tube and the adjacent epithelial somite. The somites subsequent undergo an 
epithelial-mesenchymal transition to form the dermomyotome and sclerotome, at which 
point trunk neural crest cells invade the sclerotome and migrate throughout the anterior 
half of each sclerotome resulting in their segmental migration (Bronner-Fraser, 1986; 




five somite lengths above the last formed somite. The caudal trunk neural crest 
delaminates almost a day after the completion of neurulation (Osorio et al., 2009).  
Neural crest migration is a dynamic process. For example, the chick cranial neural 
crest cells emigrate from the dorsal neural tube immediately after its closure in a rostral-
caudal wave, with cells at the midline of the caudal forebrain and midbrain emerging prior 
to those adjacent to the hindbrain. Not only are there differences in the migratory 
properties of cells originating from different axial levels, but the leader and trailer cells can 
also exhibit differences in migration rates and directionality. At the hindbrain level, these 
differences correlate with segmentation of the rhombomeres (Kulesa and Fraser, 1998, 
2000; Kulesa and Gammill, 2010; Lumsden et al., 1991). Neural crest cells migrating 
towards branchial arch 1 and 3 exhibit collective cell migration with high directionality, 
where the leader cell moves at a speed similar to the cells following in the chain. In 
contrast, cells migrating into branchial arch 2 display more directed, individual cell 
movement with low cell-cell contacts, albeit at much slower migration speeds (Kulesa and 
Fraser, 2000). The neural crest cells that originate from rhombomeres 3 and 5 migrate 
from the dorsal midline of the neural tube, following a diagonal cellular trajectory in a 
caudo- or rostro-lateral manner before migrating laterally away from the neural tube, thus 
avoiding inhibitory environments immediately lateral to r3 and r5. Interestingly, these cells 
end up getting stalled as they reach the lateral-most extent of the neural tube. Eventually, 
they either merge with their neighboring stream from rhombomere 4 migrating towards 
the second branchial arch, or they remain stationary, suggesting that the 
microenvironment adjacent to r3 is inhibitory for neural crest migration, thus establishing 
a neural crest cell-free zone. However, cells that merge with their neighboring stream 
maintain filipodial contacts with the leader cells, allowing them to alter the direction of 
their migration towards the second branchial arch (Kulesa and Fraser, 1998, 2000).  
Trunk neural crest migration is restricted to two major migratory pathways – ventral 
and dorsolateral. In the chick, neural crest cells first migrate ventrally, since repressors 
such as Slit ligands, endothelin-3, and ephrinB1 are initially expressed along the 




pathway and migrate through the inhibitor-free anterior part of the sclerotome (Harris and 
Erickson, 2007). The posterior sclerotome, on the other hand, expresses members of 
ephrin and semaphorin families, along with inhibitory Extracellular Matrix (ECM) 
molecules, Versicans, and F-spondin (Newgreen and Gooday, 1985; Newgreen et al., 
1986). The underlying mechanism of repression arises from the interaction between the 
migratory neural crest receptors eph and neuropilin2 and their antagonistic ligands 
EphrinB and Semaphorin, respectively. Indeed, when neural crest cells from the trunk 
axial level were cultured in dishes containing fibronectin-coated matrices with alternating 
ephrin stripes, the cells moved along the regions with no ephrin, while completely avoiding 
ephrin coated stripes (Davy and Soriano, 2007; Krull et al., 1997; Wang and Anderson, 
1997). Migration of these cells is also controlled temporally in a chemotactic fashion by 
the levels of Stromal cell-derived factor 1 (SDF1) along the ventro-dorsal axis 
(Kasemeier-Kulesa et al., 2010). Neural crest cells that differentiate within the sclerotome 
give rise to the dorsal root ganglia, with high levels of Notch leading to a glial fate, while 
high levels of Notch’s ligand Delta lead to a neuronal fate. Expression of the chemokine 
(C-X-C motif) receptor 4 drives the first wave of ventrally-migrating trunk neural crest cells 
towards the dorsal aorta (Saito et al., 2012). Cells that lack the expression of CXCR4 
continue to migrate and give rise to sympathoadrenal cells that then condense to form 
sympathetic ganglia as well as the adrenal medulla. BMP signaling from the dorsal aorta 
influences these cells to become sympathoadrenal while interactions with presumptive 
adrenal cortical cells influence further differentiation into the adrenal medulla (Saito and 
Takahashi, 2015). 
The second migratory pathway, the dorsolateral pathway, is followed by neural 
crest cells that are fate-restricted to become pigment cell progenitors in a FoxD3-
dependent manner (Tosney, 2004). Low levels of FoxD3 allow proper regulation of MITF, 
a transcription factor necessary for the differentiation of neural crest cells into 
melanocytes (Thomas and Erickson, 2009). Once the pigment precursors are specified, 




cells, facilitating their migration through regions that initially inhibited the migration of 
multipotent trunk neural crest cells. 
2.4 Regionalization along the anterior-posterior axis 
Neural crest cells migrate long distances in response to both environmental cues 
and various signaling cascades (Kulesa and Gammill, 2010). Once they reach their final 
destination, the cells can differentiate into a wide array of cell types. The pioneering work 
of Le Douarin and colleagues showed that the neural crest can be categorized into four 
unique, albeit overlapping regions along the body axis in avian embryos, based on their 
axial level of origin [Figure 2]. The cranial neural crest, also known as the cephalic neural 
crest, includes the forebrain, midbrain and the anterior hindbrain region; the vagal neural 
crest spans from the posterior hindbrain region to somite 7; the trunk neural crest 
comprises somite 8 – 28; and the lumbosacral neural crest represents the region posterior 
of somite 28. Within the vagal neural crest, there is another subpopulation called the 
cardiac neural crest that arises from the neural tube adjacent to the mid otic-placode to 
somite 3. The cranial neural crest contributes to the craniofacial skeleton, and the glia 
and neurons of the cranial ganglia (D’amico‐Martel and Noden, 1983; Le Douarin and 
Kalcheim, 1982). The vagal neural crest populates the gut, and the neurons and glia of 
the enteric nervous system. The cardiac neural crest gives rise to the cardiac outflow tract 
and the pharyngeal arches, and is the only neural crest subpopulation that contributes to 
proper cardiovascular development (Stoller and Epstein, 2005). The trunk neural crest 
cells form the dorsal root ganglia, sympathetic ganglia, and the adrenal medulla. Finally, 
the lumbosacral neural crest also contributes to the enteric nervous system. Interestingly, 
regardless of the axial identity, neural crest cells also differentiate into melanocytes, 




Axial level differences in differentiative ability are highlighted by transplantation 
experiments performed in chick embryos, where cranial and trunk neural crest cells were 
exchanged. Cranial neural crest cells give rise to the craniofacial skeleton, and happens 
to be the only neural crest population capable of doing so. When these cells were 
transplanted to the trunk, they not only compensated for the absence of trunk neural crest 
cells, but also differentiated into cartilage nodules (Le Douarin and Teillet, 1974; Le Lievre 
Figure 2. Neural crest derivatives along the anterior-posterior axis in chick embryos. Neural crest 
subpopulations have been designated based on their axial level of origin along the anterior-posterior axis. Cranial 
neural crest cells migrate from the cranial neural tube into the pharyngeal arches and give rise to craniofacial cartilage 
and bone, as well as glia and neurons of the cranial ganglia. The cardiac neural crest arises from the neural tube 
adjacent to the mid-otic region to somite 3 (marked in red), and plays a key role in cardiac outflow tract septation. 
Vagal neural crest spans from adjacent to somite 1 through 7 (marked in blue), and together with the lumbosacral 
neural crest, arising from the region posterior to somite 28 (marked in dark green), form the parasympathetic ganglia 
of the enteric nervous system. Trunk neural crest arises from the neural tube adjacent to somite 7 through 28 (marked 
in orange), and contributes to dorsal root and sympathetic neurons and glia, melanocytes, and the adrenal medulla. 




et al., 1980). In contrast, trunk neural crest cells failed to give rise to any cartilage when 
transplanted to the cranial level, even though they contributed to the neurons and glia of 
the cranial ganglia (Nakamura and Ayer-Le Lievre, 1982). Indeed, genomic analysis 
revealed that the endogenous levels of the neural crest specifier genes FoxD3 and Sox10 
are controlled by different set of enhancers at the cranial and trunk axial levels (Betancur 
et al., 2010, 2011; Simões-Costa et al., 2012). Not only that, but the transcriptional inputs 
these enhancers receive from their upstream genes are also different at the two axial 
levels (Simões-Costa et al., 2012). Taken together, these results suggest that there are 
intrinsic differences between the developmental fate of the two populations. 
Recently, it has been possible to “reprogram” neural crest axial identity by tweaking 
the underlying genetic circuitry. Simões-Costa and Bronner revealed a cranial crest-
specific subcircuit by performing transcriptional profiling of the migratory crest from the 
cranial and trunk axial levels (Simões-Costa and Bronner, 2016). They discovered that 
ectopic expression of a subset of this subcircuit in the trunk, the transcription factors Sox8, 
Tfap2b, and Ets1, was sufficient to alter the fate and identity of trunk neural crest into 
“cranial-like” cells. The altered identity was assessed by testing the ability of the trunk 
neural crest cells to activate Sox10e2, an enhancer that governs the expression of Sox10 
selectively in the migratory cranial neural crest cells (Betancur et al., 2010). To investigate 
the effect on trunk neural crest cell fate, they transplanted cells expressing the three 
factors from GFP donor embryos into wild-type chick embryos. Following incubation until 
embryonic day 7, they observed that cells transfected with the cranial neural crest-specific 
subcircuit had successfully differentiated into chondrocytes. The control group, on the 
other hand, did not form any part of the cartilage, suggesting that expression of the three 
transcription factors was sufficient to drive the population of the trunk neural crest towards 
a craniofacial derivative fate.  
2.5 Multipotent or fate-restricted?  
The advent of vertebrates has been suggested to overlap with the appearance of 




Gee, 1997; Glenn Northcutt, 2005), which contribute to the facial skeleton, cranial ganglia 
and sense organs. As the craniofacial skeleton and peripheral nervous system of the 
head are defining features of vertebrates, this suggests that the ability of neural crest cells 
to differentiate into a multitude of cell types played an important role in the evolution of 
vertebrates. This raises the intriguing question: how are neural crest cells able to 
differentiate into such diverse cell types? Over the last several decades, many 
hypotheses have been formulated to address this question. 
Multiple studies performed over the last three decades support the idea that the 
neural crest is a multipotent population with the ability to give rise to many or all potential 
derivatives. The first piece of evidence in vivo came from Bronner-Fraser and Fraser 
when they injected fluorescent Dextran molecules into individual trunk and cranial neural 
crest cells before their delamination and migration (Bronner-Fraser and Fraser, 1988; 
Serbedzija et al., 1994). They observed that the progeny of the injected cells were capable 
of differentiating into several cell types such as sensory neurons, Schwann cells, and 
melanocytes, thus suggesting that a part of the migratory trunk neural crest was 
multipotent. They also reported the possibility of a common precursor for both the central 
nervous system (neural tube) and the peripheral nervous system (neural crest). Around 
the same time, Baroffio et al. (1988) successfully cultured cranial neural crest cells 
obtained from quail embryos and reported that the cells exhibited a wide developmental 
potential, corroborating the in vivo results obtained by Bronner-Fraser and Fraser. In 
addition, other clonogenic culture studies of neural crest cells reported that their lineage 
decision was directly influenced by the growth factors used in the culture medium (Lahav 
et al., 1998).  
On the other hand, there is some evidence suggesting that the neural crest may 
be a heterogeneous mixture of fate-restricted cells. For example, Nitzan et al. (2013) have 
proposed that premigratory neural crest cells are unipotent and arranged in the dorsal 
neural tube in a spatiotemporal pattern in chick embryos that correlates with the 




It is important to note that the techniques used in the above-mentioned studies 
suffered from some major drawbacks. First, in vivo lineage tracing experiments using 
fluorescent Dextran only allowed for the characterization of neural crest derivatives based 
on visualization of a lineage marker that is transient and diluted with each cell division. 
Second, clonal analysis in vitro requires growing cells in a culture medium outside the 
context of the developing embryo. However, Baggiolini et al. (2015) used a confetti mouse 
model to trace neural crest cells and their derivatives in vivo, allowing them to achieve 
permanent lineage labeling at single-cell resolution and in an intact endogenous 
environment of the embryo. Using this model, they traced nearly 100 neural crest cells, 
both premigratory and migratory, and demonstrated that almost 75% of these cells gave 
rise to multiple derivatives comprising of the dorsal root ganglia, melanocytes, 
sympathetic ganglia, and Schwann cells. While they observed that a small proportion of 
the cells gave rise to a single derivative, the vast majority of the trunk neural crest cells 
were multipotent, suggesting that the neural crest is primarily a multipotent population 
and thereby confirming the work in chick embryos done by Bronner-Fraser and Fraser 
some 25 years earlier. 
2.6 Experimental strategies to study neural crest development 
Some of the earliest experiments performed in developmental biology relied on 
ablation and grafting experiments to decrypt the puzzle that was the developing embryo. 
After Wilhelm Roux first published his ablation technique, Hans Spemann used it to 
investigate the role of tissue interactions in eye development. At the time, the process of 
lens formation was not thoroughly understood. By destroying the optic vesicle before it 
associated with the overlying ectoderm, Spemann demonstrated the importance of the 
interactions between the optic vesicle and the ectoderm in inducing proper lens 
development.  
In the 19th century, the ablation technique was adapted to the chick embryo to 
address a diverse array of questions. It was through the ablation of the cardiac neural 




development was highlighted (Besson et al., 1986; Kirby and Waldo, 1995; Kirby et al., 
1985; Nishibatake et al., 1987). However, these experiments only revealed some of the 
developmental capabilities of the neural crest tissue. Moreover, it was difficult to conclude 
whether the presence or absence of structures after neural crest ablation indicated their 
site of origin. However, technical breakthroughs in biology have made it possible to 
address such questions in much finer detail. Here, we discuss some of the experimental 
techniques that are currently available to study neural crest development in chick 
embryos. 
2.6.1 Neural crest lineage tracing 
One of the biggest technical challenges in neural crest biology was the ability to 
distinguish a neural crest cell from its neighbors while it migrated through mesenchymal 
regions in the embryo. As a result, cell marking techniques that would allow investigators 
to trace individual cells were highly sought after. Radioactive labeling of nuclei with 
tritiated thymidine followed by transplantation of labeled tissue in a host embryo allowed 
Weston (1963) and Chibon (1967) to follow migration of these cells in avian and 
amphibian embryos, respectively (Chibon, 1967; Weston, 1963). The technique was soon 
adapted in a number of studies (Johnston, 1966; Noden, 1975, 1978; Weston and Butler, 
1966). However, the levels of tritiated thymidine diluted with each cell division event, 
making this technique appropriate for only short-term tracing of neural crest cells. 
Moreover, the method was also prone to giving false labeling of non-neural crest cells, as 
the radioactive label from a dead cell could spread to its neighbors. Therefore, it was 
important to look for alternative strategies for neural crest labeling. 
In the 1960s, Le Douarin devised the elegant quail-chick chimeras as a method to 
label cells and follow the long-term fate of neural crest cells, allowing her to trace neural 
crest pathways of migration and characterize their numerous derivatives (Le Douarin, 
1969, 1973). This technique was based on the difference in the heterochromatin state of 
chick and quail embryos, which could be labeled with a simple histological Feulgen stain. 




cells throughout the embryo, but also provided valuable insights into the extensive nature 
of neural crest derivatives. Using this approach, Douarin categorized the derivatives of 
the neural crest at different axial levels in chick embryos, leading to important 
observations regarding differences in properties of neural crest cells derived from different 
axial levels. 
To confirm these results using methods that did not require interspecies 
transplantation, the next generation of labeling methods made use of fluorescently 
labeled large molecules such as Lysinated Rhodamine Dextran (LRD) and vital dyes such 
as DiI (1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyamide perchlorate). While these 
labeling methods were still transient, they offered several advantages over radioactive 
labeling. For example, both LRD and DiI were not prone to leak, hence reducing false 
labeling of tissues surrounding neural crest cells. They both were transferred to their 
daughter cells for a few generations, allowing tracking of migration at single cell 
resolution, albeit for short intervals. Most importantly, using these dyes to label cells and 
track their migration within the same embryo circumvented the need for grafting labeled 
cells in a host embryo, making their application much simpler than their predecessors. 
These techniques were instrumental in demonstrating the multipotent nature of neural 
crest cells not only in avian embryos (Artinger et al., 1995; Bronner-Fraser and Fraser, 
1988; Lumsden et al., 1991; Serbedzija et al., 1989, 1990, 1994), but also in mammalian 
systems (Osumi-Yamashita et al., 1996). These labeling techniques gave valuable 
insights into the developmental potential of neural crest cells. However, given their 
transient nature, it was not possible to trace a single neural crest cell to the tissue to which 
it contributed later on during development. Hence, it was necessary to establish 
techniques that would not only allow labeling of single cells, but would also ensure long-
range tracking of their migratory pathway.  
With their ability to generate double-stranded DNA that stably integrate into the 
host cell genome, retroviruses offer an easy and effective alternative to classical cell 
labeling techniques described above. Replication Competent and Incompetent Avian 




progeny by expressing reporter genes through the viral promoter (Frank and Sanes, 
1991; Murai et al., 2015; Price et al., 1987; Sanes, 1989; Sanes et al., 1986). Injecting 
the viruses at different developmental stages at precise locations in the embryo allows 
spatiotemporal control over the labeling of neural crest cells at different axial levels. 
Pseudotyping the virus envelope protein ensures that the infection is limited to chicken 
cells. Moreover, these viruses have also been used to mis-express endogenous genes in 
neural crest cells (Eames et al., 2004).  
2.6.2 Crestospheres 
Methods employing in vitro culturing of neural crest cells were already established 
in the 1970s. However, it was not possible until very recently to successfully culture 
premigratory neural crest cells in their multipotent and self-renewal state (Cohen and 
Konigsberg, 1975). After they migrate from the neural tube, neural crest cells have a 
limited ability to self-renew for a few cell cycles (Stemple and Anderson, 1992; Trentin et 
al., 2004), and thus rapidly transit from stem cells to progenitor cells. However, more 
recently, Kerosuo et al. (2015) have successfully optimized conditions to culture 
premigratory neural crest cells as “crestospheres,” enabling long term self-renewal and 
retention of multipotency of the premigratory neural crest cells. 
Premigratory neural crest cells express a suite of neural crest specifier genes 
including FoxD3, Sox9, Snail2, and Sox10 (Simões-Costa and Bronner, 2015; Simões-
Costa et al., 2014). Kerosuo et al. (2015) tested various culture conditions that not only 
enabled proper expression of these transcription factors, but also promoted the 
maintenance of their self-renewal properties and stemness. Using a cocktail of growth 
factors that included epidermal growth factor, basic FGF, and RA, they found optimal 
conditions to culture premigratory neural crest cells in their multipotent state, as judged 
by the expression of neural crest marker genes in the cultured crestospheres. 
Interestingly, this medium also enabled culturing of crestospheres from entire neural tube 
tissue, suggesting that the correct proportion of growth factors supported culturing of 




maintained crestosphere cultures for as long as 5 weeks, albeit at a declining proliferation 
rate. By exposing them to specific differentiation media, they also demonstrated the 
differentiation potential of crestospheres into multiple neural crest derivatives. 
Taken together, this technique of in vitro culturing of premigratory neural crest cells 
offers an interesting model to study neural crest development. Not only can the 
crestospheres be used to answer questions about the stem-cell-like behavior of neural 
crest cells, but they can also be used to investigate the role of certain environmental cues 
in cell migration and differentiation. By culturing crestospheres from GFP transgenic chick 
embryos and transplanting them back into wild type embryos, one could study the 
developmental potential of neural crest cells at single-cell resolution. 
2.6.3 Antisense morpholinos 
The concept of using antisense oligonucleotides to study gene expression was first 
proposed almost 20 years ago (Baker and Monia, 1999; Crooke, 1999). The antisense 
technology relied on the understanding of nucleic acid structure and the underlying 
mechanisms governing their hybridization. Synthetic oligonucleotides designed following 
these principles were capable of inhibiting protein translation via three different pathways; 
first, by disrupting ribosome assembly at the targeted mRNA; second, by blocking splice 
junctions through direct hindrance; third, by recruiting RNase H enzymes that degrade 
the target mRNA through recognition of the synthetic oligonucleotide-mRNA duplex. 
While the specificity of these oligonucleotides was a cause for concern, subsequent 
structural and chemical modifications of the oligonucleotides made this a useful technique 
for knockdown studies in different model systems including Xenopus (Heasman et al., 
2000), zebrafish (Nasevicius and Ekker, 2000; Yang et al., 2001), and sea urchins 
(Howard et al., 2001). 
Antisense morpholino oligonucleotides were first implemented in avian embryos 
for gene knockdowns when Kos et al. (2001) demonstrated the role of FoxD3 in 
maintaining the neural crest-derived melanoblast lineage. Since then, the entire chick 




in neural crest development (Barembaum and Bronner, 2013; Basch et al., 2006; 
Betancur et al., 2010; Simões-Costa et al., 2015, 2012). Important controls for 
establishing specificity of morpholinos include rescue experiments and validating protein 
knockdown. However, given the disadvantages of using morpholinos, including rising 
concerns about non-specific effects (Gerety and Wilkinson, 2011), cost ineffectiveness, 
and inability to target non-coding regions, the community has turned to CRISPR/Cas9 
technology for more robust gene knockouts, which I will discuss in the next few chapters. 
2.7 Conclusions 
In this chapter, I have summarized aspects of the history of neural crest studies in 
avian embryos and fundamental principles underlying neural crest development. The 
neural crest is a stem-cell-like population of cells that is responsible for the emergence of 
craniofacial cartilage and bones in vertebrates, effectively parting them from invertebrate 
chordates. Through a network of transcription factors and signaling cascades, different 
segments of neural crest development are tightly regulated. Lineage tracing experiments 
in chicks (Bronner-Fraser and Fraser, 1988) are highly concordant with recent work in 
confetti mice, where Baggiolini et al. (2015) demonstrated that most of the cells are 
multipotent and hence are capable of differentiating into a diverse array of derivatives. I 
have also highlighted some of the most common experimental techniques that have been 
used to unfold the mystery of neural crest development and the gene regulatory network 
underlying different modules of neural crest development, such as induction, 
specification, migration, and differentiation. While we currently have a description of direct 
or indirect interactions between different neural crest transcription factors, several 
questions remain unanswered. For example, multiple mechanistic studies looking into 
these genetic interactions have posed questions about how non-coding RNAs such as 
lncRNAs, miRNAs, or piRNAs fit into the neural crest development paradigm. Addressing 
these questions will not only allow for the expansion of the neural crest gene regulatory 
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Gans and Northcutt’s “New Head” hypothesis proposed that emergence of the 
vertebrate lineage was accompanied by the advent of the neural crest, an embryonic stem 
cell population that arises within the forming central nervous system (CNS) in all 
vertebrates (Gans and Northcutt, 1983; Glenn Northcutt, 2005). These cells subsequently 
leave the CNS, migrate to diverse locations, and differentiate into many derivatives 
including peripheral ganglia and craniofacial skeleton (Le Douarin, 1982; Le Douarin and 
Smith, 1988). As vertebrates evolved, neural crest cells contributed to morphological 
novelties like jaws, that enabled the expansion of vertebrates.  
A pan-vertebrate neural crest gene regulatory network (GRN), invoking sequential 
deployment of signaling and transcriptional events, has been proposed to underlie 
formation of this unique cell type. Primarily studied at cranial levels, the core of the neural 
crest GRN is largely conserved across vertebrates, including the sea lamprey, 
Petromyzon marinus, a jawless (cyclostome) vertebrate. However, differences exist in 
utilization of key transcription factors, like Ets1 and Twist, which are deployed later in the 
lamprey GRN than in amniotes (Nikitina et al., 2008; Sauka-Spengler et al., 2007), 
suggesting regulatory differences between cyclostomes and gnathostomes. Furthermore, 
some neural crest derivatives are novelties of gnathostomes, such as jaws at cranial 
levels, a vagal-derived enteric nervous system, and sympathetic ganglia at trunk levels 
(Green et al., 2017; Häming et al., 2011). This raises the intriguing possibility that network 
differences in axial regionalization of the neural crest may have contributed to the 
presence of these gnathostome cell types.  
In jawed vertebrates, the neural crest is subdivided along the body axis into cranial, 
vagal, and trunk populations. In contrast, lamprey lack an intermediate vagal population, 
suggesting there are two major subdivisions: cranial and trunk (Le Douarin, 1982; Green 
et al., 2017). How axial identity in lamprey is controlled molecularly remains unknown. 
Avian embryos possess a “cranial-crest-specific” neural crest GRN subcircuit with ability 




Costa and Bronner, 2016). In this kernel, transcription factors Brn3c, Lhx5, and Dmbx1 
are expressed at the neural plate border and, in turn, activate expression of Ets1 and 
Sox8 in premigratory cranial neural crest [Figure 1A]. In contrast to their cranial-specific 
expression, Tfap2b and Sox10 are pan-neural neural crest genes expressed all along the 
body axis (Betancur et al., 2010).   
3.2 Results and Discussion 
3.2.1 Lamprey lacks a full cranial neural crest subcircuit 
Here, we assessed whether this cranial subcircuit is a general feature of 
vertebrates by examining whether lamprey possesses a homologous spatiotemporal 
regulatory state. Taking a candidate approach, we analyzed the expression of cranial 
circuit orthologues in lamprey embryos at different developmental stages. In contrast to 
Figure 1. Lamprey cranial neural crest lacks most components of a chick “cranial crest circuit.” a, Biotapestry 
model of cranial neural crest-specific gene regulatory circuit that drives skeletal differentiation in amniotes. b, 
Expression of lamprey orthologues of amniote cranial neural crest-specific genes at T21 and T23. Blue arrows, 
expression in the cranial neural crest (CNC); red arrows, expression in the trunk neural crest (TNC). c, Late expression 
of cranial neural crest-specific orthologues in pharyngeal arch neural crest derivatives (black arrow). d, Biotapestry 
model of the lamprey circuit with the addition of late module expression of markers in pharyngeal arch neural crest 





amniotes, our results show that Brn3, Lhx5, Dmbx1, and Ets1 appear to be absent from 
lamprey premigratory or migratory neural crest [Figure 1B]. The lack of most cranial-
specific regulatory factors suggests a high degree of divergence between early regulatory 
states of lamprey and amniote neural crest. In contrast, lamprey SoxE1 and Tfap2 were 
robustly expressed in premigratory and migratory neural crest along the entire body axis 
[Figure 1B, Supplementary Figure 1A-D]. No SoxE family member was restricted in 
expression to the cranial neural crest as is Sox8 in amniotes. Of note, lamprey SoxE 
transcription factors are homologous to gnathostome Sox8/9/10, and there is variation in 
SoxE paralog usage across gnathostomes (Haldin and LaBonne, 2010; Lee et al., 2016; 
McCauley and Bronner-Fraser, 2006). Consistent with the lack of restricted cranial-
specific expression, ectomesenchymal derivatives have been previously reported as 
present at trunk levels in the lamprey dorsal fin (Häming et al., 2011).  
How then did this regulatory subcircuit evolve? Intriguingly, genes from the cranial 
crest subcircuit are present in the genome and expressed later in pharyngeal arches 
populated by neural crest cells [Figure 1C,D, Supplementary Figure 1E-L]. An intriguing 
possibility is that these genes were expressed only in late neural crest derivatives of early 
vertebrates, followed by gradual co-option of components of this regulatory program to 
earlier developmental stages in gnathostomes. According to this scenario, genes involved 
in neural crest differentiation in early vertebrates were co-opted to the specification 
program of gnathostomes at all axial levels. With subsequent regulatory modifications, 
they became cranially restricted, possibly endowing the cranial neural crest with novel 
morphogenetic features while the trunk neural crest lost ability to make cranial-like 
derivatives (Green et al., 2015; Martik and Bronner, 2017).  
3.2.2 Skates add Ets1 to the cranial neural crest subcircuit 
To explore this possibility, we examined candidate elements of the cranial neural 
crest subcircuit in the little skate Leucoraja erinacea, a Chondricthyan gnathostome 
outgroup to the bony fishes. Of the SoxE genes, expression of Sox9 and Sox10, as well 




[Figure 2A, Supplementary Figure 2]. Since Ets1 appears in the little skate migratory 
neural crest as in other gnathostomes, we conclude that this early node was a novelty 
acquired by the cranial neural crest GRN prior to divergence of cartilaginous and bony 
fishes [Figure 2A,B, Supplementary Figure 2]. Later, after neural crest cells migrated to 
and populated the pharyngeal arches, SoxE, Tfap2b, and Ets1 were present within the 
arches [Supplementary Figure 3]. Trunk neural crest in the little skate produces 
ectomesenchymal dermal denticles, “cranial-like” derivatives, consistent with our 
observation that cranial subcircuit genes in the little skate are not restricted to the head 
but can drive differentiation of skeletogenic derivatives in the trunk (Gillis et al., 2017). In 
the fossil record, many stem-gnathostomes possessed extensive dermal armour, which 
has been retained, albeit with the dental component reduced and modified, within the 
Figure 2. Nodes of an early cranial-specific circuit were acquired in and restricted to the cranial neural crest 
progressively throughout gnathostome evolution. a, Expression of cranial neural crest-specific orthologues in the 
little skate at stages (S) 17 and 18. Blue arrow, expression of orthologues in the cranial neural crest; red arrows, 
expression of orthologues in the trunk neural crest. b, Biotapestry model of the skate circuit with the addition of a novel 
node, Ets1. c, Expression of cranial neural crest-specific orthologues in the zebrafish at 5–9 somite stage (ss) and 
14ss. d, Biotapestry model of the zebrafish circuit with the addition of novel early nodes, lhx5 and dmbx1. FB/MB, 
forebrain/midbrain; St, stomodeum. Scale bars, 250 µm. For skates, in situ hybridizations were reproducible on n ≥ 2 
embryos for n ≥ 2 experiments. For zebrafish, in situ hybridizations were reproducible on n ≥ 5 embryos per time point 





gnathostome crown group (e.g. dermal denticles of chondrichthyans; dentinous scales 
of Polypterus and coelacanth). Thus, dental tissues in the post cranial dermal skeleton 
appear to be ancestral for gnathostomes.  
3.2.3 Further elaboration of the neural crest subcircuit 
Interestingly, in the teleost Danio rerio, lhx5 and dmbx1 are present in the early 
cranial circuit but absent from later pharyngeal arch derivatives [Figure 2C,D, 
Supplementary Figure 4, Supplementary Figure 5]. In addition, sox8b, sox10, tfap2a, and 
ets1 are present in premigratory and migratory crest at all axial levels, though brn3c is 
missing [Figure 2C, Supplementary Figure 4]. Rather than restricted to the cranial crest, 
many of these factors also are present in the zebrafish trunk, raising the possibility that 
resolution of axial level potential may have arisen within sarcopterygians. Furthermore, in 
situ analysis of pharyngeal arch derivatives in both little skate and zebrafish lend support 
to temporal shifts of cranial specific regulatory nodes from later neural crest derivatives 
to an early specification program. With progressive loss of nodes from late derivatives 
and addition to an earlier program, this suggests that regulatory modifications arose 
gradually throughout gnathostome evolution [Supplementary Figure 1M].  
3.2.4 Lamprey cranial neural crest is more trunk-like 
Our candidate gene approach suggests that extensive changes occurred in the 
neural crest regulatory state between jawless and jawed vertebrates. To investigate 
further, we conducted a comparative transcriptome analysis of cranial and trunk neural 
crest subpopulations in lamprey and chicken [Figure 3]. Premigratory lamprey neural 
crest was obtained by microdissecting segments of cranial and trunk dorsal neural tubes 
at stages T21 and T23.5. For chick, premigratory neural crest populations were isolated 
using enhancers driving eGFP expression in cranial or trunk neural crest populations for 
FACS at stages HH9+ and HH18, respectively. After cDNA library preparation and 
sequencing, differential expression analysis revealed far fewer genes (1233 genes in 
lamprey compared with 2794 in chicken) significantly enriched in lamprey cranial versus 






Figure 3. Tissue-specific RNA-seq comparisons between lamprey and chicken reveal that the ancestral neural 
crest had a more trunk-like identity. a, Volcano plot showing lamprey differential enrichments of cranial (blue) and 
trunk (red) genes by population RNA sequencing (RNA-seq; 100 embryos were dissected for each of n = 2 biological 
replicates; adjusted P < 0.05). b, Volcano plot showing enrichment of genes in the cranial (blue) versus the trunk (red) 
neural crest in chicken (≥15 heads and 5 trunks were dissected and prepared for FACS for each of n = 3 biological 
replicates; adjusted P < 0.05). c, Hierarchical clustering analysis of all RNA-seq libraries focused on the neural crest 




To better understand how each library correlated to the others in an unbiased 
fashion, we mapped each to a common reference transcriptome, created by aligning 
proteomes using BLAT and compiling matching sequences as a consensus alignment 
between species for Bowtie mapping. We next performed hierarchical clustering analysis 
of all known neural crest GRN genes [Figure 3C]. Consistent with our previous in situ 
hybridization analysis [Figure 1B], Tfap2 was enriched at all axial levels in both chicken 
and lamprey [Figure 3C’]; Sox8 was enriched in chicken cranial neural crest but was in 
both cranial and trunk lamprey populations [Figure 3C’’]. Dmbx1 and Ets1 were enriched 
in chick but not lamprey cranial datasets [Figure 3C’’’].  
 
Figure 4. Model of the evolution of neural crest axial levels during vertebrate evolution. a, Our data suggest 
that the ancestral neural crest was a more uniform population of cells along the body axis that underwent gradual 
regulatory modifications during gnathostome evolution. b, Progressive restriction of the “cranial circuit genes” to the 




Interestingly, we found that lamprey cranial populations correlated more closely to 
chicken trunk than lamprey trunk libraries, suggesting that basal neural crest was “trunk-
like” in its regulatory program [Figure 3C]. These results suggest that cyclostomes 
possess a simpler and more trunk-like cranial crest GRN, with potentially important 
implications for evolution of neural crest subpopulations [Figure 4A]. Accordingly, we 
speculate that the ancestral neural crest may have been relatively homogeneous and 
trunk-like. Throughout evolution of the vertebrate lineage, we propose that key 
transcription factors were progressively co-opted into an early, cranial-restricted circuit, 
whereas some features like skeletogenic potential were lost from the trunk. 
These differences in axial-specific genes contrast with the deep conservation of 
the pan-neural crest program (Sauka-Spengler and Bronner-Fraser, 2008; Sauka-
Spengler et al., 2007). Transcription factors like SoxEs, Tfap2, and Id may be the rudiment 
of a larger, more complex cranial crest GRN that was expanded during early vertebrate 
evolution with incorporation of novel players such as Dmbx1, Brn3c, Ets1, and Lhx5. 
Consistent with these findings, the basal chordate Amphioxus lacks expression at the 
neural plate border of genes like Dmbx, Brn3, Ets, as well as core neural crest genes like 
SoxE, FoxD, Tfap2, and Id, although these genes are expressed in other tissues 
(Meulemans and Bronner-Fraser, 2002; Takahashi and Holland, 2004; Wada et al., 2005; 
Yu et al., 2008). Our observations also show that some of these “novel” genes are 
expressed at later stages of neural crest formation, consistent with the possibility that 
elaboration of the GRN might have involved co-option of parts of differentiation programs 
to earlier portions of the network perhaps by acquisition of new regulatory elements 
responsible for their heterochronic shift (Davidson and Erwin, 2006). Thus, the pan-neural 
crest program was likely the ancestral molecular recipe to make neural crest, with the 
subsequent elaboration of axial-specific regulatory programs conferring important 
differences in developmental potential along the body axis. Given that many key neural 
crest derivatives are gnathostome innovations, we hypothesize that gain of these 
derivatives may be due to gene regulatory differences associated with axial-specific 





Taken together, our results suggest the following scenario to explain the evolution 
of neural crest subpopulations [Figure 4]. We suggest that the neural crest of early 
vertebrates was uniform and similar to amniote trunk populations, and that the division of 
the neural crest into cranial and trunk subpopulations occurred early in vertebrate 
evolution [Figure 4A]. Consistent with evolutionary expansion of neural crest cells in the 
vertebrate lineage, our molecular analysis of the cranial neural crest reveals surprising 
differences in lamprey compared with gnathostome counterparts [Figure 4B]. Given that 
the Hox code was already linked to segmentation of the CNS in basal vertebrates, 
posteriorizing influences of Hox genes and other factors may be sufficient to account for 
the subtle transcriptional differences observed between these two populations (Parker et 
al., 2014, 2016). We cannot rule out the possibility that cyclostomes lost neural crest 
subpopulations during the course of evolution. However, the relative scarcity of cranial-
specific factors in the lamprey cranial crest might suggest that the gnathostome cranial 
neural crest GRN has undergone extensive elaboration from a regulatory standpoint. 
Thus, we propose that regionalization of the neural crest, with both emergence of new 
subpopulations and expansion of the cranial crest GRN, played a crucial part in vertebrate 
evolution as a key element for driving evolution and expansion of gnathostomes. 
What does this mean for the “New Head” hypothesis? We posit that the neural 
crest component of the New Head, rather than arising in toto at the base of vertebrates, 
underwent continued regulatory modifications, evolving gradually during the course of 
vertebrate evolution. Our data suggest that early vertebrates possessed a relatively 
simple neural crest that initially arose as a fairly uniform population along the body axis 
and lacked region-restricted regulatory programming. During gnathostome evolution, the 
cranial neural crest appears to have gained regulatory complexity that modulated 
differentiation capacity, gaining some individual cell fates while restricting others. We 
propose that co-option of distinct genes into a cranial-specific module enabled this 
progressive specialization of neural crest regulatory programs, leading to unique axial 
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3.7 Materials and methods 
3.7.1 Animal husbandry and embryo collection 
 Adult sea lamprey were obtained from the US Fish and Wildlife Service and 




protocols and staged according to Tahara staging methods (McCauley and Bronner-
Fraser, 2006; Nikitina et al., 2009). All lamprey embryology work was completed in 
compliance with California Institute of Technology Institutional Animal Care and Use 
Committee (IACUC) protocol 1436. Skate eggs were obtained by the Marine Biological 
Laboratory (MBL) Marine Resource Center, and embryos were cultured as previously 
described (Gillis et al., 2017). All skate embryology work was compliant with animal 
protocols approved by the IACUC at the MBL. Adult zebrafish were maintained in the 
Beckman Institute Fish Facility at Caltech, and all animal and embryo work was compliant 
under approved IACUC protocol 1346. Fertilized chicken eggs were obtained from a local 
farm in Sylmar, CA. 
3.7.2 Cloning of lamprey, skate, and zebrafish orthologues 
 RNA was extracted from desired embryo stages using the RNAqueous-Micro Kit 
(Thermo Fisher Scientific), and cDNA was synthesized using a SuperScript III Reverse 
Transcriptase Kit (Invitrogen). Gene specific primers were used to amplify probe template 
sequences found from transcriptome datasets. Nucleotide sequences were annotated 
and deposited on Genbank (BioProject # PRJNA497902). 
3.7.3 In situ hybridization of lamprey, skate, and zebrafish embryos, sectioning, 
imaging, and biotapestry modeling 
 Whole mount in situ hybridization was performed using previously published 
protocols (Gillis et al., 2017; Green et al., 2017; Longabaugh et al., 2005; Simões-Costa 
et al., 2012). Cryosections of lamprey, skate, or zebrafish embryo in situs were sectioned 
at 18 µm with a Microm HM550 cryostat. In situ analysis of S25 skate embryos sections 
was performed using paraffin sections as follows: After fixation, embryos were embedded 
in paraffin and sections were prepared at 5 (skate) or 10µm (lamprey) thickness on a 
Zeiss microtome. After paraffin removal with histosol, sections were hybridized with 1ng/µl 
anti-sense digoxygenin-labelled probes overnight at 70°C in a humidifying chamber. After 
hybridization, sections were washed with 50% formamide/50% 1X SSCT buffer followed 




then incubated overnight at room temperature with a 1:2000 dilution of anti-DIG-Alkaline 
Phosphatase antibody (Roche). After several washes with MABT, chromogenic color was 
developed using NBT/BCIP precipitation (Roche). Imaging was performed on a Zeiss 
AxioImager.M2 equipped with an Apotome.2. Gene network models were assembled 
using Biotapestry (Longabaugh et al., 2005).  
3.7.4 Chicken embryo electroporation, dissociated, and cell sorting 
Cranial and trunk neural crest cells were labeled using previously published neural 
crest enhancers FoxD3-NC1.1 and FoxD3-NC2, respectively (Simões-Costa et al., 2012). 
To isolate cranial neural crest cells, stage Hamburger Hamilton (HH) 4 embryos were 
bilaterally electroporated with FoxD3-NC1.1>eGFP and cultured ex ovo until stage HH9+ 
(Hamburger and Hamilton, 1951). For each biological replicate, at least 15 embryo heads 
were dissected in Ringers and washed thrice in chilled 1x PBS. For trunk neural crest 
cells, stage HH10 embryos were bilaterally electroporated with FoxD3-NC2>eGFP and 
cultured in ovo until stage HH18. Based on the expression of the reporter, five embryo 
trunks spanning the length of five somites were dissected in Ringers and washed thrice 
in chilled 1x PBS. The tissues were dissociated in Accumax (Innovative Cell 
Technologies, Inc.) for 15 minutes at 37ºC and GFP+ cells were collected using 
Fluorescence Activated Cell Sorting. 
3.7.5 Library preparation and sequencing 
Chicken libraries were prepared using the SMART-Seq Ultra Low Input RNA Kit 
(Takara) according to the manufacturer’s protocol. For lamprey embryos, tissue was 
dissected from the cranial dorsal neural tubes of T21 and trunk neural tube of T23.5 
embryos. Total RNA was extracted using the RNAqueous kit (Ambion). RNA-seq was 
performed at 50 million reads on 2 biological replicates for both the T21 cranial and T23.5 
trunk neural tube samples. Sequencing libraries were built according to Illumina standard 
protocols. SR50 sequencing was performed in a HiSeq Illumina machine. Databases 




3.7.6 Statistical analysis of lamprey and chicken axial population RNA-seq 
To identify orthologous genes between lamprey and chicken, the lamprey 
proteome obtained from SIMRbase (Smith et al., 2018) was aligned to the chicken 
proteome using the BLAT alignment software available on the UCSC genome browser 
(Karolchik et al., 2003; Kent, 2002). Briefly, every lamprey protein sequence was locally 
queried against the chicken proteome, following which regions with the longest alignment 
were matched to the respective chicken gene. Using this alignment-based approach, 
proteins with an alignment percentage score between 52-100 were identified as 
orthologues, and their respective cDNA sequences were obtained from the chicken and 
lamprey databases. Chicken cranial and trunk libraries were aligned to the chicken 
sequences, while the lamprey cranial and trunk libraries were aligned to the lamprey 
sequences using Bowtie2 (Langmead and Salzberg, 2012). Transcript counts were 
calculated using HTSeq-Count and differential gene expression analysis was performed 
using DESeq2 (Anders et al., 2015; Love et al., 2014). Using chicken gene annotations 
as a reference, we added the transcript counts for duplicated orthologues found in the 
lamprey genome to calculate an “aggregated” transcript count for each gene. These 
aggregated transcript counts were then normalized using the formula: 
𝑍! =
𝑇! −min	(𝑇)
max(𝑇) − min	(𝑇) 
where Zi – Normalized transcript count, 
 Ti – Absolute transcript count. 
A subset of genes previously identified as being part of the neural crest gene regulatory 
network (Martik and Bronner, 2017) was then isolated from the count matrix and plotted 






3.7.7 Data and code availability 
 All sequencing data is available online (NCBI BioProject# PRJNA497902). 
Sequences of in situ probe templates for Figures 1B, 1C, 2A, and 2C are available through 
this BioProject. All raw sequencing files for all RNA-seq libraries [Figure 3] are available 
through this BioProject as well. Code used to analyze sequencing datasets is available 
from the corresponding author upon request.  
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Supplementary Figure 1. Heterochronic shifts of cranial specific gene regulatory nodes from later neural crest 
derivatives to an early specification program happened gradually throughout gnathostome evolution. a-d, 
Expression of lamprey orthologues of amniote cranial specific genes at T21 (cranial) and T23 (trunk) in cross-section. 
e, Pharyngeal neural crest derivative expression in Tahara stage 26 Petromyzon marinus frontal section (illustration 
based on (Damas, 1944)). f-l, Cranial circuit orthologues are expressed in pharyngeal arch derivatives, with the 
exception of Brn3 which is present in the neural crest-derived cranial sensory ganglia (Modrell et al., 2014) in lamprey 
frontal sections. m, Gene expression matrix summarizing the heterochronic shift of cranial crest specific circuit nodes. 


















Supplementary Figure 2. Expression of cranial circuit genes in the neural crest of the little skate. a, Schematic 
of a stage 18 Leucoraja erinacea embryo with the neural crest illustrated as blue (cranial) and red (trunk). b-f, Cross-





Supplementary Figure 3. Pharyngeal neural crest derivative expression of cranial circuit orthologues in stage 
25 Leucoraja erinacea embryos. a, Dashed box on the illustration represents the region of the head for each embryo 
imaged in figures b-i, and the purple dashed line depicts the location of the frontal section for figures a’-i’. b-f’, 
Pharyngeal neural crest derivative expression of cranial circuit orthologues. g-i', Dmbx1, Lhx5, and Brn3c are absent 









Supplementary Figure 5. Expression of cranial circuit orthologues in pharyngeal neural crest derivatives of 
3dpf Danio rerio embryos. a, Schematic of head of zebrafish embryo at 3 days post fertilization (dpf). Purple dashed 
line depicts the location of the frontal sections for the insets in e–h. e–h, Expression of cranial circuit orthologues in 
pharyngeal arches. b–d, Dmbx1, Lhx5, and Brn3c are absent from pharyngeal arch derivatives at 3 dpf. Scale 
bar, 150 µm.  
Supplementary Figure 4. Expression of cranial circuit genes in the neural crest of the zebrafish. a, Schematic 
of a 14ss D. rerio embryo with the NC illustrated as blue (cranial) and red (trunk). b–h, Cross-sections as shown in a. 









CRISPR-Cas9-mediated gene knockouts in avian embryos 
A modified version of this chapter was published as: 
Gandhi, S., Piacentino, M.L., Vieceli, F.M., and Bronner, M.E. (2017). Optimization of 
CRISPR/Cas9 genome editing for loss-of-function in the early chick embryo. Dev. Biol. 







Chick embryos have long been used as a model organism to address important 
questions in developmental biology due to their accessibility to transplantation, surgical 
ablations, and other genetic perturbations. This has allowed researchers to regulate gene 
expression in a spatiotemporally controlled manner at diverse stages of development 
(Darnell and Schoenwolf, 2000; Streit et al., 2013). Traditionally, loss-of-function 
experiments have utilized anti-sense morpholinos (Corey and Abrams, 2001), dominant-
negative constructs, or shRNAs (Sauka‐Spengler and Barembaum, 2008). However, 
these techniques are transient, becoming diluted by cell proliferation during development, 
and there have been increasing concerns regarding possible lack of specificity due to 
either off-target effects or reagent toxicity (Eisen and Smith, 2008; Gerety and Wilkinson, 
2011; Kok et al., 2015; Schulte-Merker and Stainier, 2014).  
One alternative to these approaches is CRISPR-Cas9 (Clustered Regularly 
Interspaced Short Palindromic Repeats/CRISPR-Associated protein 9), a revolutionary 
technology that has enabled efficient knockout of target genes across a wide range of 
model organisms (Cong et al., 2013; Dickinson et al., 2013; Gagnon et al., 2014; Ren et 
al., 2014; Stolfi et al., 2014). CRISPR-Cas9 involves the formation of a complex between 
guide RNA (gRNA) and Cas9, an endonuclease enzyme derived from Streptococcus 
pyogenes, which then binds to specific targets in the genome. Once bound to genomic 
DNA, this complex introduces double-stranded breaks that are imperfectly repaired by 
Non-Homologous End Joining repair enzymes, often leading to a frame-shift insertion or 
deletion, and subsequent truncation and/or degradation of the target transcript (Jinek et 
al., 2012; Qi et al., 2013; Sternberg et al., 2014). Specificity is achieved through Watson-
Crick base pairing between the protospacer domain of the gRNA and the target locus in 
the genome, together with recognition of a Protospacer Adjacent Motif (PAM) by Cas9. 
Not only does CRISPR-Cas9 offer high spatiotemporal specificity (Stolfi et al., 2014), but 
it also enables investigation of the roles of non-coding genetic elements such as 
enhancers and insulators in regulating gene expression during development (Diao et al., 




In spite of all its advantages, the CRISPR-Cas9 system has not been fully 
optimized for application in chick embryos. Early attempts at implementation in avian 
embryos employed a tetracycline-inducible Cas9 system to perform gene editing of Pax7 
using Tol-2 mediated integration at stages after neural tube closure (Véron et al., 2015).  
While useful, this approach functioned at low efficiency, particularly at early 
developmental stages (Bai et al., 2016; Oishi et al., 2016; Véron et al., 2015). Since then, 
several studies performed in other model systems have reported optimizations of 
individual CRISPR-Cas9 components, improving our understanding of this gene-editing 
technology (Chen et al., 2013; Doench et al., 2016; Gandhi et al., 2017; Port et al., 2014; 
Ren et al., 2014).  
To extend the usefulness of this technique to the early chick embryo, we have 
adapted an optimized CRISPR-Cas9 system for efficient genome editing by implementing 
three modifications. First, we used a previously characterized Cas9 protein flanked with 
two nuclear localization sequences (NLS) for enhanced compartmentalization in the 
nucleus (Chen et al., 2013; Stolfi et al., 2014). Second, we used a modified gRNA “F+E” 
scaffold that has been shown to resolve issues including premature termination of RNA 
Polymerase-III-mediated transcription of the gRNA cassette and unstable interaction 
between Cas9 protein and transcribed gRNA (Chen et al., 2013; Orioli et al., 2011). Third, 
we improved gRNA expression by using a chick-specific U6 promoter that outperforms a 
human U6 promoter in chick embryos (Cong et al., 2013; Kudo and Sutou, 2005; Wise et 
al., 2007).  
In the present study, we demonstrate the efficiency of this improved CRISPR-Cas9 
system by performing functional testing in the avian neural crest. The neural crest is a 
multipotent cell population that originates at the neural plate border, then migrates 
extensively throughout the embryo to give rise to numerous cell types (Le Douarin and 
Kalcheim, 1982; Green et al., 2015; Simões-Costa and Bronner, 2015). We test the ability 
of our optimized CRISPR-Cas9 system to knock out key transcription factors in the neural 
crest, including the neural plate border specifier Pax7 (Basch et al., 2006), and the neural 




our CRISPR-Cas9 system is robust and reproducible as a means for knocking out genes 
of interest in chicken embryos.    
4.2 Results and Discussion 
4.2.1 Optimizing CRISPR-Cas9 components for application in chick embryos 
As a first step, we cloned a previously published human codon-optimized spCas9 
(Qi et al., 2013) flanked with an NLS sequence on both the N- and C-terminus under the 
regulation of the chicken beta-actin promoter (CAGG) (Alexopoulou et al., 2008) to ensure 
optimal nuclear localization of Cas9 protein in vivo [Figure 1A]. It was previously shown 
that two NLS sequences are necessary for proper nuclear localization of Cas9 protein 
(Chen et al., 2013). Co-electroporation of Cas9 (CAGG>nls-Cas9-nls) with CAGG>H2B-
RFP and a control gRNA (U6.3>Control.gRNA.f+e), followed by immunostaining for Cas9 
protein, demonstrated effective nuclear localization in transfected cells [Figure 1B-D]. 
Second, we cloned all protospacer sequences targeting genes of interest in a previously 
modified gRNA ‘F+E’ scaffold [Figure 1E] that contains a “flipped” (F) Adenine-Uracil pair 
downstream of the protospacer domain and an “extended” (E) Cas9 stem handle (Chen 
et al., 2013). These modifications were shown to improve RNA polymerase III-mediated 
gRNA transcription by minimizing the possibility of premature termination of transcription, 
as well as stabilize the interaction between Cas9 protein and the transcribed gRNA, 
respectively (Chen et al., 2013; Stolfi et al., 2014). Third, we tested different RNA 
Polymerase III-mediated promoters for their ability to drive gRNA expression in 
transfected cells in vivo. Although most CRISPR knockout experiments performed in 
mammalian systems have used a human U6 promoter to govern gRNA expression (Jinek 
et al., 2013; Mali et al., 2013; Wang et al., 2014), species-specific U6 promoters have 
been used in non-mammalian model organisms such as zebrafish, Ciona, and Drosophila 
(Ablain et al., 2015; Nishiyama and Fujiwara, 2008; Port et al., 2014).  To that effect, we 
directly compared gRNA expression levels mediated by the standard human U6 (hU6) 





To this end, we electroporated the right side of gastrulating chick embryos at 
Hamburger Hamilton stage 4 (HH4) (Hamburger and Hamilton, 1992) with different U6-
variant>bCat.gRNA.f+e.NoTermGFP constructs [Figure 1F; see Materials and methods 
for details], and allowed embryos to develop until stage HH9-10. A reporter (CAGG>H2B-
RFP) was co-electroporated to normalize electroporation variability between embryos. 
Figure 1. Optimizing individual CRISPR-Cas9 components for application in chick embryos. A. Schematic of 
the Cas9 construct used in this study. Cas9 flanked with two Nuclear Localization Signal (NLS) sequences was cloned 
under the regulation of the chicken beta actin promoter (CAGG). B-D. Gastrulating Hamburger Hamilton stage HH4 
embryos co-electroporated with CAGG>nls-Cas9-nls, U6.3>Control.gRNAf+e, and CAGG>H2B-RFP, cultured ex ovo 
until stage HH9, and immunostained for Cas9 demonstrate efficient nuclear localization of Cas9 protein. Dotted line 
represents the midline of the neural tube. E. Pax7.1 protospacer was cloned into a modified “F+E” scaffold. “F” (flip) 
modification is marked in red, “E” (extension) modification is marked in blue. Watson-Crick base pairing between the 
protospacer (highlighted in orange) and the target DNA strand is also shown. F. Design for the U6 promoter 
optimization assay. Human and chicken U6 promoters were tested for their ability to drive expression of a modified 
gRNA cassette in which the terminator domain was replaced with GFP (see Materials and methods for details). 
Transcripts synthesized through RNA Polymerase III-mediated transcription included the entire GFP sequence, which 
was then used for qualitative (in situ hybridization) and quantitative (qRT-PCR) assessment of promoter efficacy. DIG 
– Digoxigenin. G-H. The right side of stage HH4 chicken embryos was electroporated with the construct described in 
F. The embryos were cultured ex ovo until stage HH9-10, after which they were fixed and processed for in situ 
hybridization against GFP. The signal obtained in embryos electroporated with the chicken U6 promoter construct 
(n=3) was stronger than in embryos electroporated with the human U6 promoter construct (n=3). Dotted line 
represents the midline of the embryo. I. qRT-PCR primers specific to GFP were used to quantify the 4-fold increase 
in activity of the chicken U6 promoter relative to the human counterpart (n=3 for each group). Error bars represent 




Using in situ hybridization against GFP, we observed increased gRNA transcription with 
the chicken U6.3 promoter variant compared with the hU6 promoter [Figure 1G-H]. After 
isolating RNA and reverse-transcribing cDNA from three biological replicates 
electroporated with the two variants, we performed quantitative RT-PCR (qRT-PCR) 
using primers specific to GFP.  The results confirmed our in situ hybridization analysis, 
showing that the chicken-specific U6.3 promoter resulted in a 4-fold increase in gRNA 
transcription compared to a human U6 promoter used in previous studies [Figure 1I]. The 
chicken U6.3 promoter variant also outperformed an additional chick U6 promoter (data 
not shown), demonstrating that intra-species variability should be considered when 
selecting promoters to drive expression of small RNA molecules. Taken together, our 
results identify chicken-specific U6.3 promoter as an improvement over previously used 
human U6 promoters for gRNA transcription, and highlight the importance of U6 promoter 
selection for subsequent loss-of-function studies. 
In addition to improving the U6 promoter for delivery of gRNA, we incorporated a 
screening step into our gRNA design strategy to help eliminate the possibility of off-target 
effects. Multiple groups have previously highlighted design principles that correlate 
directly with the activity of the gRNA in vivo (Cho et al., 2014; Gandhi et al., 2017; Tsai et 
al., 2015). To simplify our gRNA design, we considered these principles and employed 
the MIT CRISPR program (http://crispr.mit.edu) for initial target site selection. When 
presented with multiple protospacer sequences, those with high scoring alignments 
outside the desired locus were discarded. As such, all gRNAs used for functional analysis 
in this study were designed to avoid off-target gRNA sites, thereby minimizing non-
specific effects. 
4.2.2 CRISPR-Cas9-mediated knockout of key neural crest genes         
To establish proof of principle, we first used our optimized CRISPR system to 
target the transcription factor Pax7 in chick embryos. Pax7 is one of the earliest markers 
of the neural plate border, and its loss using a translation-blocking morpholino results in 




et al., 2006; Labosky and Kaestner, 1998; Simões-Costa and Bronner, 2015; Simões-
Costa et al., 2012). We designed a gRNA targeting the splice acceptor site of the second 
exon of Pax7 [Figure 2A] and expressed it under the regulation of the optimized chicken 
U6.3 promoter (U6.3>Pax7.1.gRNAf+e).  
 




To confirm CRISPR-mediated genomic editing at the desired locus, we co-
electroporated U6.3>Pax7.1.gRNAf+e along with CAGG>nls-Cas9-nls and CAGG>H2B-
RFP bilaterally, and harvested embryos at stage HH10. Embryos were dissociated to 
isolate RFP+ cells by flow cytometry, which were then used to prepare genomic DNA for 
genotyping. The target locus was PCR-amplified and sequenced to identify CRISPR-
induced mutations. As expected, a range of different insertion (red) and deletion (gray) 
mutations were identified in the gRNA target sequence [Figure 2B], demonstrating that 
the Cas9 protein used in this study can induce targeted genomic mutations. We next co-
electroporated the Pax7-targeting gRNA (U6.3>Pax7.1.gRNAf+e) along with CAGG>nls-
Cas9-nls and CAGG>H2B-RFP on the right side of gastrulating stage HH4 embryos, and 
then cultured these until developmental stage HH9+ [Figure 2C]. The left side was 
electroporated with a control gRNA that has no recognition sites in the chick genome 
(U6.3>Control.gRNAf+e) and served as an internal control. Immunostaining using a Pax7 
antibody revealed downregulation of Pax7 protein level on the side electroporated with 
Pax7.1 gRNA compared to the control side [Figure 2D], consistent with the anticipated 
splicing errors and/or frame shifts following Cas9-induced mutations. When overlaying 
RFP and Pax7 channels, we observed that all cells that were successfully transfected 
Figure 2. CRISPR-Cas9-mediated knockout of Pax7. A. (Top) The G. gallus Pax7 gene contains 12 exons (black 
solid boxes). (Bottom) Nucleotide sequence surrounding the splice junction of exon 2 with the Protospacer Adjacent 
Motif (PAM) marked in red, and the Pax7.1.gRNA protospacer sequence highlighted with a red bar. B. Genotyping of 
Pax7 knockout cells isolated from HH10 chicken embryos following electroporation of Pax7-targeting CRISPR 
reagents identified multiple mutations that would result in a splicing error or frameshift in the predicted protein. C. 
Stage HH4 embryos were electroporated with U6.3>Control.gRNAf+e and U6.3>Pax7.1.gRNAf+e on the left and right 
side, respectively, along with CAGG>nls-Cas9-nls and CAGG>H2B-RFP on both sides, then cultured ex ovo until 
stage HH10. Dotted line represents midline of the neural tube. D. CRISPR-Cas9-mediated knockout of Pax7 resulted 
in a dramatic decrease in Pax7 protein level as assessed by immunostaining (n=21/21). E. Overlay of RFP (red) and 
Pax7 (green) channels revealed that all RFP+ (solid arrowhead) cells were Pax7-, indicating that all transfected cells 
lost Pax7 protein. Conversely, untransfected cells (E’, E’’) retained endogenous Pax7 expression (empty arrowhead), 
suggesting that the protein levels in transfected cells on the right side of the embryo were lost as a result of CRISPR-
Cas9-mediated activity. F. Embryos were cultured until stage HH10 and immunostained for migratory neural crest 
expression of HNK1. HNK1 levels on the Pax7 knockout side were considerably reduced compared to the internal 
control, consistent with the role of Pax7 upstream of migratory neural crest formation. G. Another stage HH4 embryo 
unilaterally electroporated with U6.3>Pax7.1.gRNAf+e, CAGG>nls-Cas9-nls and CAGG>H2B-RFP on the right side 
was cultured ex ovo until stage HH9 and stained for RFP and Pax7. Nuclei were labeled using DAPI stain. Transverse 
sectioning through this embryo revealed a nearly complete loss of Pax7 expression in the neural tube (dotted line). 
The zoomed-in images of the dorsal neural tube show high transfection rate (RFP+ cells; G’), loss of Pax7 on the right 






with the H2B-RFP plasmid showed no detectable Pax7 protein compared to the control 
side, where transfected neural crest cells were double-positive for RFP and Pax7 [Figure 
2E, E’, E’’). This was particularly interesting because Pax7 is expressed in the neural 
plate border as early as stage HH4+ (Basch et al., 2006; Roellig et al., 2017). Given that 
several hours after electroporation are required for the production of Cas9 protein after 
electroporation (Stolfi et al., 2014), this suggests that the half-life of Pax7 protein is short 
enough for our CRISPR-Cas9 system to cause loss of Pax7 protein expression within 14 
hours. To confirm that loss of Pax7 would manifest itself in a loss of the neural crest 
migration phenotype, we co-immunostained stage HH10 embryos for HNK1, a surface 
antigen that has traditionally been used as a marker for migratory neural crest cells 
(Basch et al., 2006). As expected, we saw a strong loss of HNK1 expression on the Pax7 
knockout side of the embryo compared to the control side [Figure 2F], suggesting that 
loss of Pax7 protein resulted in the failure of neural crest specification and, ultimately, 
migration. In other embryos, we co-electroporated CAGG>nls-Cas9-nls and 
U6.3>Pax7.1.gRNAf+e unilaterally on the right side at stage HH4, and allowed the 
embryos to develop until stage HH9. Transverse sections through a representative 
embryo revealed an almost complete loss of Pax7 expression in the dorsal neural tube 
[Figure 2G-2G’’]. Looking more closely at this region, we saw that the number of cells, as 
assessed by 4,6–diamidino-2-phenylindole (DAPI) staining, appeared unchanged [Figure 
2G’’’]. This suggests that the loss in Pax7 expression was a result of CRISPR-Cas9-
mediated modification of the Pax7 locus, and that the concentration of plasmids 
electroporated in the embryo did not result in cellular toxicity.  
Once we verified efficient reduction in protein levels, we asked whether this effect 
reflects the presence of fewer transcripts of target genes following CRISPR-Cas9-
mediated mutations. To test this, we designed a gRNA targeting the start codon of Sox10 
[Figure 3A], a transcription factor expressed in the migrating neural crest [Figure 3C] that 
plays a critical role in the migratory neural crest gene regulatory network (Betancur et al., 
2010; Carney et al., 2006; Ghislain et al., 2003). We began by co-electroporating 




HH4 embryos, and genotyping RFP+ cells sorted by flow cytometry as described above 
for the Pax7 locus. Similar to Pax7, we identified several mutations surrounding the Sox10 
target sequence [Figure 3B]. We co-electroporated CAGG>nls-Cas9-nls, 
U6.3>Sox10.1.gRNAf+e, and a reporter CAGG>H2B-RFP on the right side of a stage 
HH4 embryo. The left side was electroporated with U6.3>Control.gRNAf+e and served 
as an internal control. Embryos were cultured ex ovo until stage HH9-10, then processed 
for in situ hybridization. 




The results revealed a substantial decrease in Sox10 transcript levels on the side 
electroporated with the Sox10.1 gRNA [Figure 3D, E], both in the neural crest and in the 
otic placode [Figure 3E’] (Betancur et al., 2011). The loss of transcripts detected by in situ 
hybridization is consistent with the degradation of mutant transcripts by nonsense-
mediated decay (Losson and Lacroute, 1979). To confirm that the effect on Sox10 
transcripts was reflected at the Sox10 protein level, we immunostained for Sox10 protein 
in embryos electroporated using the same strategy. We observed a nearly complete loss 
of Sox10 in the right side of the embryo following Sox10.1 gRNA electroporation [Figure 
3F, F’]. Similarly, knockout of Pax7 caused a near complete loss of Pax7 transcripts 
[Figure 4A].  Taken together, these results show that our CRISPR-Cas9 system is highly 
robust at causing loss of function of target genes. 
4.2.3 Establishing epistatic relationships using CRISPR-Cas9  
The ability to knock out genes of interest is particularly important when constructing 
gene regulatory networks underlying developmental events. To demonstrate that 
CRISPR-Cas9 can be used to interrogate regulatory relationships between genes, we 
examined the effects of knocking out Pax7 and Sox10 on other neural crest transcription 
Figure 3. CRISPR-Cas9-mediated knockout of Sox10. A. (Top) Schematic of the G. gallus Sox10 gene, which 
contains 4 exons (black solid boxes). (Bottom) Nucleotide sequence surrounding the Sox10 start codon, with the PAM 
marked in red, and the Sox10.1.gRNA protospacer sequence highlighted with a red bar. B. Genotyping of Sox10 
knockout cells isolated from HH10 chicken embryos following electroporation of Sox10-targeting CRISPR reagents 
identified multiple mutations that would result in a splicing error or frameshift in the predicted protein. C. A cartoon 
model of a stage HH10 chicken embryo with the Sox10-expressed migratory cranial and vagal neural crest (highlighted 
in violet). Stage HH4 embryos were electroporated with U6.3>Control.gRNAf+e and U6.3>Sox10.1.gRNAf+e on the 
left and right side, respectively, along with CAGG>nls-Cas9-nls and CAGG>H2B-RFP on both sides, then cultured ex 
ovo until stage HH9-10, after which they were processed for in situ hybridization against Sox10. D-E. Reduced Sox10 
expression levels were observed at stage HH9 in the emigrating cranial neural crest cells (D) and at stage HH10 in 
the migratory cranial neural crest cells (E). E’. Expression of Sox10 (embryo described in E) was reduced in the vagal 
neural crest and in the otic placode. Notably, the right side shows a nearly complete loss of Sox10 expression in the 
neural crest. F. Another stage HH4 embryo electroporated with U6.3>Control.gRNAf+e and U6.3>Sox10.1.gRNAf+e 
on the left and right side, respectively, along with CAGG>nls-Cas9-nls and CAGG>H2B-RFP on both sides, was 
cultured ex ovo until stage HH10, and then immunostained for Sox10 and RFP. The right side shows a nearly complete 
loss of Sox10 protein compared to the left side control (n=9/9), indicating that CRISPR-Cas9-mediated mutations at 
the Sox10 locus affected both transcript and protein levels. F’. Expression of Sox10 is detected in RFP+ transfected 






factors. To this end, we co-electroporated CAGG>nls-Cas9-nls, CAGG>H2B-RFP, and 
control U6.3>Control.gRNAf+e on the left side with Pax7-targeting 
U6.3>Pax7.1.gRNAf+e or Sox10-targeting U6.3>Sox10.1.gRNAf+e on the right side of 
gastrulating stage HH4 embryos. The embryos were cultured ex ovo until stage HH9-10 
and then processed for in situ hybridization for Pax7, FoxD3, Ets1, and Sox10 [Figure 
4A]. Pax7 knockout resulted in reduced staining for Pax7, FoxD3, Ets1, and Sox10 
Figure 4. Application of CRISPR-Cas9 to study epistatic relationships. A. A gene regulatory network model 
derived from previous studies shows regulatory interactions between key neural crest transcription factors. B-I. 
Gastrulating embryos were electroporated with CAGG>nls-Cas9-nls, CAGG>H2B-RFP, U6.3>Control.gRNAf+e on 
the left and either U6.3>Pax7.1.gRNAf+e (B-E) or U6.3>Sox10.1gRNAf+e (F-I) on the right side, cultured until stage 
HH9-10, then processed for in situ hybridization for Pax7 (B, F), FoxD3 (C, G), Ets1 (D, H), and Sox10 (E, I). Pax7 
loss resulted in reduced expression of each downstream target in the neural crest (B-E), while Sox10 loss had no 




transcripts in the migratory neural crest [Figure 4B-E]. On the other hand, knockout of 
Sox10 caused a loss of its own expression, but as expected had no effect on Pax7, FoxD3 
or Ets1 [Figure 4F-I], all of which are expressed prior to Sox10 and upstream in the neural 
crest GRN. Thus, these results recapitulate previously demonstrated gene regulatory 
interactions (Simões-Costa and Bronner, 2015) and confirm that Pax7 acts as an 
upstream regulator of FoxD3, Ets1, and Sox10, whereas Sox10 expression is 
downstream of these transcription factors and its subsequent loss does not affect 
expression of its upstream regulators.  
To further test the ability of CRISPR-Cas9 to decipher direct gene regulatory 
interactions, we examined the effects of Pax7 loss on one of its direct transcriptional 
targets, FoxD3. We have previously shown that Pax7 directly regulates activity of FoxD3 
at cranial levels by binding to the NC1 enhancer element upstream of the FoxD3 coding 
sequence (Simões-Costa et al., 2012) [Figure 5A]. To confirm this epistatic relationship, 
we asked if knocking out Pax7 using CRISPR-Cas9 would reduce exogenous FoxD3 NC1 
enhancer activity. To this end, we co-electroporated CAGG>nls-Cas9-nls, 
U6.3>Pax7.1.gRNAf+e, and FoxD3-NC1.1>eGFP reporter construct containing a 
constitutively active version of the FoxD3-NC1 enhancer on the right side of stage HH4 
embryos [Figure 5B]. The left internal control side was co-electroporated with CAGG>nls-
Cas9-nls, FoxD3-NC1.1>eGFP, and U6.3>Control.gRNAf+e. After electroporation, 
embryos were cultured ex ovo until stage HH9-9+. Consistent with the observed Pax7 
knockout detected by immunostaining [Figure 5C], the level of eGFP expression was 
reduced on the side of the embryo that was electroporated with Pax7.1 gRNA compared 
to the control side [Figure 5D], validating the requirement of Pax7 for the activation of the 
FoxD3-NC1 enhancer. While the exogenous reporter activity through the NC1 enhancer 
was effectively lost, we further hypothesized that the absence of a transcriptional input 
from Pax7 would result in reduced endogenous FoxD3 protein levels. To test this, we 
electroporated stage HH4 embryos with U6.3>Pax7.1.gRNAf+e and 




Cas9-nls and CAGG>H2B-RFP on both sides; cultured embryos until stage HH9+; and 
collected cell lysates for immunoblotting. 
Figure 5. CRISPR-Cas9 allows investigation of direct gene regulatory interactions. A. Pax7 regulates the 
expression of FoxD3 by direct transcriptional input into the NC1 enhancer. The expression pattern in cranial neural 
crest cells is reproduced by strong expression from the mutated FoxD3-NC1.1 enhancer. B-D. Stage HH4 embryos 
were co-electroporated with U6.3>Control.gRNAf+e and U6.3>Pax7.1.gRNAf+e on the left and right side, 
respectively, along with CAGG>nls-Cas9-nls, FoxD3-NC1.1>GFP, and CAGG>H2B-RFP on both sides. Embryos 
were cultured ex ovo until stage HH9-9+, and reduced Pax7 level was verified using immunostaining (C). The FoxD3-
NC1.1 enhancer driven expression of eGFP was almost completely lost on the side that was electroporated with 
U6.3>Pax7.1.gRNAf+e (D, arrow), recapitulating the previously published epistatic relationship between Pax7 and 
FoxD3. E. Knockout embryos were cultured until stage HH9+ and dissected along the midline. Whole cell lysates 
were isolated from the two groups, and immunoblots were performed using antibodies against Pax7, FoxD3, and 
Cas9. F-G. Quantitative western blot analysis normalized to Cas9 demonstrates efficient reduction in Pax7 and 
FoxD3 protein levels following Pax7 knockout when compared to control reagents (n=3 technical replicates). H-J. 
We overexpressed Pax7 using CAGG>Pax7CDS-IRES-H2B-RFP (H), and co-electroporated this construct with 
CAGG>nls-Cas9-nls, U6.3>Pax7.1.gRNAf+e, and FoxD3-NC1.1>GFP reporter on the right side of stage HH4 
embryos (I-J). The left side was electroporated with control reagents. Overexpression of Pax7 rescued the activity of 
the FoxD3-NC1.1 enhancer (J), demonstrating the specificity of Pax7 knockout mediated by our optimized CRISPR-




Consistent with our hypothesis, both Pax7 and FoxD3 protein levels were 
significantly reduced on the side electroporated with the Pax7-targeting gRNA [Figure 
5E]. Quantification of these data revealed a 4-fold and 15-fold decrease in the levels of 
Pax7 and FoxD3 protein, respectively [Figure 5F, G], on the side electroporated with the 
Pax7-targeting gRNA compared to the control side. Taken together, these results 
demonstrate the applicability of our optimized CRISPR-Cas9 system for investigating 
direct epistatic relationships among different genes. 
 The “gold standard” control for demonstrating specificity in loss-of-function 
experiments is to perform a rescue that recovers function when the lost protein is 
exogenously supplied.  To extend this to our CRISPR-Cas9 system, we asked if we could 
restore FoxD3-NC1.1 enhancer activity after Pax7 knockout by over-expressing Pax7 
exogenously. To this end, we electroporated the coding sequence of Pax7 under the 
control of a basal promoter (CAGG>Pax7CDS-IRES-H2B-RFP (Roellig et al., 2017)) 
[Figure 5H] along with CAGG>nls-Cas9-nls, U6.3>Pax7.1.gRNAf+e, and FoxD3-
NC1.1>eGFP on the right side of stage HH4 embryos [Figure 5I]. The left side was 
electroporated with U6.3>Control.gRNAf+e and served as an internal control. The PAM 
adjacent to the Pax7.1 gRNA target site lies in the first intron, and hence would be missing 
from the Pax7 coding sequence. Since identification of the PAM is essential for Cas9 
binding, we predicted that our Pax7 overexpression construct would not be recognized 
by the Cas9-Pax7.1.gRNA complex. Embryos were developed until stage HH9-10, after 
which they were imaged for FoxD3-NC1.1 enhancer driven eGFP reporter expression. 
The activity of the FoxD3-NC1.1 enhancer appeared similar on both the control and 
experimental sides of the embryo [Figure 5J], indicating that exogenous Pax7 rescued 
the CRISPR-Cas9-mediated loss of endogenous Pax7 protein, and consequently, the 
FoxD3-NC1.1 reporter activity, thereby demonstrating specificity. Taken together, these 
results suggest that our optimized CRISPR system is specific in causing functional gene 
knockouts at target loci in the chicken genome and demonstrate the functionality of this 




4.2.4 Rapid screening of gRNAs using a Cas9-integrated chicken DF-1 fibroblast 
cell line 
Validating individual gRNAs for knocking out genes in vivo using CRISPR-Cas9 
can be cumbersome and as a result continues to be one of the potential limitations of 
designing CRISPR-Cas9 experiments in chick embryos. Although we have reported a 
simple sorting-based protocol to quantify gRNA efficacy in vivo, we sought to develop a 
simpler strategy to overcome the need for cell sorting. To this end, we have modified the 
chicken DF-1 fibroblast cell line to constitutively express Cas9 that has been integrated 
in the genome using a Tol2-flanked CAGGS-driven Cas9-2A-PuroR cassette and T2TP 
transposase (Sato et al., 2007) [Figure 6A]. We validated the constitutive nuclear 
expression of Cas9 by immunostaining using an antibody against Cas9, followed by DAPI 
counterstaining [Figure 6B-D]. Interestingly, the expression level was variable in different 
cells, suggesting that the transposase-mediated genomic integration events were distinct. 
Once we verified the stable integration of Cas9 in DF-1 cells, we used this system to 
assay the efficacy of gRNAs for in vivo application in embryos. To this end, we transfected 
Cas9-integrated DF-1 cells with gRNAs targeting the genomic loci of genes Pax7 and 
Sox10 using gRNAs described in previous sections (U6.3>Pax7.1.gRNAf+e or 
U6.3>Sox10.1.gRNAf+e). As a control for transfection and to calculate the transfection 
rate, we also transfected a different well of cells with CAGG>H2B-RFP. After 48 hours of 
incubation, we isolated genomic DNA from the Pax7 and Sox10-targeted cells for 
genotyping. As expected, both gRNAs generated mutations around the gRNA targeting 
site for the two genes [Figure 6E-F] that would have resulted in a splicing error and/or 
frameshift in the coding sequence. Importantly, the efficacy rates for the two gRNAs from 
unsorted DF-1 cells were consistent with the results obtained from sorted chick embryo 
cells [Figure 2B, 3B]. Taken together, these results demonstrate the utility of our Cas9-
DF-1 cell line in simplifying the experimental designs for future CRISPR-Cas9 knockout 






 In summary, here we demonstrate the application of the CRIPSR-Cas9 system for 
effective somatic cell genome editing in chicken embryos. The chick embryo offers many 
advantages for analysis of gene function in amniotes in vivo because of its accessibility, 
Figure 6. Construction of a Cas9-DF1 fibroblast cell line to validate gRNAs. A. The strategy employed to stably 
integrate a Cas9-2A-PuroR in chicken DF-1 fibroblasts using a T2TP transposase to access gRNA efficacy for in vivo 
applications. Cells were transfected with the two constructs and grown for 48 hours before the first round of selection 
on puromycin. gRNA plasmids were transfected using a simple lipofectamine-based protocol. B-D. After puromycin 
selection, the cells were immunostained for Cas9 to validate its stable integration and constitutive expression in the 
cells. Overlay of Cas9 (green) expression with DAPI (magenta) revealed its proper nuclear localization in the cell line. 
E-F. Genotyping of Cas9-DF1 cells following transfection with Pax7 (E) and Sox10 (F) targeting gRNA plasmids 




ease of manipulation, and low cost. Moreover, the ability to perform bilateral 
electroporations enables an internal control within a single embryo. In the past, loss-of-
function studies have relied upon morpholinos, dominant negatives, or RNAi approaches, 
all of which are transient, and thus useful for relatively short-term analysis. Although 
morpholinos offer a rapid and efficient method to block translation or splicing, concerns 
regarding the possibility of toxicity and off-target effects make it important to consider 
alternative approaches. To this end, we optimized our Cas9 and gRNA expression 
plasmids by incorporating three modifications: first, by employing two NLS sequences for 
higher nuclear expression of Cas9 protein (Chen et al., 2013); second, by using a 
modified gRNA (“F+E”) scaffold to enhance in vivo gRNA transcription (Chen et al., 2013; 
Stolfi et al., 2014); and third, by using a species-specific chicken U6 promoter. In addition, 
we have generated a Cas9-DF1 cell line that greatly streamlines the process of gRNA 
design for knockout experiments in chick embryos. The results highlight the robustness 
and reproducibility of this modified CRISPR-Cas9 system for generating loss-of-function 
in chick embryos in a manner that can be applied to many developmental processes, 
including protein functional analysis and the dissection of gene regulatory interactions.  
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4.7 Materials and methods 
4.7.1 Molecular cloning 
The Pax7 and Sox10 genomic loci were obtained from the UCSC genome browser 
(Karolchik et al., 2003). The initial set of gRNA targets was designed by searching these 
loci for the motif G-<N20>-GG. Protospacer sequences overlapping with splice junctions 
were preferred over ones within coding sequences. The Gallus gallus 5.0 genome 
assembly available on the UCSC genome browser was used to screen for 
polymorphisms. Using this approach, we generated the gRNA targets used in this study: 
Pax7 (GGCCCAGCGGGGTGGACACT), Sox10 (GAGATCTTGGTCATCAGCCA). We 
also designed a control gRNA with a protospacer sequence not found in the chicken 
genome (GCACTGCTACGATCTACACC). Previously described design principles 
(Doench et al., 2014; Gandhi et al., 2017; Moreno-Mateos et al., 2015) were followed 
when choosing between multiple gRNA targets for the same gene to avoid off-target 
effects. All protospacers were cloned into a modified gRNA “F+E” backbone, which was 
a gift from Lionel Christiaen (Addgene plasmid # 59986). The human codon-optimized 
Cas9 was obtained as a gift from Lionel Christiaen (Addgene plasmid # 59987). nls-Cas9-
nls was PCR amplified using High-Fidelity Phusion polymerase (NEB) and inserted 
downstream of the chicken beta-actin promoter (CAGG). Our gRNA and Cas9 vectors 
can be obtained through Addgene (https://www.addgene.org/Marianne_Bronner/). 
For the U6 promoter optimization assay, the “gRNA.f+e” backbone was PCR 
amplified to remove the terminator sequence from the 3’ end of the scaffold. This amplicon 




cloned downstream of the human U6 and chicken U6.3 promoter (gift from Chao-Yuan 
Yeh at the Cheng-Ming Chuong lab). 
For qRT-PCR, following electroporation with the human and chicken U6 promoter 
constructs, RNA was extracted using the RNAqueous kit (Ambion). cDNA strands were 
synthesized using SuperScript III Reverse Transcriptase (Invitrogen) using random 




Fertilized chicken embryos were obtained from local farmers, and were 
electroporated at stage HH4 using previously described techniques (Sauka‐Spengler and 
Barembaum, 2008). For Pax7 and Sox10 knockout experiments, the right side of the 
embryos were electroporated with 2µg/µL CAGG>nls-Cas9-nls, 1.5µg/µL 
U6.3>Pax7/Sox10gRNAf+e, and 2µg/µL CAGG>H2B-RFP, while the left side was 
electroporated with 1.5µg/µL U6.3>Control.gRNAf+e along with Cas9 and H2B-RFP 
reporter. For the epistasis experiment, 2µg/µL of FoxD3-NC1.1>eGFP was 
electroporated on both sides of the embryo, combined with CRISPR-Cas9 reagents as 
described above. For overexpression of Pax7, 2µg/µL of CAGG>Pax7CDS-IRES-H2B-
RFP was electroporated on the right side, leaving the other side as control. Electroporated 
embryos were cultured ex ovo in 35mm dishes with 1mL of albumen at 37°C in humidified 
chambers until the desired Hamburger Hamilton stages were reached (Hamburger and 
Hamilton, 1992). 
4.7.3 Genotyping 
Whole embryos were electroporated with CAGG>nls-Cas9-nls and CAGG>H2B-
RFP together with either U6.3>Pax7.1.gRNAf+e or U6.3>Sox10.1.gRNAf+e at stage 
HH4, then incubated to stage HH10. Live embryos were dissected in Ringer’s solution on 




(EMD Millipore). Dissociation was terminated by addition of Hanks Buffered Saline 
Solution (HBSS) (Corning) supplemented with 25mM HEPES pH 7.0, 2.5mg/mL BSA 
Fraction V (Sigma), and 10mM MgCl2. Cells were then passed through a 40 µm filter to 
remove debris, and RFP+ cells were then isolated using a Sony Synergy 3200 cell sorter 
equipped with a 561nm laser (Caltech Flow Cytometry Facility). Cells were pelleted, then 
genomic DNA was prepared in 20 µL 1x AccuPrime PCR Buffer II (ThermoFisher). This 
resuspension was incubated at 95°C for 15 minutes, after which 2.5 µL of 20 mg/mL 
Proteinase K was added and the suspension was reincubated at 55°C for 2 hours with 
frequent pipetting to mix, then heated to 95°C for another 15 minutes. The resulting 
preparation was used for PCR amplification using AccuPrime High Fidelity Taq 
Polymerase (ThermoFisher) with Pax7 (for 5’-TAAATCGCGAGGCAATTTCT-3’, rev 5’-
GTCCCCTCGACCCTACTTTC-3’) or Sox10 (for 5’-GGAGATATGTGAGCAGACAGG-3’, 
rev 5’-TTCCATTGACCCGAACAGG-3’) locus primers. Amplicons were then PCR purified 
(QIAGEN) and TA cloned into pGEM T Easy (Promega) for transformation and Sanger 
sequencing (Laragen).  
4.7.4 In situ hybridization  
Whole mount embryos were fixed in 4% paraformaldehyde for 2 hours at room 
temperature. Post-fixation, embryos were washed three times in PBS-0.1% Tween, and 
were serially dehydrated in methanol, after which they were stored at -20°C. In situ 
hybridization for Sox10 (Betancur et al., 2010), Pax7 (Basch et al., 2006), FoxD3 (Kos et 
al., 2001), and Ets1 (Barembaum and Bronner, 2013) was performed using a previously 
described protocol (Acloque et al., 2008). In situ hybridization for GFP was performed 
using a modified protocol which involved incubating the embryos in DNase I (Promega) 
at 37°C for 1 hour (Arede and Tavares, 2008). The DIG-labeled RNA probe against GFP 
was a gift from Marcos Simões-Costa.     
4.7.5 Immunostaining and Imaging 
Whole-mount immunostaining was performed using previously described 




electroporation were fixed in 4% paraformaldehyde in phosphate buffer for 20 minutes at 
room temperature.  Embryos were then washed three times in PBS-0.1% Triton for 5 
minutes each, after which they were blocked for 2 hours at room temperature in 5% 
donkey serum for Pax7 and Sox10 staining, and 5% goat serum for Pax7 and HNK1 co-
staining. Embryos were incubated with primary antibody at 4°C for 1 night for Pax7, and 
2 nights for Sox10. The concentrations of primary antibodies used were: Pax7 (1:10; 
Developmental Studies Hybridoma Bank, Iowa city, Iowa), Sox10 (1:250; R&D Systems 
Cat # AF2864), HNK1 (1:5; Developmental Studies Hybridoma Bank, Iowa city, Iowa), 
RFP (1:500; MBL Cat # PM005), GFP (1:500; Abcam Cat # Ab290), Cas9 (1:500; 
Diagenode Cat # C15200216). The signal was detected using secondary antibodies 
Donkey anti-mouse IgG1 Alexa Fluor 488 and Goat anti-mouse IgG1 Alexa Fluor 488 (for 
Pax7 and Cas9), Donkey anti-goat IgG1 Alexa Fluor 488 (for Sox10), Goat anti-mouse 
IgM Alexa Fluor 350 (for HNK1), Donkey anti-rabbit IgG1 Alexa Fluor 594 (for RFP), and 
Donkey anti-rabbit IgG1 Alexa Fluor 488 (for GFP), respectively, all diluted to 1:500 final 
concentrations in PBS-0.5% Triton with 5% donkey or goat serum. For DAPI staining, 
transverse sections were incubated with DAPI (0.1µg/mL) for 5 minutes. Whole mount 
embryos were imaged on a Zeiss Imager M2 with an ApoTome module. Transverse 
sections were imaged on Zeiss 710 inverted confocal microscope at the Caltech 
Biological Imaging Facility. All images were processed using FIJI imaging software 
(Schindelin et al., 2012). 
4.7.6 Cryosectioning 
Whole mount embryos immunostained for Pax7 and RFP were incubated in 5% 
sucrose for 2 hours at room temperature, followed by overnight incubation in 15% 
sucrose. The next day, embryos were incubated in gelatin at 37°C for 6 hours and then 
mounted in silicone molds before they were frozen in liquid nitrogen and stored at -80°C 
until sectioning. 12um wide sections were obtained, incubated in PBS for 30 minutes at 






4.7.7 Western Blots 
Stage HH4 gastrulating embryos co-electroporated with CAGG>nls-Cas9-nls and 
CAGG>H2B-RFP together with U6.3>Pax7.1.gRNAf+e (right) and 
U6.3>Control.gRNAf+e (left) were cultured ex ovo until stage HH9+, and the cranial 
region was dissected in Ringer’s. Dissected heads were split at the midline to collect both 
“Control” and “Treatment” halves, which were homogenized in 8M urea/2.5% Sodium 
Dodecyl Sulfate (SDS). 10µg of total protein from the control and treatment groups was 
run on a 4-12% polyacrylamide gel (ThermoFisher) and transferred to nitrocellulose for 
1h at 100V at 4°C (Amersham Protran Premium 0.2 NC). The membrane was incubated 
with primary antibodies against Pax7 (1:50), RFP (1:5000), Cas9 (1:5000), and FoxD3 
(Santa Cruz; 1:2000) diluted in 5% BSA/TBS-Tween in a sealed bag overnight at 4°C. 
The membranes were then incubated in secondary antibodies (KPL; α-Mouse 1:15,000; 
α-Rabbit 1: 30,000) dissolved in 5% milk/TBS-Tween. The Amersham ECL 
chemiluminescence reagents were used to develop signal, which was then visualized and 
captured by X-ray autoradiography. Quantification of the films was performed using FIJI 
(Schindelin et al., 2012). 
4.7.8 Cell culture, transfection, and genotyping 
Immortalized chicken DF-1 fibroblast cells (ATCC CRL-12203) were cultured at 
37°C in 5% CO2 in DMEM (Corning) supplemented with 10% fetal bovine serum (Gibco) 
and penicillin/streptomycin (Corning). To generate the Cas9-DF-1 cell line, Cas9-2A-
PuroR was cloned into pT2K-CAGGS (Sato et al., 2007) using Gibson Assembly (NEB). 
Cells were transfected in 12-well plates at approximately 80% confluency using 
Lipofectamine 3000 (Invitrogen). Briefly, each well received 2µL of Lipofectamine 3000 
reagent, 0.5µg of T2K-CAGG>Cas9-2A-PuroR, and 0.5µg of CAGG>T2TP (Sato et al., 
2007), and 2 µL P3000 reagent following the manufacturer’s instructions. Transfected 
cells were incubated for 48 hours before the media was changed. At this point, the first 




(Alfa Aesar) for 6 days, making sure that the media was changed every 48 hours. 
Selected cells were then passaged twice in 8 days in media containing 4µg/mL puromycin 
to ensure propagation of a pure population of Cas9-integrated DF-1 cells. To test gRNAs, 
these cells were transfected with 1µg of U6.3>Pax7.1.gRNAf+e or 1µg of 
U6.3>Sox10.1.gRNAf+e using Lipofectamine 3000 as described above. To validate our 
transfection protocol, a separate well was transfected with 1µg of CAGG>H2B-RFP. Cells 
transfected with gRNA plasmids were then reincubated for 48 hours at which point they 
were washed with sterile PBS, then trypsinized, and genomic DNA was harvested 
following the QIAGEN DNeasy Blood and Tissue kit instructions. Genotyping was 
performed as described above.  
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The advent of CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic 
Repeats-CRISPR-associated protein 9) is a highlight of the past decade, having enabled 
genome editing across multiple species (Chen et al., 2013; Cong et al., 2013; Dickinson 
et al., 2013; Gagnon et al., 2014; Stolfi et al., 2014). Recently, it has been applied to early 
gene perturbations at stages ranging from gastrulation to neurulation in the chick embryo 
(Gandhi et al., 2017; Williams et al., 2018), an important model organism due to its 
amenability to transplantation, surgical ablation, live imaging, and gene perturbation 
(Darnell and Schoenwolf, 2000; Li et al., 2019; Streit et al., 2013). 
Conventional molecular perturbation studies in chick embryos have relied upon 
electroporation of dominant negative transgenes, antisense morpholinos, or short-hairpin 
RNAs (Corey and Abrams, 2001; Sauka-Spengler and Barembaum, 2008), and more 
recently, Cas9 and guide RNAs (gRNAs) (Gandhi et al., 2017; Williams et al., 2018). A 
major drawback of the latter approach was that Cas9 and gRNAs were delivered through 
separate constructs. While only those cells co-transfected with both plasmids were 
mutants, those could not be distinguished from cells transfected with the fluorescent 
marker alone. In addition, the transient nature of electroporation resulted in the dilution of 
transcripts and encoded proteins over time (Andreason and Evans, 1988; Eisen and 
Smith, 2008; Nakamura and Funahashi, 2001). As a result, knocking out genes 
expressed at later embryonic stages was challenging, particularly in tissues that are not 
easily amenable to electroporation. Moreover, the absence of permanent labeling 
compromised the ability to identify/trace the descendants of individually perturbed cells.  
Here, we report several improvements to the CRISPR-Cas9 toolkit for generation 
of fluorescently-labeled mutant cells in different tissues of the chick embryo. First, we use 
a self-cleaving-ribozyme-mediated approach to facilitate production of the optimized 
gRNAf+e scaffold (Chen et al., 2013; Gandhi et al., 2017) through an RNA-polymerase 
(RNA-pol) II-based promoter. By eliminating the need for a chick U6 promoter to drive 




Second, we incorporate this ribozyme gRNA downstream of Cas9 flanked with nuclear 
localization signal sequences followed by a fluorescent protein (Williams et al., 2018) to 
enable fluorescent readout of mutant cells. We use this single-plasmid approach to knock 
out b-catenin in vitro in multiple species. Next, we demonstrate the ability to knock out 
Sox10 and Pax7 in the neural crest, and Pax6 in the optic vesicle and hindbrain of chicken 
embryos using electroporation, and the ability to analyze the movement of Sox10-mutant 
cells through live imaging. Finally, we enable cistronic integration of Cas9, Citrine, and 
gene-specific gRNA in the host genome by constructing Replication-incompetent avian 
(RIA-CRISPR) retroviruses. We demonstrate that virally-infected identifiable cells can be 
successfully perturbed, labeled, and their progeny tracked long-term. Taken together, our 
approach combines the targeted-knockout ability of CRISPR-Cas9 with retroviral delivery 
to establish a method that enables genetic perturbations of identifiable mutant cells in an 
otherwise normal microenvironment of both early and late-stage chick embryos, and 
potentially other species. 
5.2 Results and Discussion 
5.2.1 Single-plasmid approach to deliver CRISPR components  
Our previously reported modifications in designing individual CRISPR-Cas9 
constructs substantially improved gene editing in early chick embryos (Gandhi et al., 
2017), allowing successful gene knockouts in numerous studies following electroporation 
in early embryos (Gandhi et al., 2020a; Hutchins and Bronner, 2018; Piacentino and 
Bronner, 2018; Tani-Matsuhana et al., 2018; Vieceli and Bronner, 2018). However, 
because Cas9 and guide RNAs were delivered via separate constructs, a complication 
was that only cells co-transfected with Cas9 and gRNA plasmids were mutants.  
To circumvent this limitation and facilitate delivery of all components through a 
single construct, we explored alternate strategies to transcribe gRNAs that eliminated the 
requirement for a U6 promoter, thereby enabling Cas9 and gRNA production via the same 
promoter. We turned to a ribozyme-based approach (Gao and Zhao, 2014; He et al., 




and the hepatitis delta virus (HDV) ribozyme on the 3’ end  [Figure 1A]. Once transcribed, 
the precursor HH:gRNAf+e:HDV transcript undergoes self-catalyzed cleavage to release 
a functional gRNA molecule, allowing Cas9-mediated genome targeting [Figure 1B]. As 
a marker for successful transfection, we also included Citrine, which was separated from 
Cas9 by the self-cleaving 2A peptide sequence as described by Williams et al. (2018).  
We tested this cistronic system by cloning the HH:ControlgRNAf+e:HDV fragment 
downstream of Cas9-2A-Citrine under regulation of the ubiquitous chicken β-actin 
promoter [Figure 1A]. We electroporated gastrula stage chick embryos with this construct, 
cultured them ex ovo until HH9 [Figure 1C’], and then processed them for immunostaining 
Figure 1. Optimizing delivery of CRISPR components in chick embryos. A. A single-plasmid engineered vector 
for optimal delivery of Cas9, gene-specific gRNA, and Citrine fluorescent protein in transfected cells. B. After 
transfection, the cistronic transcript is cleaved at the HH and HDV ribozyme sites, thereby releasing the gene-specific 
gRNA. Following translation of the remaining transcript, Cas9 and Citrine will be separated through self-cleavage of 
the 2A peptide. C-C’’’. Embryos electroporated with the plasmid depicted in (A) at HH9 (C’) and stained with antibodies 
against Citrine (C’’) and Cas9 (C’’’) to verify cellular localization. D. A transverse cross-section through the embryo in 
(C) with DAPI-stained nuclei. E-E’’. Citrine was enriched in the cytoplasm (E, white empty arrowheads), whereas 
Cas9, in the absence of a gene-specific gRNA, was restricted to the nucleolus (E’, white empty arrowheads) within 




against Cas9 and Citrine [Figure 1C]. As expected, Citrine [Figure 1C’’] and Cas9 [Figure 
1C’’’] were expressed in transfected cells throughout the embryo. Transverse sections 
further validated the respective localizations of individual components [Figure 1D,E], with 
Citrine expression in the cytoplasm [Figure 1E], and Cas9 [Figure 1E’] expression in the 
nucleus overlapping with that of DAPI [Figure 1E’’]. In fact, Cas9 was retained in the 
nucleolus, consistent with previous work that demonstrated this phenomenon when Cas9 
is not associated with a gene-specific gRNA (Gu et al., 2018). Together, these results 
indicate that addition of the HH:gRNAf+e:HDV precursor does not interfere with the nuclear 
and cytoplasmic localization of Cas9 and the fluorescent protein, respectively.  
5.2.2 Single-plasmid strategy can efficiently perturb function across species 
To validate that the HH:gRNAf+e:HDV precursor cleaves properly to release a 
functional gRNA molecule, we turned to an in vitro transfection-based approach, targeting 
the β-catenin (CTNNB1) locus in the human epithelial Osteosarcoma U2OS cells [Figure 
2A]. We identified a protospacer in the third exon of the Ctnnb1 coding sequence and 
produced the plasmid CAG>nls-Cas9-nls-2A-Citrine-HH-HsCtnnb1gRNAf+e-HDV to 
knock out β-catenin. We transfected U2OS cells with this plasmid, incubated them for 24 
hours at 37°C, and then fixed and processed them for immunostaining against β-catenin. 
Cells in the “control” well were transfected with the CAG>nls-Cas9-nls-2A-Citrine-HH-
CtrlgRNAf+e-HDV plasmid. Whereas β-catenin was retained at the cellular junctions  of 
control cells [Figure 2B,B’], those successfully electroporated with the Ctnnb1gRNA-
containing construct, as identified by the expression of Citrine, had reduced levels of β-
catenin at cell junctions [Figure 2C,C’]. β-catenin fluorescence intensity across cell 
junctions was quantified by line scan analysis, with transfected cells displaying significant 
reduction in β-catenin protein production following CTNNB1 knockout compared to those 
transfected with non-binding control gRNA construct [Figure 2D; p<0.001, Kolmogorov-
Smirnov test]. This confirms that Ctnnb1 gRNA molecules were successfully synthesized 
in transfected human U2OS cells, and this single plasmid was sufficient to reduce β-





Figure 2. Single CRISPR plasmid efficiently perturbs function across multiple species. A. The genomic locus 
for Ctnnb1 in the human genome. A gRNA protospacer targeting the third exon was designed. B-C. Representative 
images from human epithelial cells following transfection with the single CRISPR plasmid harboring control gRNA (B) 
and human Ctnnb1-targeted gRNA (C). D. Mean fluorescence intensity from line scan analysis (dashed lines in B ,C’) 
shows that junctions between transfected cells display reduced β-catenin immunoreactivity following Ctnnb1 knockout 
(Kolmogorov-Smirnov test, ***p<0.001). E. Sequence alignment surrounding the Ctnnb1 gRNA protospacer between 
human and chicken. Red characters within the HsCtnnb1 gRNA protospacer indicate non-conserved nucleotides 
(asterisks). F-H. Representative images from chicken fibroblast cell culture following transfection with the single 
CRISPR plasmid harboring control gRNA (F), chicken Ctnnb1-targeted gRNA (G), and human Ctnnb1-targeted gRNA 
(H). F’-H’. Dotted line (yellow) represents cell boundary for representative cells transfected with control gRNA (F’), 
chicken Ctnnb1-targeted gRNA (G’), and human Ctnnb1-targeted gRNA (H’) that were used to calculate cell 
fluorescence. I. Empirical cumulative distribution frequency analysis indicates that gRNAs targeting human or chicken 
Ctnnb1 cause significant reduction of β-catenin immunolabeling within chicken fibroblasts compared to non-binding 




We next asked if our single-plasmid approach would allow CRISPR-Cas9-
mediated gene knockout in multiple species using the same single construct. To do this, 
we looked for homology between the human and chicken Ctnnb1 genomic locus and 
discovered an 85% conservation between these species in the third exon. Importantly, 
the gRNA protospacer that allowed a robust β-catenin knockdown in human U2OS cells 
was highly conserved between the two species, with only three nucleotide differences 
distal to the PAM sequence [Figure 2E; asterisks]. Therefore, we tested the ability of our 
single-plasmid strategy to knock out Ctnnb1 in chicken fibroblast cells (DF-1) using both 
human and chicken gRNA sequences. To this end, we transfected chicken DF-1 
fibroblasts with the CAG>nls-Cas9-nls-2A-Citrine-HH-HsCtnnb1gRNAf+e-HDV plasmid, 
while transfecting CAG>nls-Cas9-nls-2A-Citrine-HH-CtrlgRNAf+e-HDV or CAG>nls-
Cas9-nls-2A-Citrine-HH-GgCtnnb1gRNAf+e-HDV plasmids as negative and positive 
controls, respectively. 24 hours post-transfection, we immunostained these cells against 
β-catenin. Interestingly, both chicken [Figure 2G,G’] and human [Figure 2H,H’] plasmids 
were sufficient to reduce the levels of β-catenin compared to the control group [Figure 
2F,F’]. We quantified this phenotype using cumulative distribution frequency analysis, 
which revealed significantly diminished β-catenin protein levels in transfected DF-1 cells 
when supplied with either the chicken or human gRNA constructs, compared with the 
non-binding control gRNA construct [Figure 2I]. That the same construct produced 
CRISPR-Cas9-mediated knockouts in both chick and human cells illustrates the versatility 
of our single-plasmid approach in performing perturbation experiments across species, 
especially when regions with high homology near the PAM site are targeted.  
5.2.3 Early effects of loss of Sox10 using single-plasmid approach 
Using the loss of the gene of interest as a readout for efficient gene knockout, we 
next used our single-plasmid strategy to target the pan-neural crest marker Sox10. An 
important member of the neural crest gene regulatory network, Sox10 is critical for proper 
specification, migration, and differentiation of neural crest cells into mature neurons and 
glia of the peripheral nervous system (Martik and Bronner, 2017). To test if the modified 




electroporated the right side of gastrula stage embryos with the CAG>nls-Cas9-nls-2A-
Citrine-HH-Sox10gRNAf+e-HDV plasmid [Figure 3A] encoding a Sox10 protospacer 
previously shown to result in its efficient knockdown (Gandhi et al., 2017).  
After culturing embryos ex ovo until HH9/HH9+ to capture premigratory [Figure 
3B’] and migratory [Figure 3F’] neural crest cells, respectively, we processed them for 
immunohistochemistry and in situ hybridization. Antibody staining for Citrine, Cas9, and 
Sox10 revealed expression of both Citrine [Figure 3B] and Cas9 [Figure 3C] on the 
electroporated side, as well as a drastic reduction in Sox10 protein levels in emigrating 
neural crest cells [Figure 3D]. Moreover, in situ hybridization revealed a significant 
downregulation in Sox10 mRNA levels in migrating neural crest cells [Figure 3E]. For 
quantification, we processed targeted embryos for high resolution in situ Hybridization 
Chain Reaction (HCR). We first labeled nascent Citrine transcripts [Figure 3F] and 
Figure 3. Electroporation-mediated early knockout of Sox10 using single CRISPR plasmid. A. Electroporation 
strategy to target Sox10 in the neural crest. The right side of gastrula stage HH4 embryos was electroporated with 
single CRISPR plasmid containing validated gRNA protospacer. B-C. Embryos electroporated with the knockout 
construct developed to HH9 (B’) and immunostained for the expression of Citrine (B) and Cas9 (C). D. The single-
plasmid approach efficiently reduced Sox10 protein levels in emigrating cranial neural crest cells at HH9. E. 
Chromogenic in situ hybridization revealed a notable reduction in Sox10 mRNA levels in migrating cranial neural crest 
cells on the knockout side at HH9+. F-J. Knockout embryos (F’) were processed for in situ HCR against Citrine (F), 
Tfap2B (G), and Sox10 (I). Quantification of migration area (H) and Sox10 fluorescence intensity (J) showed significant 
reduction in total area occupied by cranial neural crest cells (H; paired Student’s t-test, ***p<0.001), and Sox10 mRNA 
levels (J; paired Student’s t-test, **p<0.01) following single-CRISPR-plasmid-mediated Sox10 knockout. Error bars 




observed a strong signal, confirming active transcription through the electroporated single 
CRISPR plasmid on the transfected side. Next, we labeled the transcripts for the neural 
crest marker Tfap2B, which allowed us to quantify the effect of reduced Sox10 on neural 
crest migration. We observed a 50% reduction in the migration area (n=6), with cranial 
neural crest cells occupying an area of 87336±7203 a.u.2 on the control side compared 
to 44264±6224 a.u.2 on the treatment side [Figure 3H; p<0.001, paired Student’s t-test]. 
Finally, consistent with chromogenic in situ hybridization, we observed a notable 
reduction in the levels of Sox10 mRNA [Figure 3I] on the knockout side. Quantification of 
the Corrected Total Cell Fluorescence (CTCF) intensity revealed a 70% reduction in 
Sox10 intensity (n=7) between the control and knockout sides [Figure 3J; p<0.01, paired 
Student’s t-test]. Together, these results demonstrate that the single-plasmid approach is 
efficient in perturbing the levels of Sox10 in vivo.  
5.2.4 Using single-plasmid approach for live imaging 
Next, we explored the possibility of applying live imaging to analyze the effects of 
CRISPR-Cas9-mediated knockouts, not previously possible in chick cells since 
components were delivered using separate plasmids. To test this, we electroporated the 
neural tube of HH10 chick embryos with FoxD3-NC2>Cerulean, CAG>H2B-RFP, and 
CAG>nls-Cas9-nls-2a-Citrine-HH-Sox10gRNA-HDV on the right side [Figure 4A]. Control 
embryos were electroporated with FoxD3-NC2>GFP at the same concentration. FoxD3 
is a neural crest specifier gene, expressed in premigratory and early migrating neural 
crest cells along the entire anterior-posterior axis (Stewart et al., 2006; Teng et al., 2008) 
of developing embryos. Its enhancer, NC2 (Simões-Costa et al., 2012), drives strong 
reporter expression in post-otic neural crest cells (Gandhi et al., 2020a; Ling and Sauka-
Spengler, 2019), including the trunk neural crest (Simões-Costa and Bronner, 2016). 
H2B-RFP was electroporated in knockout embryos as a nuclear transfection control to 
complement the cytoplasmic expression of Citrine. The embryos were cultured in ovo at 
37˚C for 24h before harvesting. Using FoxD3-NC2-mediated reporter activity as a 




in length (Li et al., 2020), which were then imaged for 12 hours with a temporal resolution 
of ten minutes.  
To establish the baseline migration pattern of trunk neural crest cells as they 
migrated ventrally away from the dorsal neural tube toward the sensory and sympathetic 
ganglia, we visualized labeled control neural crest cells and their progeny [Figure 4B]. 
Control daughter cells after cell division migrated extensively and typically moved out of 
the imaging frame and/or plane during the imaging session [Figure 4C-G, supplementary 
movie 1]. In contrast, labeled cells lacking Sox10 exhibited aberrant cell migration [Figure 
4H-L, supplementary movie 2]. While Sox10-mutant cells still underwent mitosis [Figure 
Figure 4. Live imaging application of the single CRISPR plasmid. A. Strategy for processing control and mutant 
embryos for live imaging. Neural crest cells were labeled using the FoxD3 enhancer NC2; knockout embryos were 
also electroporated with the single CRISPR plasmid targeting Sox10 and H2B-RFP as a transfection marker. B-F. In 
control embryos, trunk neural crest cells divide (B,C; empty arrowheads) and migrate properly (D,E,F), with the 
daughter cells leaving the imaging frame/plane in (E) and (F). G. Tracking migration of cells highlighted in (C) reveals 
proper trunk neural crest migration. H-L. When Sox10 was  knocked out before neural crest emigration, mutant cells 
still divided (H,I; empty arrowheads), but migrated in a circle (J,K) before undergoing apoptosis (L). M. Cell tracking of 




4H,I], thus demonstrating that loss of Sox10 did not inhibit their ability to divide, trajectory 
analysis revealed abnormal migration of the resultant sister cells before their apoptosis 
[Figure 4M]. These results are consistent with previous literature, in which loss of Sox10 
in premigratory neural crest resulted in premature apoptosis shortly after delamination 
(Dutton et al., 2001; Kelsh, 2006). Taken together, these results confirm that loss of Sox10 
prior to delamination of neural crest cells results in aberrant migration and premature 
apoptosis (Carney et al., 2006; Dutton et al., 2001), whereas its primary effects at later 
stages of neural crest development appear to be on neuronal and glial differentiation 
(Britsch et al., 2001). To our knowledge, this is the first instance that combines CRISPR-
Cas9-mediated knockouts with live imaging in chick embryos. 
5.2.5 Incorporating CRISPR components into RIA retroviruses  
While the electroporation strategy works well for gastrula and neurula stage 
embryos, many other tissues that form in late embryos are inaccessible to electroporation. 
Therefore, we asked whether using viruses, which allow integration into the genome and 
ease of delivery, might represent an alternative method of introducing CRISPR-Cas9 
components. In the chick embryo, replication-incompetent avian (RIA) retrovirus has 
served as a versatile tool for long-term lineage tracing (Li et al., 2017, 2019; Tang et al., 
2019). Once a susceptible cell is infected with this virus, the viral RNA is reverse 
transcribed and stably integrated into the host genome. Since the integrated viral DNA 
lacks the gene for the envelope protein to produce virus, it fails to horizontally transfer its 
genetic material into neighboring cells (Chen et al., 1999; Witte and Baltimore, 1977). On 
the other hand, as an intrinsic component of the host genome, the viral DNA can be 
vertically transferred to daughter cells through mitosis, resulting in permanent labeling of 
the entire lineage derived from infected progenitors. These combined attributes make RIA 
a powerful system for exploring lineage relationships within complex tissues (Li et al., 
2017; Tang et al., 2019). Recently, this RIA-mediated approach has been extended for 




localization of fluorophores that result from simultaneous infection of more than one virion 
(Tang et al., 2019). 
Our initial attempt involved injecting two different viruses in the neural tube: one 
encoding for nuclear Cas9 and the other encoding a gene-specific gRNA. However, this 
approach was unsuccessful in knocking out Sox10 in the trunk neural crest due to the low 
probability of double infection. As an alternative, we explored the possibility of 
incorporating our single-plasmid design into the RIA virus for targeting later stages of 
development.  However, given the relatively larger size of the nls-Cas9-nls-2a-Citrine-
HH-gRNAf+e-HDV fragment, it was necessary to improve the RIA virus preparation 
protocol to accommodate this large insert. We achieved this by making three 
modifications to maintain the functionality of the recombinant virus [Figure 5A]. First, we 
minimized the time duration that secreted virus stayed in the culture medium by 
transfecting RIA and VSVG expression constructs directly in 15 cm dishes instead of 
sequentially passaging transfected cells from 6 to 10 to 15 cm dishes (Chen et al., 1999), 
which often led to the deletion of inserted genes in the viral particles over time. Second, 
Figure 5. Incorporating single CRISPR plasmid into RIA retroviruses. A. Illustration of optimized protocol to 
synthesize high-titer avian retroviruses that contain large inserts. Viral particles are produced in 15cm plates 
supplemented with sodium butyrate. Supernatant can be pooled and stored at -80˚C for several months, while 
concentrated virus can be injected the same day or stored at -80˚C for a few weeks. B-E. Chicken DF1 fibroblasts 
were infected with RIA-CRISPR retrovirus and collected 24 (B), 48 (C), and 72 hours (D) post-infection. Citrine 
expression was first observed at the 48 hours timepoint, as validated by the quantification of Citrine fluorescence 




we used polyethylenimine (PEI), a polymer composed of repeating units of amine group 
and carbon spacer (Tang et al., 2015), as a less expensive substitute for previously used 
commercial transfection reagents (Chen et al., 1999), making the transfection process 
better suited for large-scale production. Finally, we added sodium butyrate, a histone 
deacetylase inhibitor that has been shown to enhance viral DNA transfection (Sakoda et 
al., 1999). Together, these modifications allowed us to successfully make high titer 
retrovirus encoding three large inserts of variable sizes, nls-Cas9-nls (4.2kb), nls-Cas9-
nls-eGFP (4.9kb), and nls-Cas9-nls-2a-Citrine-HH-gRNAf+e-HDV (5.1kb), hereby referred 
to as RIA-Cas9, RIA-Cas9-GFP, and RIA-CRISPR retroviruses, respectively.   
To test the time-course of protein expression following infection with the RIA-
CRISPR retrovirus, we infected chicken DF-1 fibroblast cells, incubated them at 37˚C and 
5% CO2, and collected cells in triplicates at 24 [Figure 5B], 48 [Figure 5C], and 72 hours 
[Figure 5D] post-infection. Infected cells collected at these three timepoints were then 
processed for immunostaining against Cas9 and Citrine. Robust Citrine expression was 
first observed in cells collected at 48 hours [Figure 5C], suggesting a delay between the 
time of initial infection and formation of readily detectable protein. Quantification of Citrine 
CTCF intensity confirmed that significant differences existed in Citrine protein levels 
between the 24 and 48 hours [Figure 5E; p<0.05, ANOVA followed by Tukey’s HSD] and 
24 and 72 hours timepoints [Figure 5E; p<0.01, ANOVA followed by Tukey’s HSD], 
respectively. These data agree well with our previous findings that detection of robust 
fluorescent protein in vivo in neural crest cells infected with RIA retroviruses is observed 
after 2 days (Tang et al., 2019). We next sought to test these retroviruses in ovo by 
targeting Sox10, Pax7, and Pax6 in the neural crest, segmental plate, and retina, 
respectively. 
5.2.6 Targeting Sox10 in neural crest derivatives using RIA-CRISPR retroviruses 
Sox10 is known to affect differentiation of several neural crest lineages. Therefore, 
we cloned the cistronic fragment nls-Cas9-nls-2A-Citrine-HH-Sox10gRNAf+e-HDV into 




injected into the lumen of the chick neural tube [Figure 6B] at HH10 (n=20), and we 
examined subsequent effects on neural crest derivatives at a population level.  
High-titer RIA-membrane-RFP retrovirus was co-injected as a readout for infection 
efficiency. As expected, RIA infection failed to robustly label migratory neural crest cells 
shortly after delamination due to the time needed to generate proteins after viral 
integration [Figure 5E]. The proportion of Citrine expressing cells increased with time, 
reflecting synthesis of Cas9 protein and gRNA molecules that results in Sox10 knockout 
at later stages of neural crest migration. Embryos at >2 days of development contained 
Figure 6. RIA retrovirus-mediated knockout of Sox10 in neural crest derivatives. A. Schematic diagram for 
cloning Sox10-RIA-CRISPR virus plasmid. B. Sox10-RIA-CRISPR retrovirus was injected into the neural tube lumen 
of HH10. At HH25, embryos were fixed, cryosectioned, and immunostained. C. Knockout of Sox10 following emigration 
from the neural tube does not affect survival but rather causes downregulation of Snail2, a neural crest specification 
marker. D-E. Early (D) and Late (E) migrating neural crest cells labeled with Citrine fluorescent protein (D’,E’’) do not 
express Snail2 (empty arrowheads). F-G. Transverse section through an injected embryo (F) shows labeled migrating 
trunk neural crest cells mutant for Sox10 expression close to the sympathetic ganglion (G,G’), with DAPI-labeled nuclei 
(G’’). H. Labeled cells were also observed in the dorsal root ganglion. I. While most Citrine-positive cells were Sox10-
negative (I’; empty arrowheads), Sox10 protein was detected in a couple of labeled cells (I’; solid arrowheads). (nt-




clusters of Citrine+ cells migrating along the ventromedial neural crest migratory pathway 
[Figure 6C]. Contrasting with early loss of Sox10, neural crest cell death was not 
observed. Rather, there was loss of the neural crest transcription factor Snail2 in 
migratory neural crest cells [Figure 6D-E], and Sox10 protein was diminished in the 
Citrine-labeled cells [Figure 6F-G,G’,G’’]. That these cells did not undergo premature 
apoptosis and appeared to migrate properly suggested that Sox10 plays distinct roles in 
early and later stages of neural crest development, and confirms that our retroviral 
approach can be used to analyze phenotypes at later stages.  
After 4 days, labeled cells were observed in the dorsal root ganglion in transverse 
sections through the trunk [Figure 6H]. Immunostaining revealed discrete clusters of 
Citrine-labeled cells, 96±2.7% of which had lost Sox10 protein [Figure 6I], suggesting a 
clean knockdown. As expected given potential perdurance of protein generated prior to 
the knockout and/or incomplete knockout in cells where only a single allele was deleted, 
a low level of Sox10 protein was detectable in 4±2.7% of the Citrine-labeled cells [Figure 
6I’; white solid arrowheads]. Given the relatively sparse Citrine expression, it is easy to 
identify a small number of mutant cells in an otherwise normal embryonic background. 
Taken together, these results suggest that our RIA-CRISPR retroviruses can be used to 
decouple early function of Sox10 in maintaining neural crest cell viability from its later role 
in cell differentiation. 
5.2.7 Targeting Pax6 in the chick retina 
In the chick, outgrowth of the optic vesicles in the forebrain marks the first sign of 
eye development (O’Rahilly and Meyer, 1959). This is followed by formation of layers with 
the neural retina as the inner layer and outer retinal pigment epithelium. In Pax6-/- mice, 
the optic cup and other ocular tissues fail to develop (Marquardt et al., 2001), suggesting 
that expression of this paired-box transcription factor plays a critical role in the survival of 
optic vesicle cells (Canto-Soler and Adler, 2006). After optic vesicle formation, Pax6 
maintains multipotentiality of retinal progenitor cells (Marquardt et al., 2001). Similarly, in 




results in formation of ectopic eyes (Chow et al., 1999; Halder et al., 1995). While 
inducible Cre-LoxP has contributed greatly to understanding the role of Pax6 in murine 
eye development, the only feasible method for genetic perturbations in the chick retina 
has been electroporation at different stages (Sebastián-Serrano et al., 2012), which has 
limitations, including reduced tissue accessibility and lack of permanent labeling of 
transfected cells. To establish the feasibility of applying our modified RIA-CRISPR 
retroviruses to the chick retina, we targeted Pax6 in the optic vesicle. We first sought to 
identify a functional gRNA that would successfully knock out chick Pax6. The genomic 
locus in the chicken genome spans 16.8kb on chromosome 5 and consists of 14 exons, 
with the paired-box domain spanning between exons 5 to 8, and the homeodomain 
spanning between exons 9 to 11 [Figure 7A]. 
We designed two gRNAs, one targeting the splice acceptor site of exon 5 and 
another targeting the splice acceptor site of exon 7, and individually tested their efficacy 
by electroporating the right side of gastrula stage embryos with constructs encoding 
Cas9, the two individual gRNAs, and nuclear RFP (as a transfection control). Only the 
gRNA targeting the splice acceptor site of exon 5 was successful in knocking out Pax6 in 
electroporated cells within the neural tube [Figure 7B-D], as confirmed by loss of Pax6 
protein [Figure 7D]. Next, we incorporated this protospacer into our single-plasmid design 
to synthesize the CAG>nls-Cas9-nls-2A-Citrine-HH-Pax6gRNAf+e-HDV construct, which 
we electroporated on the right side of gastrula stage embryos that were fixed and 
processed for cryosectioning and immunostaining at HH9. The quantified Pax6 CTCF 
intensity (4 sections obtained from two representative embryos) was significantly different 
in the neural tube of the knockout side compared to the control side [Figure 7E; p<0.05, 
paired Student’s t-test]. Therefore, we selected this gRNA for all our subsequent 
experiments.  
Given the large size of Cas9 and the fluorescent protein insert, we began by 
confirming that injection of a large-insert virus would sufficiently label cells in the 
developing chick retina and not interfere with normal retinal development. To this end, we 




embryos, co-injecting RIA-H2B-RFP retrovirus as an infection control. Embryos were 
harvested after 3 days, and the eyes were dissected, cryosectioned, and immunostained. 
Imaging of sections revealed distinct clusters of GFP+ and RFP+ cells in the developing 
retina and the retinal pigmented epithelium layer [Figure 7F]. The eye developed 
normally, and cells labeled with the two retroviruses were evenly distributed throughout 
the presumptive outer and inner nuclear layers [Figure 7F’], confirming lack of 
interference of the large insert size with normal eye development, efficiency of infection, 
and subsequent fluorescent protein expression. Accordingly, we incorporated the nls-




Cas9-nls-2A-Citrine-HH-Pax6gRNAf+e-HDV fragment into the RIA vector to synthesize 
Pax6-RIA-CRISPR virus for injection in the optic vesicle of HH9 embryos [Figure 7G]. 
Following injections, expression of Citrine was first observed in the developing eye 48 
hours post-injection [Figure 7H].  
Next, we harvested injected embryos following 4-5 days of development (n=25) 
and obtained transverse sections through the dissected eyes. Given the delay between 
infection and expression of Citrine, targeting Pax6 in the optic vesicle allows us to 
decouple Pax6’s early and later roles. Indeed, immunostaining of sections through eyes 
infected with the Pax6-RIA-CRISPR retrovirus demonstrated several distinct clones 
distributed along the retinal pigmented epithelium, the ganglion cell layer, and as 
elongated migratory cells in the inner cell layer [Figure 7I]. Using the intensity of Citrine 
expression and levels of endogenous Pax6 protein, we were able to identify labelled cells 
within the retinal pigmented epithelium layer that are likely to be sister cells [Figure 7J’]. 
One such “clone” had high levels of Citrine (outlined in white) and retained Pax6 
expression, while the second had low levels of Citrine (outlined in yellow) and diminished 
Pax6 expression. Labeled cells with high Citrine [Figure 7K] and downregulated Pax6 
Figure 7. Targeting Pax6 in the developing chick retina using RIA-CRISPR retrovirus. A. The genomic locus for 
Pax6 in the chick with paired-box (green) and homeodomain (purple) indicated. Of the tested gRNAs, the one targeting 
the splice acceptor site of exon 5 was most efficient. B-E. The right side of gastrula stage embryos was electroporated 
with constructs encoding Cas9, RFP, and Pax6 gRNA. Transfected cells (C) lacked expression of Pax6 (D), as seen 
in the overlay image (B). Cross-sections through embryos electroporated with single CRISPR plasmid targeting Pax6 
were used to quantify fluorescence intensity of Pax6 in the neural tube; results reveal a significant difference in PAX6 
expression between the knockout and control sides (E; * p<0.05, paired Student’s t-test). F-F’. Section through the 
eye at embryonic day (F) injected with RIA-Cas9-GFP and RIA-H2B-RFP retroviruses. Labeled cells were evenly 
distributed (F’) through all layers of the developing retina. G. The injection strategy for targeting Pax6 in retinal 
progenitor cell precursors residing in the optic vesicle. H-H’. Citrine expression (H) in the developing eye (H’) was first 
observed 48 hours post-infection. I-K’. Citrine-labeled cells (I,J,K) in both the retinal pigmented epithelium and the 
ganglion cell layers were negative for Pax6 expression (J’,K’; solid white arrowheads). Intensity of Citrine expression 
together with endogenous Pax6 levels allowed identification of two clones in the retinal pigmented epithelium layer 
(J’): outlined in white – high Citrine, high Pax6; outlined in yellow – low Citrine, no Pax6. L. Relative Citrine fluorescence 
intensity per labeled cell was significantly higher in the ganglion cell layer (GCL) compared to the retinal pigmented 
epithelium (RPE) (* p<0.01, paired Student’s t-test). M-O’. 77.08±5.5% of Citrine-labeled cells (M,N,O) were biased 
towards an amacrine cell fate based on expression of Islet1 (N’,O’; solid white arrowheads). Several migratory cells 
were observed in the inner nuclear layer. P-Q’. 80.24±3.1% of Citrine-labeled cells (P,Q) in the ganglion cell layer 
failed to turn on TUBB3, a marker for differentiated mature neurons (Q’; solid white arrowheads). nt-neural tube; nc-
notochord; ect-ectoderm; rpe-retinal pigmented epithelium; inl-inner nuclear layer, gcl-ganglion cell layer. Error bars 






expression [Figure 7K’] were also scattered within the developing ganglionic cell layer. 
Interestingly, the signal intensity of Citrine was stronger in the ganglionic cell layer 
compared to the inner nuclear or the retinal pigmented epithelium layer (n=9), with a 
statistically significant difference in the Citrine CTCF intensity per unit cell between the 
two layers [Figure 7L; p<0.01, paired Student’s t-test].  
Finally, we assessed effects of the Pax6-RIA-CRISPR retrovirus on the fate of 
retinal progenitor cells by immunostaining cross-sections through the eyes with antibodies 
against Islet1, a marker for amacrine cells, one of the six cell types that are derived from 
the retinal progenitor cells. In the chick retina, retinal gangliogenesis begins around 
embryonic day 6, marked by expression of the Brn3 family of proteins (Doh et al., 2010; 
Liu et al., 2000). Consistent with previous findings suggesting that temporally-restricted 
loss of Pax6 is associated with preferential generation of amacrine interneurons 
(Marquardt et al., 2001), examination of representative sections revealed that 
77.08±5.5% of Citrine+ cells in the ganglionic cell layer expressed Islet1 [Figure 7M-O], 
supporting the possibility that in the virally-infected cells initiate amacrine differentiation. 
We tested whether these labeled cells were terminally differentiated neurons by staining 
sections for β-III tubulin, a marker for post-mitotic mature neurons. Of the representative 
sections examined, 80.24±3.1% of Citrine+ cells within the ganglionic cell layer were β-
III tubulin negative, suggesting that these were amacrine precursors rather than  
prematurely differentiated amacrine neurons [Figure 7P-Q]. This was consistent with 
results in a Pax6lacZ mutant mouse model, where cells failed to turn on Tuj1 in the absence 
of Pax6 (Oron-Karni et al., 2008). Of note, the RIA approach successfully labeled a 
subpopulation of retinal cells, suggesting that this sparse labeling approach is well-suited 
for examination and long-term tracking of mutant cells in an otherwise normal 
environment. Taken together, our results show that the RIA-CRISPR viruses can be used 
for later stage knockdown of genes of interest in the chick retina, enabling new lines of 





5.2.8 Targeting Pax7 in the neural crest and presomitic mesoderm 
 In early chick embryos, neural crest cells are induced shortly after gastrulation at 
the neural plate border, a region between the neural plate and non-neural ectoderm 
(Gandhi and Bronner, 2018). Expression of Pax7 primes neural plate border cells to 
become neural crest at the expense of other lineages (Gandhi et al., 2020b; Roellig et al., 
2017). To test that the single-plasmid strategy reduces Pax7 levels, we electroporated 
the right side of gastrula stage embryos with the CAG>nls-Cas9-nls-2A-Citrine-HH-
Pax7gRNAf+e-HDV plasmid [Figure 8A], which contained a previously validated Pax7 
protospacer (Gandhi et al., 2017). As an internal control, the left side was either not 
injected, or injected with a control plasmid (CAG>nls-Cas9-nls-2A-Citrine-HH-
CtrlgRNAf+e-HDV), with similar results in both cases. Embryos were cultured ex ovo until 
HH9+ [Figure 8B], fixed, and stained for PAX7 expression.  
Levels of Pax7 were very notably reduced in cranial neural crest cells [Figure 8C], 
as quantified by measuring the number of cranial neural crest cells and Pax7 CTCF 
intensity on the treated and control sides. Following Pax7 knockout, we observed a 33% 
reduction in the number of neural crest cells [Figure 8D; p<0.05, paired Student’s t-test] 
and a 37% reduction in the Pax7-CTCF intensity [Figure 8E; p<0.05, paired Student’s t-
test]. Furthermore, levels of Pax7 mRNA were also notably downregulated, as 
demonstrated by in situ HCR [Figure 8F]. Next, we focused on the area occupied by 
neural crest cells on the control and knockout sides. Pax7 mRNA signal was used to trace 
the extent of migration on either side of the embryo [Figure 8G]. Indeed, the migration 
area (n=9) was significantly downregulated by 31%, with neural crest cells occupying an 
area of 125143±17353 a.u.2 on the control side compared to 85079±12109 a.u.2 on the 
treatment side [Figure 8H; p<0.01, paired Student’s t-test]. Finally, given that Pax7 acts 
upstream of the neural crest specifier gene FoxD3 and directly regulates its activity by 
binding to a proximal enhancer (Simões-Costa et al., 2012), we processed knockout 
embryos for in situ HCR against FoxD3 [Figure 8I], and noticed a significant reduction in 
its CTCF intensity (n=4) on the right side of the embryo [Figure 8J; p<0.05, Student’s t-




As the embryo develops, Pax7 is expressed in other tissues, including the dermis 
and skeletal muscle progenitors that reside in the dorsal dermatome and ventral 
myotome. The myogenic progenitors delaminate from the myotome, migrate to the 
developing limb bud, and proliferate (Buckingham et al., 2003). Once these cells are in 
the limb bud, expression of MyoD, a determination factor for the myogenic lineage, results 




in their differentiation into skeletal muscle (Rudnicki et al., 1993). Expression of Pax7 is 
critical for the proper development of muscle satellite cells, that are also derived from the 
Pax7-expressing precursors residing in the dermomyotome (Von Maltzahn et al., 2013). 
  To diversify the application of our single-plasmid approach, we sought to target 
Pax7 not only in presumptive neural crest, but also later in the muscle progenitor 
population of the developing dermomyotome.  We cloned this transgene into the RIA viral 
vector and generated RIA-CRISPR virus with the aim of infecting cells that express Pax7 
in the dorsolateral region of the developing somites that gives rise to the dermis and 
skeletal muscles. While in ovo electroporation of the presomitic mesoderm is possible 
(Itasaki et al., 1999), the technique requires puncturing the egg yolk to insert the positive 
electrode, which can reduce viability. Instead, we injected the Pax7 RIA-CRISPR virus 
directly in the segmental plate of HH11 chick embryos on the right side [Figure 8K] and 
allowed them to develop for 3-4 days post-infection (n=18). RIA-CFP fluorescent protein 
tagged with a mitochondrial localization sequence served as an infection control. At 
Figure 8. Targeting Pax7 in the dermomyotome and hindlimb using RIA-CRISPR retrovirus. A. Electroporation 
strategy for knocking out Pax7 in the neural crest. The right side of gastrula stage embryos was electroporated with 
the single CRISPR plasmid. B. Embryos developed to HH9+ displayed robust expression of Citrine fluorescent protein 
on the right side. C-E. The engineered single plasmid efficiently knocked out Pax7 (C) on the electroporated side. The 
number of neural crest cells (D; * p<0.05, paired Student’s t-test) and Pax7 fluorescence intensity (E; * p<0.05, paired 
Student’s t-test) were significantly reduced on the knockout compared to control side. F-H. In situ Hybridization Chain 
Reaction showed that Pax7 mRNA levels were also downregulated on the knockout side. The boundary of migration 
area (G) occupied by cranial neural crest cells in (F) was identified using the position of the lateral-most leader cell for 
both control (magenta) and knockout (green) sides. Quantification of this difference revealed a significant reduction in 
neural crest migration on the knockout side (H; ** p<0.01, paired Student’s t-test). I-J. In the absence of Pax7, the 
expression of the neural crest specifier gene FoxD3 is severely downregulated (I), especially in the hindbrain, where 
the effect of the CRISPR plasmid is most penetrant (I’). Quantification of the FoxD3 fluorescence intensity revealed 
significant difference between knockout and control sides (J; * p<0.05, paired Student’s t-test). K. Injection strategy 
for targeting Pax7 in the presomitic mesoderm of HH11 embryos using the Pax7-RIA-CRISPR retrovirus. L. 
Transverse section through embryos developed to HH25 shows positive labeling with tracer virus (mito-CFP) on the 
injected side. M-N’. Citrine+ cells in the dorsal (M) and ventral (N) aspects of the dermomyotome were Pax7-negative 
(M’,N’; solid white arrowheads). O. In infected embryos developed to embryonic day 6, the limb was dissected and 
sectioned along the coronal plane, shown in magenta. P. Several Citrine+ mutant cells were observed in the dorsal 
and ventral muscle mass. Q-U’. Pax7-mutant cells (Q,S,S’) robustly turn on the skeletal muscle marker MF20 
(Q’,T,T’,U,U’). Several Citrine+/MF20- cells that failed to turn on Pax7 (R,R’; solid white arrowhead) were observed in 
close to ventral and dorsal muscle masses, perhaps corresponding to muscle satellite cell precursors. Q and Q’ are 
adjacent sections that captured the same cell.  dml-dorsomedial lip; d-dermatome; dm-dermomyotome; m-myotome; 







HH25, embryos were harvested, sectioned through the region caudal to the injection site, 
and immunostained. We found Citrine+ infected cells that lacked Pax7 expression on the 
injected side [Figure 8L], within the dorsal [Figure 8M,M’] and ventral aspects [Figure 
8N,N’] of the dermomyotome. The high proportion of infected cells was likely derived from 
proliferating progenitors that had successful integration of Cas9, Pax7 gRNA, and Citrine 
in their genome. The injected embryos had a high survival rate (>90%), suggesting that 
targeted retroviral injection was less likely than in ovo electroporation to affect long-term 
viability of embryos.  
Finally, in a subset of embryos that were injected with the RIA-CRISPR virus 
targeting Pax7 (n=6), the hindlimb on the injected side was strongly labeled with Citrine. 
Therefore, we dissected these hindlimbs [Figure 8O], made coronal sections, and stained 
them for the myogenic marker MF20. We found several clusters of Citrine+ cells in both 
the ventral and dorsal muscle mass of the hindlimb [Figure 8P]. To confirm that the cells 
that successfully differentiated into muscles were indeed mutant for Pax7 expression, we 
also stained adjacent sections for Pax7. Consistent with the loss of Pax7 expression in 
the dermomyotome [Figure 8L], Citrine-positive cells did not express PAX7 [Figure 
8Q,S,S’] showing that Pax7 was successfully knocked out in their progenitors but mutant 
cells expressed strong levels of MF20 [Figure 8Q’,T,T’,U,U’]. On the other hand, we 
observed several infected cells that were anatomically adjacent to the muscle cells but 
were negative for MF20 and Pax7 expression [Figure 8R], which we speculate 
correspond to muscle satellite cell precursors [Figure 8R’], although further 
characterization is required to validate their identity. Taken together, these results 
establish an additional potential application of our engineered RIA-CRISPR retroviruses 
to a tissue that that was previously difficult to access in chicken embryos.   
5.2.9 Coupling RIA-CRISPR retrovirus-mediated perturbation with clonal lineage 
tracing 
Finally, we asked if the RIA-CRISPR retrovirus-mediated gene editing can be used 




principle for this application, we chose the developing spinal cord as our tissue of interest, 
and co-injected RIA-CRISPR retrovirus targeting Pax7 (Citrine+) with an RIA retrovirus 
encoding only nuclear RFP (H2B-RFP) at a volumetric ratio of 10:1 into the lumen of the 
neural tube of HH12 embryos [Figure 9A].  
 
Figure 9. Proof-of-principle experiment to show application of RIA-CRISPR retroviruses for clonal analysis. 
A. Experimental design for performing clonal analysis using RIA-CRISPR retroviruses. Clones were identified as 
single-infected cells with shared fluorescence intensity for Citrine, or double-infected cells with shared fluorescence 
intensity for Citrine and RFP. B-E’. Examples of clonally-related cells observed in the medial neural tube (B) and 
developing outflow tract (D). In the neural tube, clones were horizontally distributed (C,C’), whereas in the outflow 
tract, clones were distributed evenly within the aorticopulmonary septum (E,E’). F. In a representative embryo, double-
labeling with Citrine and RFP, together with intensity of Citrine and RFP and expression levels of Pax7 indicate clonal 
relationships. G-G’’. This allowed identification of three distinct clones: outlined in white – high Citrine (G), low RFP 
(G’), low Pax7 (G’’); outlined in cyan – low Citrine (G), high RFP (G’), no Pax7 (G’’); outlined in yellow – high Citrine 




Following a three-day incubation in ovo, embryos were fixed, cryosectioned, and 
processed for immunostaining, allowing us to identify labeled cells both within the neural 
tube and in neural crest-derived cells in the periphery. Building upon our previously 
published work (Tang et al., 2019), we estimated that the probability of infection with the 
RIA-CRISPR virus alone was 1:10,000, whereas the probability of double infection with 
the RIA-CRISPR and RIA-H2B-RFP retrovirus was 1:100,000 (detailed in the Materials 
and methods). Moreover, given that the number and location of integrations varies with 
each infection event, the progeny of the infected cell share similar levels of fluorescent 
protein expression, thus facilitating identification of clonally-related cells [Figure 9A]. The 
labeling in the neural tube was sparse, and we therefore posited that Citrine-positive cells 
in close proximity and with similar fluorescence intensity, reflecting the integration site, 
were likely to be clonally related. In rare cases, we also observed cells that were double 
labeled with RIA-CRISPR and RIA-H2B-RFP retroviruses, and we predicted that these 
cells also represented a clone. As expected, if Pax7 was successfully knocked out in a 
particular cell, the entire clone also lacked Pax7 expression. If only one allele was 
targeted, then similar levels of residual Pax7 expression would be apparent in all clonally 
related progeny. 
Based on these criteria, we identified putative clonally-related cells in both the 
neural tube [Figure 9B-C] and periphery [Figure 9D-E]. Within the developing spinal cord, 
immunostaining revealed either no or low levels of Pax7 expression in Citrine labeled 
cells [Figure 9G’’]. The deletion of only one of the alleles in some cases likely accounts 
for persistence of Pax7 expression in some cells. Interestingly, two different double-
labeled clones within the neural tube were distinguishable based on their levels of RFP, 
Citrine, and endogenous Pax7 protein expression [Figure 9F]. One clone of neural tube 
cells with high Citrine and low RFP (outlined in white) had low Pax7 expression [Figure 
9G-G’’], whereas the other adjacent clone with high RFP but low Citrine (outlined in blue) 
appeared to lack Pax7 expression. Together, we identified 18 double-labeled clones 
across 6 embryos, of which 11 lacked Pax7 expression. In addition, Citrine+ only clones 




within the neural tube (n = 22 Citrine+ only clones), of which 10 lacked Pax7 expression; 
one such example is outlined in yellow [Figure 9G-G’’]. Together, these results 
demonstrate that long-term lineage analysis can be accomplished with our RIA-CRISPR 
retroviruses in chick embryos at either the single cell or population level. In principle, our 
single construct can be incorporated into a number of different viruses, including lentiviral 
or adenoviral vectors, and can therefore be utilized to assess gene functions in diverse 
morphogenic events within an otherwise normal embryonic environment in multiple 
species. 
5.3 Conclusions 
Cell lineage analysis is an essential tool for following cell fate by marking 
progenitor cells and determining the cell types into which they differentiate. By combining 
lineage tracing with perturbation methodologies, one can challenge the cell’s 
developmental potential and interrogate the role of particular genes in normal 
developmental processes. Our single plasmid technology enables concomitant delivery 
of guide RNAs, Cas9 and a fluorescent tag into embryonic cells by electroporation or via 
replication-incompetent avian retroviral delivery. By targeting genes in the neural tube 
and neural crest, retina, and segmental plate, we have demonstrated the versatility of our 
engineered RIA-CRISPR viruses. This single-plasmid approach can also be incorporated 
in other virus families, including adeno- and lenti-viruses for application in other species. 
Moreover, we have expanded the application of the CRISPR-Cas9 system to 
investigations involving live imaging. These modified constructs can be efficiently adapted 
to several tissues in the developing embryo to study behavior of mutant cells for either 
short term or long term analysis in their endogenous wildtype environment.  
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5.7 Materials and Methods 
5.7.1 Chicken embryos  
Fertilized chicken embryos (Gallus gallus) were commercially obtained from local 
farms (Sun Valley and AA Laboratory Eggs, Inc) and developed to desired stages as per 
Hamburger and Hamilton (1951) in humidified incubators set to 37°C. For ex ovo 
experiments, embryos were developed for 18-21h, while for in ovo experiments, eggs 
were incubated for 36-48h to obtain HH10-HH12 embryos. Ex ovo electroporations were 
performed as previously described (Sauka-Spengler and Barembaum, 2008) by passing 
five 5.2V pulses for 50ms each every 100ms. The electroporated embryos were then 
cultured in 1mL albumin supplemented with penicillin/streptomycin at 37°C. The next day, 
the embryos were screened for transfection efficiency (high fluorescence intensity within 
the neural tube in wholemount embryos), and unhealthy and/or poorly transfected 
embryos were discarded. All plasmids were injected at a final concentration of 2.5µg/µL. 
Specific-pathogen-free fertilized chicken eggs were also commercially obtained from 





5.7.2 Molecular cloning 
The plasmid CAGG>nls-Cas9-nls-2a-Citrine (a gift from Tatjana Sauka-Spengler; 
Addgene plasmid # 92393) was modified by inserting an EcoRI restriction enzyme site 
downstream of the Citrine sequence. The HH and HDV ribozyme sequences were PCR 
amplified from the plasmid pUDP044 (a gift from Jean-Marc Daran; Addgene plasmid # 
101168), cloned upstream and downstream of the previously published Pax7 and Sox10 
(Gandhi et al., 2017) or the newly designed Pax6 protospacer, respectively. This allowed 
synthesis of the HH-gRNAf+e-HDV fragments, which was directionally cloned in the 
modified CAGG>nls-Cas9-nls-2a-Citrine vector [Appendix B]. Finally, the nls-Cas9-nls-
2a-Cit-HH-gRNA-HDV fragment was digested with AscI and NotI and cloned in the 
Replication Incompetent Avian retrovirus backbone (Tang et al., 2019) under the 
regulation of the RIA promoter.  
The following gRNA protospacers were used in this study: 








5.7.3 Tissue culture transfection experiments 
Human osteosarcoma cells (U2OS, ATCC CRL-3455) were cultured in McCoy’s 
5a Modified Media (ThermoFisher), and chicken fibroblasts (DF-1, ATCC CRL-12203) 
were cultured in DMEM (Corning), both supplemented with 10% fetal bovine serum 
(Gibco) and penicillin/ streptomycin (Corning) at 37°C with 5% CO2. Cells were seeded 
at a density of 0.04x106 cells per well into ibidi µ-Slide 8-well glass bottom imaging slides 
(ibidi #80827) and incubated for 48 hours before transfection using Lipofectamine 3000 
(Invitrogen). For antibody staining, cells were washed 24 hours post transfection with 1x 




washed 2x with TBST+Ca+2 (50mM Tris + 150mM NaCl + 1mM CaCl2 + 0.1% Tween-
20), blocked in 10% donkey serum in TBST+Ca+2, then incubated in primary antibody 
solution overnight at 4°C. The following day, cells were washed 3x with TBST+Ca+2 then 
incubated in secondary antibody solution at room temperature for 1h, washed 3x with 
TBST+Ca+2, and imaged using a Zeiss LSM 800 inverted confocal microscope. 
5.7.4 Virus preparation and injection 
Virus particles were harvested and concentrated using a protocol optimized for 
large insert size [Appendix C]. Viruses that contained fluorescent reporters were 
synthesized using previously described protocols. (Li et al., 2019). For the optimizations, 
chick DF-1 fibroblasts cells were transfected with the RIA-nls-Cas9-nls-2a-Citrine-HH-
gRNA-HDV plasmid together with a plasmid encoding VSVG mixed with PEI. The next 
day after transfection, sodium butyrate was added to the media. 6h later, the media was 
replaced with fresh DMEM and the cells were given 24h to start producing virus particles. 
The supernatant was collected every 12 hours for several days and stored at -80˚C to 
enable pooling. Finally, the viruses were concentrated by centrifugation and the pellet 
dissolved in DMEM on the day of the experiment. 0.5µL of 2% red food dye was added 
to the virus to enable visualization of the injection solution. RIA-nls-Cas9-nls-2a-Cit-HH-
Sox10.gRNAf+e-HDV  and RIA-nls-Cas9-nls-2a-Cit-HH-Pax6.gRNAf+e-HDV  viruses were 
injected in ovo into the lumen of the neural tube of HH10 embryos, whereas the RIA-nls-
Cas9-nls-2a-Cit-HH-Pax7.gRNAf+e-HDV virus was injected in the segmental plate of 
HH11 embryos. The embryos were developed for 3-5 days following injections, 
harvested, screened for the expression of Citrine, and processed for cryosectioning and 
immunostaining. 
5.7.5 Clonal analysis in the neural tube with RIA-CRISPR viruses 
Pax7-RIA-CRISPR and RIA-H2B-RFP retrovirus were mixed at a volumetric ratio of 
10:1 and injected into the lumen of the neural tube in chick embryos at HH12. 72 hours 
post injection, embryos were fixed with 4% PFA in PB for 30mins at 4 degrees Celsius. 




gelatin. Transverse cryosections were made across the spinal cord to reveal clonal 
structures. Subsequently, frozen sections were washed in 1xPBS at 42˚C until residual 
gelatin was removed. Immunohistochemistry was performed using primary antibodies 
against Citrine, RFP, and Pax7. Slides were counterstained with DAPI to reveal tissue 
morphology and imaged on a Zeiss Imager M2 with an ApoTome module. All images 
were processed using Apotome Raw Convert in Zen Blue software. Single infection with 
the RIA-CRISPR virus and double infection with RIA-CRISPR and RIA-H2B-RFP viruses 
were both defined as rare clones. Cells distributed horizontally along the neural tube, 
together with ones that shared similar fluorescence intensity for Citrine, RFP, and/or 
endogenous Pax7 were identified as clonally-related. Because clones were generally 
thicker along the anterior-posterior axis than the transverse sections made, cells 
expressing the same combination of viruses but spanning multiple transverse sections 
were recorded as a single clone. 
5.7.6 Calculating probability of co-infection 
The probability of “k” number of infections given a specific multiplicity of infection 
(MOI) “λ” for each virus can be modeled by a Poisson distribution, such that: 
𝑃(𝑋 = 𝑘) =
λ"𝑒#$
𝑘!  
where k = number of infections, 
 λ = multiplicity of infection. 
Typically, the titer of RIA retrovirus prepared using our standard protocol is 
approximately 107 pfu/mL for fluorescent proteins, including the H2B-RFP-encoding 
retrovirus used in this experiment. Since the RIA-H2B-RFP was diluted at a volumetric 
ratio of 1:10, the resulting titer of the injected virus was 106 pfu/mL. In our previous work 
where we performed clonal analysis on the trunk neural crest (Tang et al., 2019), we had 
calculated the volume of virus injected in the embryo to be 0.5µL, which corresponded to 




independent, using the Poisson distribution, the probability of a neural tube cell getting 
infected with the RIA-H2B-RFP retrovirus is calculated to be: 
𝑃(RIA − H2B − RFP) 	= 	
(10#%)%	.		2.7#%&!"
1! 	= 	0.0911. 
On the other hand, the increased insert length for the RIA-CRISPR virus results in 
a titer that is 100-1000 fold lower than that of the RIA-H2B-RFP retrovirus. Therefore, the 
probability of a neural tube cell getting infected with the RIA-CRISPR retrovirus can be 
calculated as: 
𝑃(RIA − CRISPR) 	= 	
(10#')%	.		2.7#%&!#
1! 	= 	0.0001. 
Finally, the probability of co-infection of a single neural tube cell with both the RIA-
H2B-RFP and RIA-CRISPR retroviruses can be calculated as: 
𝑃(RIA − H2B − RFP	𝑎𝑛𝑑	RIA − CRISPR) 	= 	0.0911	 ∗ 	0.0001 = 	0.00000911. 
5.7.7 Slice culture and live imaging 
 Embryos electroporated with pCAG>nls-Cas9-nls-2a-Cit-HH-Sox10.gRNAf+e-
HDV, pCAG>H2B-RFP, and FoxD3-NC2>Cerulean plasmids were incubated at 37˚C, 
harvested after 24 hours, and screened for the expression of nuclear RFP that was co-
electroporated as a transfection control. Embryos that were poorly transfected were 
discarded, while the rest were processed as follows: Transverse cuts spanning 2 somites 
were made through the trunk region using a micro-knife (Fine Science Tools). The slices 
were washed in ringers and transferred into fluorodish containing prewarmed Neuro-basal 
media (GIBCO) supplemented with glutamine and PenStrep. The slices were positioned 
under custom made nylon grids and given 15 minutes to stabilize, after which the whole 
fluorodish was transferred into the incubation chamber of a Zeiss LSM 800 microscope 





For imaging the tissue slices, one-photon laser excitation was used at wavelengths 
of 405, 488 and 561nm, respectively. For these experiments, the 20x/0.8 NA M27 
objective was used and Z-stacks comprising 25 slices spanning 38.4µm were collected 
every 10 minutes for 11 hours. The images were imported into Imaris to generate movies. 
5.7.8 In situ hybridization, immunohistochemistry, and hybridization chain 
reaction 
Chromogenic in situ hybridization for Sox10 was performed as previously 
described (Simões-Costa and Bronner, 2016; Simões-Costa et al., 2015).  
For antibody staining of whole-mount embryos, embryos fixed in 4% PFA were 
washed in 0.1% PBS-Triton, blocked in 10% donkey serum in 0.5% PBS-Triton for 2 hours 
at room temperature, and incubated in primary antibody solution at 4˚C for 2 nights. On 
the third day, the embryos were washed in 0.5% PBS-Triton (30 minutes per wash, 6 
washes) and incubated in secondary antibody solution for 2 nights at 4°C. Stained 
embryos were then washed in 0.5% PBS-Triton (30 minutes per wash, 6 washes) and 
processed for imaging and/or cryosectioning.  
For antibody staining of cross-sections, slides were degelatinized in 1X PBS for 10 
minutes at 42°C, permeabilized in 10% donkey or goat serum in 0.3% PBS-Triton, 
incubated in primary antibody solution overnight at 4°C, washed the following day in 1X 
PBS (4 washes, 15 minutes per wash), incubated in secondary antibody solution at room 
temperature for 1h, washed in 1X PBS twice, soaked in 1x PBS containing 0.1µg/mL 
DAPI for 2 minutes, and washed in 1x PBS followed by distilled water. Fluoromount 
medium was used to mount coverslips on slides.  
Primary antibodies that were used in this study: Mouse anti-Cas9 (diagenode, 
Cat#C15200216; 1:500), Goat anti-GFP (Rockland, Cat#600-101-215; 1:500), Rabbit 
anti-GFP (Abcam, Cat#ab290; 1:500), Rabbit anti-Pax6 (Biolegend, Cat#PRB-278P, 
1:250), Mouse IgG2b anti-HuC/D (Invitrogen- Cat#A21271; 1:500), Mouse IgG2a anti-




1:200), Mouse IgG1 anti-Pax7 (Developmental Studies Hybridoma Bank; 1:10), Mouse 
IgM anti-HNK1 (Developmental Studies Hybridoma Bank; 1:5), Mouse IgG2b anti-Islet1 
(Developmental Studies Hybridoma Bank; 1:100), Rabbit anti-Snail2 (Cell Signaling, 
Cat#95855; 1:200), Mouse IgG2b anti-MF20 (Developmental Studies Hybridoma Bank; 
1:100), Mouse IgG1 anti-β-catenin (Abcam, Cat#ab6301; 1:250). Primary antibodies 
were detected using 1:250 Alexa Fluor 350/488/647-conjugated secondary antibodies 
(Molecular Probes). 
For hybridization chain reaction, the manufacturer’s (Molecular Technologies) 
recommended protocol was used as previously described (Gandhi et al., 2020b). 
5.7.9 Cryosectioning and imaging  
Whole mount embryos were fixed in 4% paraformaldehyde (PFA) at 4°C for 20 
minutes, which was followed by three washes in 1X PBS at room temperature. Fixed 
embryos were incubated in 5% and 15% sucrose at 4˚C for one night each. The following 
day, embryos were transferred to molten gelatin, incubated at 37°C for one night, 
embedded in silicone molds, frozen in liquid nitrogen, and stored at -80°C. Embedded 
embryos were sectioned on a micron HM550 cryostat to obtain 16µm or 20µm sections. 
Embryos and sections were imaged on a Zeiss Imager M2 with an ApoTome module. 
Images were post-processed in FIJI imaging software (Schindelin et al., 2012). For 
corrected total cell fluorescence (CTCF) calculations, the following formula was used: 
𝐶𝑇𝐶𝐹 = 𝐼𝑛𝑡𝑒𝑔𝑟𝑎𝑡𝑒𝑑𝐷𝑒𝑛𝑠𝑖𝑡𝑦 − (𝑆𝑒𝑙𝑒𝑐𝑡𝑒𝑑𝑎𝑟𝑒𝑎 ∗ 𝑀𝑒𝑎𝑛𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒). 
To count number of Citrine positive cells in individual layers of the chick retina, a 
median filter was applied to 8-bit images, followed by a Bernsen-based auto local-
thresholding method (Bernsen, 1986) and watershed segmentation to identify cell 







 For direct comparisons between two conditions, a one-sided pairwise Student’s t-
test was performed to calculate significance after the conditions for normality were 
verified. For multiple comparisons, ANOVA followed by Tukey’s HSD test correction was 
employed. Experiments were repeated on different days to ensure uniformity. No data 
were excluded. Group allocation was random and different batches of fertilized eggs were 
separately incubated in different incubators and electroporated with fresh DNA solutions. 
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The neural crest is a vertebrate-specific stem cell population with the capacity to 
migrate long distances during embryonic development (Bronner and LeDouarin, 2012; Le 
Douarin, 1980; Simões-Costa and Bronner, 2013). Originating at the neural plate border, 
these cells occupy the leading edges of the closing neural folds during neurulation. 
Subsequently, premigratory neural crest cells that initially reside within the dorsal aspect 
of the developing neural tube undergo an epithelial-to-mesenchymal (EMT) transition in 
order to delaminate and migrate extensively. Upon reaching their terminal locations within 
the embryo, neural crest cells differentiate into a plethora of derivatives, including 
craniofacial cartilage, pigment cells, smooth muscle, and peripheral neurons and glia 
(reviewed in Gandhi and Bronner, 2018). 
A feed-forward gene regulatory network (GRN) underlies the formation of the 
neural crest, from induction at the neural plate border to final differentiation into a 
multitude of cell types. This GRN is comprised of transcription factors and signaling 
pathways, partitioned into developmental modules (Martik and Bronner, 2017; Simões-
Costa and Bronner, 2015). Recently, new tools like single-cell RNA sequencing (scRNA-
seq) and Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq) 
have enabled analysis of the neural crest GRN at a global level, helping to clarify lineage 
trajectories and elucidate key biological processes therein, ranging from proliferation to 
differentiation (Williams et al., 2019). These approaches have opened the way to 
extensive functional analysis of important nodes within the GRN, particularly at early 
stages of neural crest development, which are less well-studied.  
Neural crest formation begins at the gastrula stage, with establishment of the 
presumptive neural ectoderm bordering the non-neural ectoderm. Quantitative gene 
expression analysis of gastrula stage chick embryos has revealed a surprisingly high 
degree of overlap of multiple transcription factors associated with diverse cell types within 
single cells in the early neural plate border region, ranging from markers characteristic of 




2017). This is consistent with the possibility that cells in the neural plate border are 
transcriptionally primed toward multiple cell fates, rather than committed to a particular 
lineage. What then leads to cell lineage commitment and specification toward neural crest 
rather than alternative fates, and to their subsequent ability to initiate migration from the 
neural tube? One possibility is that previously unidentified transcriptional and epigenetic 
regulators play a critical role in these processes.  
In this study, we used scRNA-seq to identify novel transcription factors and 
chromatin remodelers expressed in neural crest cells of the early chick embryo. We first 
describe the single-cell transcriptome of early migrating neural crest cells emerging from 
the hindbrain, with a focus on identifying new transcriptional regulators. One of the genes 
uncovered in the neural crest cluster was Hmga1, a non-histone chromatin remodeler 
that has known roles in tumor metastasis (Resar et al., 2018), but has been understudied 
in development. We first characterized the expression and function of Hmga1 during 
neural crest development using in situ Hybridization Chain Reaction (HCR) and observed 
Hmga1 transcripts enriched in the neural crest, with the onset of expression preceding 
neural crest specification in the neural plate border. To test its functional role in neural 
crest development, we used plasmid- and protein-based CRISPR-Cas9 strategies to 
knock out Hmga1 in neural crest progenitors with temporal precision. The results 
demonstrate an early role for Hmga1 in neural crest lineage specification in a Pax7-
dependent manner, resulting in the downregulation of neural crest specifier genes such 
as Snail2, FoxD3, and Sox10. Interestingly, loss of Hmga1 after completion of neural crest 
specification revealed a distinct set of defects in cranial neural crest emigration and 
migration. Using in situ hybridization and a fluorescent protein-based reporter, we show 
that this is a consequence of reduced canonical Wnt activity mediated by Wnt1, which 
can be rescued by concomitantly expressing stabilized ß-catenin, thus establishing a 
separate role for Hmga1 in delaminating neural crest cells as a Wnt pathway activator. 
Taken together, these results identify a dual role for Hmga1 in neural crest development 




via the canonical Wnt signaling pathway, mechanisms that may be inappropriately 
redeployed during tumorigenesis.  
6.2 Results  
6.2.1 Single-cell RNA-seq of early migrating hindbrain neural crest reveals novel 
transcriptional regulators 
Many RNA-seq datasets have sought to examine genes that are enriched in cranial 
neural crest cells compared with other tissues (Simões-Costa et al., 2014) or axial levels 
(Martik et al., 2019). However, here we aimed to identify highly expressed transcription 
factors and chromatin remodelers that may have been missed due to overlapping 
expression between neural crest cells and surrounding tissues. To this end, gastrula 
stage Hamburger Hamilton (HH) 4 embryos were electroporated with the neural crest 
enhancer FoxD3-NC2:eGFP and cultured ex ovo until stage HH12 (Hamburger and 
Hamilton, 1951). The NC2 enhancer labels early migrating neural crest cells (Simões-
Costa et al., 2012), thereby facilitating dissection of the region surrounding the 
rhombomere (r) 6 migratory neural crest stream for dissociation [Figure 1A-A’]. To aid 
downstream analysis and clustering, we introduced an “outgroup” of dissected primary 
heart tube cells into the single-cell suspension and generated barcoded Gel Bead-In-
Emulsions (GEMs) on the 10X Genomics platform. The library was sequenced at a depth 
of 50,000 median reads/cell to profile a total of 1268 cells, out of which 1241 cells passed 
the quality control filters [Supplementary Figure 1A-C].  
Following mapping and dimensional reduction, the cells split into distinct cellular 
subtypes [Figure 1B], including five cell types (mesoderm, otic, ectoderm, hindbrain, and 
neural crest) derived from the dissected tissue, and the spiked-in outgroup (“Heart tube”; 
Myl2+, Tnnt2+). Known genetic markers that were enriched in each population served to 
distinguish the neural crest subcluster (Tfap2B+, ItgB3+) from the surrounding tissues [i.e. 
otic placode (Cldn3+, Gbx2+); hindbrain (Pax6+, Zic2+); ectoderm (Epcam+, Crabp2+); 





Figure 1: Single-cell (sc) RNA-seq of hindbrain neural crest reveals known and novel transcriptional 
regulators. A. Schematic diagram illustrating the pipeline for performing scRNA-seq on the 10X Genomics platform. 
Reporter expression mediated by the FoxD3-NC2 enhancer (A’) was used as reference to dissect the hindbrain of 
HH12 chick embryos. B. Dimensional reduction using UMAP identifies 6 subpopulations (including the spike-in) 
contained within the dissociated embryonic hindbrain. C. Subset of B showing cells from hindbrain (Hb), ectoderm 
(Ect), and neural crest (NC). D-D’. Feature plots used to visualize the expression of known marker genes as a means 
of identifying subpopulations in (C) in low dimensional space. Single-cell expression distribution for marker genes (D’) 
in each cluster is shown as violin plots. E. Genes that were associated with the GO terms “DNA binding,” “regulation 
of transcription,” or “transcription factor” were characterized as transcriptional regulators and the relative expression 
and abundance of a subset of them was visualized as a dot plot. The size of each dot corresponds to the percentage 
of cells expressing that specific gene in a given cluster, while the color represents the average expression level. F. 
Feature plots showing expression of previously uncharacterized transcription factors or chromatin remodelers 
expressed in neural crest cells. G-K. Hybridization Chain Reaction was used to validate the expression of a few factors 
that were identified in (E). Dorsal view of the hindbrain of HH12 shows migratory neural crest streams at r4 and r6 




Consistent with the anatomical diversity of the mesoderm, the latter was further 
subdivided into specific cell types like myocardium (Hand2+) and paraxial mesoderm 
(Prrx1+) [Supplementary Figure 1D-E]. We particularly focused our subsequent analysis 
on the neural crest cluster in the context of the neighboring tissues of hindbrain and 
ectoderm [Figure 1C,D,D’]. We sought to determine all transcription factors and chromatin 
regulators that were expressed in the neural crest-specific subcluster, regardless of their 
expression in other cell types. To this end, we shortlisted all genes associated with the 
gene ontology terms “DNA-binding,” “regulation of transcription,” and “transcription 
factor.” This revealed several chromatin remodelers and transcription factors with high 
levels of expression in neural crest cells [Figure 1E; Supplementary Figure 2C]. The 
identified genes fell into two groups, the first of which was comprised of transcription 
factors enriched in neural crest cells, with little overlap in surrounding cell types. As 
expected, many of these genes, including Sox10, Ets1, MafB, and Nrip1, are known for 
their expression in the neural crest (Gandhi et al., 2020; Tani-Matsuhana et al., 2018). 
Importantly, the second group was comprised of chromatin remodelers and/or 
transcriptional regulators previously overlooked in bulk transcriptomic datasets, including 
Hmga1, Dact2, Ssrp1, and Tbxl1x, due to overlapping expression in other tissues. Indeed, 
their distribution in low dimensional space confirmed that a high proportion of cells in the 
hindbrain and/or ectoderm also expressed these genes [Figure 1F]. The expression of a 
subset of the above genes was validated at HH12 [Figure 1G-K] by in situ Hybridization 
Chain Reaction (HCR), which revealed an abundance of transcripts in both r4 and r6 
neural crest streams that emerge from the hindbrain. Taken together, the results show 
that our single-cell gene expression analysis is sufficient to resolve the underlying 
heterogeneity of the chick hindbrain. We also identified several genes expressed in 
migrating neural crest cells not highlighted in previous datasets given their broad 






6.2.2 Hmga1 is expressed in the neural plate, neural plate border, and neural crest 
cells  
Of the novel transcriptional regulators that were previously overlooked in bulk 
transcriptomic datasets, we were particularly intrigued by the chromatin remodeler 
Hmga1, due to its extensively studied role in tumorigenesis. A member of the High Motility 
Group A (HMGA) superfamily, Hmga1 encodes a small, nonhistone chromatin remodeling 
protein that binds to the minor groove of DNA, thereby affecting the chromatin landscape 
and facilitating the binding of other transcription factors in the opposing major groove 
(Grosschedl et al., 1994). In developing mouse embryos, Hmga1 has been shown to have 
widespread expression across several tissues, including the brain, where its loss has 
been correlated with reduced developmental potential of neural precursor cells (Kishi et 
al., 2012). While well-studied in cancer (Masciullo et al., 2003; Sarhadi et al., 2006), little 
was known about its developmental function in neural crest cells. Given the parallels 
between the mechanisms that regulate delamination, migration, proliferation, and survival 
of neural crest cells and tumor cells (Ahsan et al., 2017), we sought to characterize the 
expression of Hmga1 during neural crest development.  
At HH12, Hmga1 was observed in migrating neural crest streams emanating from 
rhombomeres 4 and 6 [Figure 1K], and in the cranial mesenchyme, suggesting that its 
expression is not restricted to the hindbrain neural crest. Therefore, to determine its 
spatiotemporal pattern at early stages of neural crest development, we performed HCR 
for Hmga1 at stages ranging from gastrulation (HH4), when neural crest cells are 
undergoing induction in the neural plate border [Figure 2B’’’], to HH10, when neural crest 
cells have delaminated from the dorsal neural tube [Figure 2E’’’] and are mid-migration in 
the cranial region [Figure 2F’’’]. As an early marker for the neural plate border and neural 




Hmga1 transcripts were first detected in the neural plate and neural plate border, 
but not in the non-neural ectoderm at HH4+, and preceded the expression of Pax7 in the 
neural plate border. Hmga1 expression remained high at HH5-6 [Figure 2A-B], 
overlapping in the neural plate border [Supplementary Figure 3A] with Pax7 transcripts 
[Figure 2B’], as observed in transverse sections [Figure 2B”, Supplementary Figure 3B-
B’]. As the neural plate border elevated to form neural folds between HH7 and HH8 
[Figure 2D’’’], expression of Hmga1 was retained in the neural tube [Figure 2C-D] and 
continued to overlap with Pax7 in the dorsal neural folds [Figure 2D’, Supplementary 
Figure 2: Hmga1 is expressed in the neural plate, neural plate border, and premigratory and migratory neural 
crest cells. A. HCR against Hmga1 at HH5 reveals expression in the neural plate and neural plate border. B-B’. A 
wildtype HH6 chick embryo double-labeled with Hmga1 (B) and Pax7 (B’) probes. Hmga1 expression overlaps with 
Pax7 in the neural plate border. B’’-B’’’. Transverse section through the embryo in (B) shows Hmga1 and Pax7 
transcripts in the neural plate and neural plate border, respectively, but not the non-neural ectoderm. C-D’. As the 
neural folds elevate, Hmga1 expression is retained in the dorsal neural tube. D’’-D’’’. Transverse section through the 
embryo in (D) shows Hmga1 transcripts in the neural tube. E-F. As neural crest cells delaminate (E’’’) and migrate 
laterally from the neural tube (F’’’), Hmga1 is expressed in emigrating (E’’) and migrating neural crest cells (F’’), along 
with Pax7 (E’ and F’). Arrow points towards delaminating (E’’) and migrating (F’’) cranial neural crest cells. hn, 
Hensen’s node; npb, neural plate border; np, neural plate; nne, non-neural ectoderm; ect, ectoderm; dNF, dorsal 




Figure 3C-D’]. Between stages HH9 and HH10, when neural crest cells delaminated from 
the dorsal neural tube [Figure 2E’’’] and started migrating laterally [Figure 2F’’’], Hmga1 
expression was retained in delaminating [Figure 2E,E’,E’’, Supplementary Figure 3E-F’] 
and migrating [Figure 2F,F’,F’’, Supplementary Figure 3G-H’] neural crest cells. 
Interestingly, transverse sections through a representative HH10 embryo revealed that 
within the migrating neural crest stream, Hmga1 was expressed in both leader and 
follower cells, as compared to Pax7, which appeared to be downregulated in the leader 
cells [Figure 2F’’]. Together, these results show that the onset of Hmga1 in the neural 
crest occurs in precursors at the neural plate border region prior to their specification, and 
is retained in premigratory and migrating neural crest cells. 
6.2.3 Hmga1 is necessary for neural crest specification 
Given that Hmga1 transcripts were enriched in the cranial neural crest, we sought 
to interrogate its possible role therein. To this end, we designed guide RNA plasmids 
(gRNAs) targeting the coding sequence of Hmga1 [Supplementary Figure 4A] and 
electroporated them together with constructs encoding Cas9 and nuclear RFP on the right 
side of HH4 gastrula stage embryos [Figure 3A]. The left side of the embryo was 
electroporated with Cas9, nuclear RFP, and a control gRNA, chosen for its lack of binding 
in chick cells (Gandhi et al., 2017). Embryos were cultured ex ovo until stage HH9/9+ 
[Figure 3B], after which they were processed for immunohistochemistry, in situ 
hybridization, and HCR.  
We first validated our knockout approach by probing for the expression of Hmga1 
itself in knockout embryos using HCR. This revealed a significant reduction in the 
abundance of Hmga1 transcripts on the knockout side [Figure 3C]. We quantified this 
phenotype in whole-mount embryos and observed a 25% reduction in Hmga1 expression 
[Figure 3D; p < 0.05, Wilcoxon rank test]. Notably, the loss of Hmga1 transcripts in the 
neural crest was more dramatic than in the neural tube, due to targeted electroporation 




Next, we investigated the effect of knocking out Hmga1 on Pax7 expression in 
neural crest cells. We examined Pax7 mRNA expression by HCR in embryos where 
Hmga1 was knocked out on the right side, relative to the left side which served as an 
internal control. Consistent with their hierarchical onset of expression, loss of Hmga1 
Figure 3: Hmga1 knockout results in loss of neural crest specification. A. The electroporation strategy for 
knocking out Hmga1 using CRISPR-Cas9 in gastrula stage chick embryos. B. Electroporated embryos were allowed 
to develop until HH9+ and screened for the expression of H2B-RFP. C. Electroporation of Cas9 and Hmga1 gRNAs 
on the right side resulted in loss of Hmga1 transcripts in the neural crest as confirmed using HCR. D. Hmga1 
expression in the neural crest quantified as corrected total cell fluorescence (CTCF) intensity in wholemount Hmga1-
mutant embryos processed for HCR. A significant reduction in expression was observed (p-value<0.05, Wilcoxon rank 
test) on the experimental compared to the control side. A ratio of 1 (dotted line) corresponds to similar levels of Hmga1 
expression on both sides. E-F. Hmga1 knockout results in reduced Pax7 expression in the neural crest, likely resulting 
from a significant reduction in Pax7+ cell count (F) on the knockout compared to the control side (****p<0.0001, 
Student’s t-test). G-H. Transverse section through the hindbrain of a representative knockout embryo (G’) was stained 
for Pax7 (H) and the neural crest specifier Snail2 (H’). I. Hmga1 knockout also resulted in a reduction of Pax7 
transcripts on the knockout side. J-L. Hmga1-mutant embryos were processed for in situ hybridization against neural 
crest specifier genes FoxD3 (J, J’), Tfap2b (K), and Sox10 (L, L’). M. Transverse section through a representative 
embryo probed for the expression of Sox10 showed reduced expression of the migratory neural crest marker, HNK1. 




resulted in a notable reduction in Pax7 mRNA levels [Figure 3E]. Next, we assessed 
whether the reduction in Pax7 transcripts would consequently result in a loss of Pax7 
protein in the neural crest by immunostaining Hmga1-knockout embryos with a Pax7 
antibody. As expected, Pax7 protein levels were dramatically reduced in the migratory 
cranial neural crest [Figure 3F,H’], with further analysis revealing a significant decrease 
in the number of Pax7+ cells on the knockout side compared to the control side [Figure 
3G; p < 0.0001, Student’s t-test]. Moreover, in the absence of Hmga1, cranial neural crest 
cells failed to migrate properly, as depicted by the expression of the migratory neural crest 
marker HNK1 [Supplementary Figure 4B]. A transverse section through the hindbrain 
[Figure 3H] of another representative Hmga1-knockout embryo stained for Pax7 [Figure 
3H’] revealed a notable reduction in the expression of Pax7 [Figure 3I] as well as the 
neural crest specifier Snail2 on the knockout side [Figure 3I’]. Furthermore, using in situ 
hybridization, we found that other neural crest specifier genes including FoxD3 [Figure 
3J,J’, Supplementary Figure 4D,E’,E’’], Tfap2b [Figure 3K], Sox10 [Figure 3L,L’], and c-
Myc [Supplementary Figure 4C] were also downregulated on the knockout side. In 
transverse sections through Hmga1-knockout embryos labeled for Sox10 expression 
[Figure 3L], we also detected fewer Pax7+ cells [Figure 3N] and diminished levels of 
HNK1 expression [Figure 3M]. On the other hand, no notable difference in the thickness 
of the neural tube was observed [Figure 3H,J’,M’’, Supplementary Figure 4E], suggesting 
that the targeted knockout of Hmga1 in the neural plate border affected the neural 
folds/dorsal neural tube but not the neural plate itself. Taken together, our results indicate 
that Hmga1 is important for proper specification of neural crest cells. 
6.2.4 Hmga1 regulates expression of Pax7 in neural crest precursors in the neural 
plate border 
 As the expression of Hmga1 precedes that of Pax7 in the neural plate border, and 
its loss also causes a reduction of Pax7 levels in neural crest cells [Figure 3F], we next 
asked if this regulation occurs in the neural crest precursors that reside in the neural plate 
border. In the preceding experiments, we characterized the expression of neural crest 




early stages of neural crest emigration and migration. However, one caveat to our plasmid 
knockout strategy is that it takes time after electroporation of the CRISPR constructs in 
gastrula stage embryos for Cas9 to transcribe, translate, and properly fold to form a 
functional Cas9-gRNA complex. As specification of neural crest cells at the neural plate 
border is ongoing at HH4, this means that functional Cas9 would not be available until 
well after initial electroporation. Given that neural crest development occurs in a rostral-
to-caudal wave along the body axis (Gandhi and Bronner, 2018), we speculated that 
effects of plasmid electroporation would be more penetrant in the hindbrain compared to 
anterior regions of the embryo, such as the midbrain. To test this possibility, we generated 
transverse sections through the midbrain [Figure 4A] and hindbrain [Figure 4B] of Hmga1-
knockout embryos and quantified the number of Pax7+ cells as a ratio of cell count on 
the experimental versus control sides. Accordingly, we noticed that while this ratio was 
0.948±0.036 (n=5) at the midbrain level, it was significantly reduced in the dorsal 
hindbrain, with a mean ratio of 0.69±0.08 (n=5; p<0.05, paired Student’s t-test) [Figure 
4C]. These results supported our assumption that specification may have already 
occurred at the midbrain level by the time Cas9 was functionally active. 
To circumvent this issue and test the earliest effects of knocking out Hmga1 
concomitant with its onset of expression, we turned to an alternative CRISPR knockout 
strategy that enabled the loss of Hmga1 immediately after transfection. To this end, we 
electroporated recombinant Cas9 protein with in vitro-transcribed Hmga1 or control gRNA 
as ribonucleoprotein (RNP) complexes on the right and left sides of gastrula stage 
embryos, respectively [Figure 4D], and cultured embryos ex ovo until HH6. First, to 
validate the Cas9-protein-mediated knockout strategy, we labeled Hmga1 transcripts in 
knockout embryos using HCR and observed a very efficient reduction in Hmga1 
expression [Figure 4E], especially in the neural plate border, thereby offering precise 









Next, we assayed for the expression of Pax7 in the neural plate border by 
immunostaining Hmga1-knockout embryos and found that the levels of Pax7 protein in 
the neural plate border [Figure 4F, Supplementary Figure 5A] were severely 
downregulated. Transverse sections through the experimental compared with control 
sides revealed that neural plate border cells no longer expressed Pax7 after the loss of 
Hmga1 [Figure 4H,I], and that this was not a result of premature apoptosis or aberrant 
cell proliferation [Supplementary Figure 5B-G’]. In further support of the latter, the 
thickness of the neural plate border remained unchanged [Figure 4H’,I’]. We also 
quantified the corrected Pax7 total fluorescence intensity (C.T.C.F) in the neural plate 
border and observed a statistically significant difference between the control and 
knockout sides (p<0.01, paired Student’s t-test), with mean Pax7 intensity on the control 
side being 89.853±23.388 a.u. (n=5) as compared to 42.763±16.079 a.u. (n=5) on the 
knockout side [Figure 4J, Supplementary Figure 5H]. Taken together, these results 
suggest that Hmga1 is required for the expression of Pax7 in neural crest precursors that 
are induced in the neural plate border.  
Figure 4: The effects of Hmga1 knockout on neural crest specification are Pax7-dependent. A-B. Transverse 
sections through a representative embryo show a dramatic reduction in the number of Pax7+ cells in the hindbrain (B, 
asterisk) as compared to the midbrain (A) at HH9/9+. As the hindbrain develops later than the midbrain due to the 
anterior-posterior progression of neural development, the effect on neural crest specification is more penetrant in the 
hindbrain (asterisk) due to the time lag between Cas9 plasmid electroporation and its activation in transfected cells. 
C. The ratio of Pax7+ cells between the experimental and control sides quantified at the midbrain and hindbrain levels 
is significantly different (* p<0.05; Student’s t-test). A ratio of 1 (dotted line) corresponds to a similar number of Pax7+ 
cells on both sides. D. Electroporation strategy for knocking out Hmga1 using Cas9 protein and in vitro-transcribed 
gRNAs. This strategy was used to immediately reduce the levels of Hmga1 on the knockout side. E. HCR against 
Hmga1 in mutant embryos shows dramatic transcriptional reduction on the experimental side (arrowhead). F. Cas9-
protein-mediated loss of Hmga1 resulted in downregulation of Pax7 expression in the neural plate border on the right 
side (experimental side; arrowhead). G. Illustration of the neural plate border. H-I’. Transverse section through embryo 
shown in F. Electroporation of the control ribonucleoprotein (RNP) complex had no effect on the expression of Pax7 
in the neural plate border (H), whereas the knockout side showed an almost complete loss (I, asterisk). No difference 
in the thickness of the neural plate border was observed between the two sides (H’,I’). J. Quantification of relative 
fluorescence intensity for Pax7 signal calculated as corrected total cell fluorescence (C.T.C.F) revealed a statistically 
significant difference between the control (left) and knockout (right) sides (** p<0.01, paired Student’s t-test). K-P’’. 
Representative Hmga1-mutant embryos that were processed for HCR against neural plate border genes Tfap2a (K; 
experimental side - arrowhead) and Msx1 (N; experimental side - arrowhead). While Hmga1 loss resulted in reduction 
of Pax7 transcripts on the experimental sides (M,P; asterisk) compared to the control sides (L,O), the expression of 
Tfap2a (L’,M’) and Msx1 (O’,P’) was relatively unchanged. No notable difference was observed in the thickness of the 
neural plate border (L’’,M’’,O’’,P’’). Q. Transcriptional response to the loss of Hmga1 was quantified as the ratio of 
knockout versus control C.T.C.F per unit area. While Pax7 expression was significantly reduced (*** p<0.001, paired 
Student’s t-test), no significant difference in Msx1 expression was observed (n.s. p>0.05, paired Student’s t-test). 




6.2.5 Hmga1 is not required for expression of neural plate border genes Msx1 or 
Tfap2a  
The neural plate border was initially thought to contain discrete domains 
corresponding to neural, neural crest, placodal, and epidermal precursors. However, 
recent work has demonstrated that cells in this region co-express genes characteristic of 
different cell fates and exhibit a broad developmental potential, suggesting they are not 
restricted to individual cell fates until later in development (Roellig et al., 2017). In chick 
embryos, Tfap2a and Msx1 are expressed in the neural plate border, with Tfap2a 
transcripts spanning both the neural plate border and the non-neural ectoderm (De Crozé 
et al., 2011; Luo et al., 2003), whereas Msx1 transcripts are expressed within a subset of 
Pax7+ cells in the neural plate border region (Khudyakov and Bronner-Fraser, 2009). 
Given that loss of Hmga1 resulted in a reduction in Pax7 protein levels in the neural plate 
border, we asked if this was a result of a general neural plate border defect versus a 
selective effect on Pax7. To test this, we examined the expression of Tfap2a [Figure 4K] 
and Msx1 [Figure 4N] transcripts together with Pax7 using HCR in Hmga1-knockout 
embryos developed to neurula stages. Consistent with the loss of Pax7 protein in the 
neural plate border, Hmga1 knockout caused reduced Pax7 mRNA levels on the 
experimental [Figure 4M,P] compared to the control [Figure 4L,O] sides. However, the 
expression of Tfap2a [Figure 4L’,M’] and Msx1 [Figure 4O’,P’] was retained in the 
absence of Hmga1, together with no noticeable difference in the thickness of the neural 
plate border [Figure 4L’’,M’’,O’’,P’’]. Since Pax7 and Msx1 are specifically expressed in 
the neural plate border, we quantified the corrected total cell fluorescence intensity per 
unit area associated with their transcripts and calculated the ratio between the 
experimental and control sides. Under control conditions, this ratio would be close to 1. 
However, for Pax7, the mean calculated ratio was 0.552±0.06 (n=6), with a statistically 
significant difference between the experimental and control sides (p<0.001, paired 
Student’s t-test). On the other hand, while the mean calculated ratio for Msx1 was 




the two sides [Figure 4Q]. Taken together, these results show that Hmga1 specifically 
regulates Pax7 expression at the neural plate border. 
6.2.6 Hmga1 and Pax7 rescue the effects of losing Hmga1 on neural crest 
specification  
Given that loss of Hmga1 affects neural crest specification, we asked if its 
overexpression would have the converse effect. To exogenously provide Hmga1, we 
designed a plasmid construct containing the coding sequence of Hmga1 under the 
regulation of a ubiquitous enhancer/promoter combination [Figure 5A]. This construct also 
contained the coding sequence for nuclear RFP downstream of an Internal Ribosome 
Entry Site (IRES), allowing identification of successfully transfected cells. To test the 
effect of overexpressing Hmga1, we electroporated this construct on the right side of 
gastrula stage embryos and cultured them ex ovo until HH9+. The left side served as an 
internal control and was electroporated with an equal concentration of a construct 
encoding nuclear RFP alone [Figure 5B]. The results show that, rather than having the 
opposite effect to loss of function, overexpression of Hmga1 also resulted in a notable 
reduction in Pax7 expression on the experimental side [Figure 5C]. This suggests that 
maintaining appropriate levels of Hmga1 is critical for proper neural crest specification.  
The gold standard to demonstrate specificity for loss-of-function experiments is to 
perform a rescue. We posited that if modulating the levels of Hmga1 was important for 
neural crest formation, then exogenous expression of Hmga1 in an Hmga1-knockout 
background should successfully rescue neural crest cell numbers. Since the Protospacer 
Adjacent Motifs (PAMs) adjacent to both Hmga1 gRNAs are located in the introns 
[Supplementary Figure 4A], the coding sequence on the plasmid would be guarded 
against the endonuclease activity of Cas9. To test our hypothesis, we knocked out Hmga1 
using CRISPR plasmids as described above, but co-electroporated the “rescue” construct 
on the right side. The left side was electroporated with an equal concentration of a plasmid 





Figure 5: Ectopic expression of Hmga1 or Pax7 rescues cranial neural crest specification. A. Plasmid construct 
used to rescue Hmga1. An independent ribosome entry site (IRES) controls translation of nuclear RFP in transfected 
cells. The electroporation strategy for knocking out Hmga1 using CRISPR-Cas9 in gastrula stage chick embryos. B. 
Embryos were electroporated with the “rescue” construct on the right side and a control nuclear RFP plasmid on the 
left side. C. Exogenous expression of the Hmga1 coding sequence under the regulation of a ubiquitous 
enhancer/promoter combination causes cranial neural crest migration defects. D-G’’’. Overexpression of the coding 
sequence (G’’’) of Hmga1 compensates for its loss of function, rescuing proper cranial neural crest migration (D), as 
assayed by number of Pax7-positive neural crest cells (E), and expression of the neural crest specifier gene Sox10 
(F) in migratory cranial neural crest (G,G’) and Pax7 in the dorsal neural tube (G’’). Electroporated embryos were 
allowed to develop until HH9+ and screened for the expression of H2B-RFP. H-H’. The coding sequence for Pax7 
was ectopically expressed in an Hmga1-knockout background. Transverse section through a representative embryo 
shows the comparison between endogenous (left) and overexpressed (right; arrow) Pax7 transcript levels in the dorsal 
neural tube. I-K. Ectopic expression of Pax7 rescued neural crest specification defects caused by the loss of Hmga1 
as assayed by the expression of neural crest specifier genes Tfap2b (I) and Snai2 (I’) in transverse cross-sections 




Embryos cultured to HH9+ and immunostained for Pax7 revealed that 
overexpression of Hmga1 concomitant with knocking out the endogenous gene 
successfully rescued Pax7 levels in cranial neural crest cells [Figure 5D]. To quantify the 
extent of rescue, we calculated the ratio of the number of Pax7+ cells on the experimental 
versus control sides in both wholemount “knockout” [from Figure 3G] and “rescue” 
embryos [Figure 5D]. In unperturbed embryos, this ratio will be close to 1, reflecting similar 
numbers of Pax7+ cells on both sides of the embryo. However, in the “knockout” group, 
we observed a mean ratio of 0.767±0.041 (n=11), which was significantly different from 
the ratio of 0.946±0.016 (n=8) observed in the “rescue” group (p<0.001, Welch two-
sample t-test) [Figure 5E]. Next, we probed for the expression of the neural crest specifier 
gene Sox10 to ask if rescuing the expression of Hmga1 truly restored the process of 
neural crest specification. To do this, we processed “rescue” embryos for HCR against 
Sox10 [Figure 5F] together with Pax7 [Figure 5G]. Indeed, restoring the levels of Hmga1 
was sufficient to rescue the expression of Sox10 [Figure 5G’] and Pax7 [Figure 5G’’] in 
early migrating crest, and Pax7 in the premigratory crest residing in the dorsal neural 
tube, as visualized in transverse sections through the embryo. We also confirmed that the 
expression of the “rescue” construct was restricted to the dorsal neural tube [Figure 5G’’’], 
thereby precluding unintended effects on neural tube development.  
Finally, given that the loss of Hmga1 specifically affected Pax7 expression in 
neural crest precursors, we asked if exogenous expression of Pax7 would be sufficient to 
rescue the effects of losing Hmga1 on neural crest specification. We tested this by 
overexpressing the coding sequence of Pax7 (Roellig et al., 2017) on the right side of 
gastrula stage embryos together with CRISPR plasmids targeting Hmga1 [Figure 5H,H’]. 
Given that the effect of CRISPR-plasmid-mediated loss of Hmga1 was more penetrant 
posteriorly, we developed “Pax7-rescue” embryos to HH9+, processed them for HCR 
against the neural crest specifier genes Tfap2b [Figure 5I] and Snai2 [Figure 5I’], and 
generated transverse sections through the hindbrain. Tfap2b is expressed in delaminating 
and migrating neural crest cells (Simões-Costa and Bronner, 2016), whereas Snai2 is 




to migrate (Taneyhill et al., 2007). Compared to the Hmga1-knockout embryos in which 
Tfap2b mRNA [Figure 3K] and Snail2 protein [Figure 3I’] levels were notably 
downregulated, restoring the levels of Pax7 in an Hmga1 knockout background rescued 
the expression of both Tfap2b [Figure 5J] and Snai2 [Figure 5K] in the dorsal hindbrain. 
Together, these results suggest that maintaining the correct levels of Hmga1 is necessary 
for proper neural crest specification in a Pax7-dependent manner.  
6.2.7 Hmga1 activates Wnt signaling to mediate neural crest emigration 
 Neural crest induction, specification, and emigration from the neural tube are 
intricate processes that require an interplay between Wnt, FGF, and BMP signaling 
pathways (Piacentino and Bronner, 2018; Woda et al., 2003) working reiteratively at 
different stages of development. For example, at the onset of neural crest emigration, 
Wnt1 is prominently expressed in the dorsal neural tube, where premigratory neural crest 
cells reside (Simões-Costa et al., 2015). As a result, these cells turn on Snai2, a critical 
regulator of EMT (Nieto et al., 1994) known to function downstream of the Wnt signaling 
pathway. After knocking out Hmga1 using CRISPR plasmids, we noted not only perturbed 
emigration but also a dramatic reduction in Snail2 levels, even within the subset of Pax7-
expressing cells in the dorsal neural folds [Figure 3I’]. These results raised the intriguing 
possibility that this might be due to an effect on Wnt signaling in already-specified 
premigratory neural crest cells. Accordingly, we hypothesized that Hmga1 may function 
as a Wnt activator in these cells. If so, its loss would be predicted to result in reduced Wnt 
signaling in the dorsal neural tube. To test this possibility, we used a reporter construct 
expressing nuclear GFP under the regulation of six Tcf/Lef binding sites and a minimal 
promoter as a readout for canonical Wnt signaling (Ferrer-Vaquer et al., 2010) [Figure 
6A]. Plasmids encoding Cas9, gRNAs targeting Hmga1, nuclear RFP, and Tcf/Lef:H2B-
GFP were electroporated on the right side of gastrula stage embryos, while the left control 





As described above, this plasmid-based knockout strategy resulted in the loss of Hmga1 
after neural crest specification in the midbrain but well before their emigration. Embryos 
were allowed to develop until HH9, by which time neural crest cells have started 
delaminating from the neural tube at the midbrain level [Figure 6B]. Consistent with our 
hypothesis, the results show that Hmga1 knockout caused a notable reduction in 
canonical Wnt reporter activity on the knockout side compared to the control side [Figure 
6C] at the midbrain level. 




 Interestingly, these embryos had a neural crest migration defect [Supplementary 
Figure 6C-D] but no notable difference in the number of Pax7+ cells between the two 
sides [Supplementary Figure 6E’], as expected if the Hmga1 knockout occurred after 
specification was complete; this is consistent with previous work showing that 
perturbation of canonical Wnt signaling following specification does not affect the number 
of Pax7+ cells at cranial EMT stages (Hutchins and Bronner, 2018). Quantitation of this 
effect revealed a significant reduction in reporter activity following the loss of Hmga1 
[Figure 6D; p<0.01; Student’s t-test], as measured by comparing the ratio between the 
knockout and the control sides of transfected cells (RFP+) that turned on Wnt signaling 
within the Pax7+ domain, therefore expressing GFP. While this ratio was expected to be 
1 for embryos with unperturbed Wnt signaling on both sides, we observed a mean ratio 
of 0.325±0.082 (n=5), suggesting that Wnt activity was disrupted in the absence of 
Hmga1.  
Next, to investigate the mechanism by which Hmga1 regulates Wnt signaling, we 
turned to a recently published cranial neural crest chromatin accessibility dataset 
Figure 6: Hmga1 activates Wnt signaling pathway in delaminating neural crest cells. A. Plasmid construct used 
as a readout for Wnt activity (after Ferrer-Vaquer et al., 2010). Six TCF/Lef binding sites together with a minimal 
promoter regulate the expression of nuclear GFP in transfected cells in response to Wnt signaling. B. Transverse 
section through the midbrain of a representative HH9+ embryo immunostained for Pax7, GFP, RFP, and DAPI. C-C’’. 
Individual channels of the image in B focused on the dorsal neural tube. In the absence of Hmga1, Wnt reporter activity 
was downregulated, resulting in fewer cells that expressed nuclear GFP (arrowheads) on the right side (C), even 
though cells were uniformly transfected on both experimental and control sides (C’), and the thickness of the neural 
tube remained unaffected (C’’). D. The reduction in Wnt reporter output was quantified as a ratio of number of cells 
that expressed nuclear GFP, and the number of cells that were successfully transfected and therefore expressed 
nuclear RFP. The observed difference in GFP+/RFP+ ratio between the knockout and control sides was statistically 
significant (**p<0.01, Student’s t-test). E-F. In situ hybridization against Wnt1 in an Hmga1-knockout background. 
Transverse section through the midbrain (E) and hindbrain (F) shows reduced and unchanged levels of Wnt1 ligand 
in the dorsal neural tube on the experimental (arrow) versus control neural tubes, respectively. E’-F’. The number of 
Pax7-positive cells in the midbrain appeared unchanged (E’), while a reduction was observed in the hindbrain (F’). G-
H. Transverse section through a representative embryo where Hmga1 was knocked out using CRISPR plasmids (G), 
and an embryo where Draxin was ectopically expressed (H) on the right side, immunostained for Laminin. Similar to 
Draxin overexpression, Hmga1 loss caused the laminin channel to remain blocked on the experimental side (arrows). 
I-J. Expression of stabilized ß-catenin (NC1-∆90ß-cat) in delaminating cranial neural crest of Hmga1-knockout 
embryos was sufficient to rescue the migration defect. K. Quantification of the area covered by cranial neural crest 
cells on the experimental versus control sides. In the absence of Hmga1, cranial neural crest cells fail to migrate 
properly, a defect that can be separately rescued in Hmga1-knockout background by overexpression (OE) of stabilized 
ß-catenin in delaminating cranial neural crest, or exogenous expression of Hmga1 coding sequence ectopically 




(Williams et al., 2019) and looked for open chromatin regions surrounding genes that 
encode for known Wnt ligands. In particular, Wnt1 expression in the dorsal neural tube is 
known to be necessary for proper delamination of cranial neural crest cells (Simões-Costa 
et al., 2015). Interestingly, we discovered a putative enhancer downstream of Wnt1 
[Supplementary Figure 6A] that contained an AT-rich domain consistent with Hmga1 
binding motifs [Supplementary Figure 6B] (Reeves and Nissen, 1990). Therefore, we 
hypothesized that Hmga1 may modulate Wnt signaling by regulating Wnt1 expression. 
To test this, we knocked out Hmga1 on the right side of gastrula stage embryos using 
CRISPR plasmids, cultured them ex ovo until HH9, and examined Wnt1 mRNA 
expression using in situ hybridization. Indeed, the dorsal neural tube expression of Wnt1 
was severely downregulated [Figure 6E] in the midbrain. Consistent with the effect of 
losing Hmga1 after neural crest specification, the number of Pax7+ cells in the dorsal 
neural tube appeared unchanged [Figure 6E’]. In contrast, no change in Wnt1 expression 
was observed at the hindbrain level [Figure 6F], which, being developmentally “younger,” 
instead exhibited a specification defect that resulted in fewer Pax7+ cells in the dorsal 
neural tube on the experimental side compared to the control side [Figure 6F’]. 
Interestingly, following Hmga1 knockout, we also observed defects in basement 
membrane remodeling and laminin channel formation at midbrain levels [Figure 6G], 
another Wnt-dependent process necessary for neural crest EMT; consistent with Wnt 
inhibition via Draxin overexpression (Hutchins and Bronner, 2019), loss of Hmga1 
abrogated laminin remodeling and resulted in physical blockage of the channel through 
which migrating cranial neural crest cells normally transit [Figure 6H]. Together, these 
data indicate that after neural crest specification, Hmga1 is necessary for the expression 
of Wnt1 and activation of canonical Wnt signaling in the dorsal neural tube, and by 
extension, Wnt-dependent neural crest delamination/EMT. 
Finally, given that Hmga1 functions as a canonical Wnt pathway activator, we 
asked if the migration defects caused by the loss of Hmga1 post-specification can be 
rescued by restoring canonical Wnt signaling in premigratory neural crest cells. To 




upregulate canonical Wnt signaling output specifically in premigratory neural crest cells, 
thus circumventing the critical process of neural crest induction at the neural plate border 
(Hutchins and Bronner, 2018). If loss of Hmga1 in premigratory neural crest cells resulted 
in migration defects due to reduced canonical Wnt signaling, expression of a stabilized ß-
catenin would be predicted to restore those levels, thereby rescuing proper migration. To 
test this, we knocked out Hmga1 on the right side of gastrula stage embryos using 
CRISPR plasmids as previously described, but co-electroporated NC1-∆90ß-cat-GFP on 
the right side. The left side was electroporated with control reagents [Figure 6I]. Embryos 
were cultured ex ovo until HH9+ and processed for immunohistochemistry against Pax7.  
Consistent with our hypothesis that Hmga1 functions as a Wnt activator in neural 
crest cells, expression of stabilized ß-catenin was sufficient to rescue proper cranial 
neural crest migration from Hmga1 knockdown [Figure 6J]. We also calculated the ratio 
of the area occupied by migrating cranial neural crest cells between the experimental and 
control sides [Figure 6K]. For wildtype embryos, this ratio would be close to 1, reflecting 
equal neural crest migration on both sides of the embryo. However, after the loss of 
Hmga1, the ratio of areas on experimental versus control sides was 0.642±0.028 (n=5). 
Importantly, co-expression of stabilized ß-catenin in premigratory neural crest rescued 
migration, with an average migration ratio of 1.015±0.035 (n=4), which was significantly 
different from the knockout group (p<0.0001, ANOVA and post hoc Tukey HSD). 
Similarly, ubiquitous expression of the Hmga1 coding sequence also rescued neural crest 
migration, with an average migration ratio of 0.972±0.044 (n=5), which was also 
significantly different from the knockout group (p<0.001, ANOVA and post hoc Tukey 
HSD). Taken together, our results suggest that Hmga1 mediates the process of EMT by 
activating canonical Wnt signaling in premigratory neural crest cells, thus enabling them 
to emigrate from the neural tube. 
6.3 Discussion 
While chromatin modifiers are known to influence gene expression and cell fate 




Miller and Hendrich, 2018; O’Shaughnessy-Kirwan et al., 2015), parsing cell-type-specific 
functions and targets for these proteins is often challenging due to broad expression 
across multiple tissues and time points. In this study, we have used scRNA-seq to identify 
a chromatin-remodeling protein, Hmga1, as highly expressed in neural crest cells. Using 
high resolution in situ HCR and temporally controlled knockdowns, we present evidence 
for a dual role of Hmga1 in the formation and migration of neural crest cells. At early 
stages, we find that the neural plate border gene Pax7 is a downstream target of Hmga1, 
such that loss of Hmga1 blocks neural crest specification in a manner that can be rescued 
by restoring Pax7 expression. After neural crest specification is complete in the closing 
neural tube, Hmga1 plays a second role in modulating canonical Wnt signaling via 
alterations in the levels of Wnt1 in premigratory neural crest cells. This in turn influences 
neural crest EMT and delamination from the dorsal neural tube [Figure 7].  
The canonical Wnt signaling pathway is a major input in a complex GRN that 
activates transcriptional circuits and controls neural crest specification and cell lineage 
decisions (Martik and Bronner, 2017; Simões-Costa and Bronner, 2015; Williams et al., 
2019), influencing multiple aspects of neural crest development from induction at the 
neural plate border to proliferation, onset of migration via EMT, and differentiation (Milet 
and Monsoro-Burq, 2012; Rabadán et al., 2016; Simões-Costa and Bronner, 2015; 
Figure 7: Current model for Hmga1 function in chick neural crest development. Our data suggest that Hmga1 
plays temporally distinct roles in the neural plate border and dorsal neural tube. At the neural plate border, Hmga1 
acts upstream of Pax7 and is required for proper neural crest specification. Later, in the dorsal neural tube, Hmga1 
regulates the levels of Wnt1, thereby modulating the levels of canonical Wnt signaling to control neural crest 




Steventon et al., 2009; Wu et al., 2003; Yanfeng et al., 2003). For example, regulation of 
the levels of canonical Wnt signaling is critical for progressive basement membrane 
remodeling during neural tube closure and neural crest delamination. Consequently, 
perturbation of Wnt signaling output at different stages of basement membrane 
remodeling or delamination causes severe defects in neural crest EMT (Hutchins and 
Bronner, 2019; Rabadán et al., 2016). Interestingly, early inhibition of canonical Wnt 
signaling in gastrula stage chick embryos has been shown to reduce Pax7 expression 
(Basch et al., 2006), whereas canonical Wnt inhibition after neural crest specification does 
not alter Pax7 expression but has a marked effect on EMT (Hutchins and Bronner, 2018). 
This suggests that there are separable early versus late effects of canonical Wnt signaling 
during neural crest development. 
Hmga1 has been shown to upregulate canonical Wnt signaling components and 
downstream targets in the intestinal stem cell niche, thereby amplifying signaling output 
(Xian et al., 2017) presumably through increased promotor accessibility. Our results are 
consistent with a similar role for Hmga1 in the neural crest, where its loss resulted in 
decreased output from a canonical Wnt reporter [Figure 6] as well as downregulation of 
the Wnt1 ligand [Figure 6] and the canonical Wnt target Snail2 [Figure 3]. However, 
temporally controlled knockdowns revealed that loss of Hmga1 reduced Wnt1 expression 
following completion of neural crest specification, but not at earlier stages of neural crest 
induction. Conversely, Hmga1 knockdown affected Pax7 expression during neural crest 
induction but not after specification is complete. One possible explanation is that once 
open/remodeled, the chromatin landscape surrounding the Pax7 regulatory regions form 
topologically-associating domains (TADs) that are stable and resistant to repression. 
Alternatively, other Hmga1-independent cis-elements may influence Pax7 expression 
following neural crest induction. Given that neural crest cells appear to have highly 
dynamic chromatin accessibility surrounding spatiotemporally-regulated enhancer 
elements (Williams et al., 2019), we would predict the latter, though further investigation 




An intriguing possibility is that Hmga1, in addition to regulating neural crest EMT, 
is necessary for maintaining the broad developmental potential of neural crest cells. 
Neural crest cells exhibit stem-cell-like properties, including multipotency and self-
renewal. Thus, the early expression of Hmga1 in neural crest precursors, together with 
its reported role in maintaining stemness and self-renewal properties in various stem cell 
and cancer systems (Battista et al., 2003; Schuldenfrei et al., 2011; Shah and Resar, 
2012), may indicate a role in maintaining neural crest stemness. In the dorsal neural tube, 
self-renewal within the premigratory neural crest is driven by the transcription factor c-
Myc (Kerosuo and Bronner, 2016), which together with its binding partner regulates cell 
cycle progression. Consistent with this possibility, we found that the mRNA expression of 
c-Myc is downregulated in the dorsal neural tube following Hmga1 knockout. However, 
given that canonical Wnt signaling also regulates stem cell self-renewal (Xu et al., 2016), 
as well as cell cycle progression in neural crest (Burstyn-Cohen et al., 2004), Hmga1 may 
have additional Wnt-dependent and/or Wnt-independent roles in the maintenance of the 
neural crest stem cell pool. 
Hmga1 is a member of the high motility group A (HMGA) family of genes that are 
characterized by their A/T-hook domains and the ability to transform chromatin 
architecture to regulate transcription of target genes. To date, two members of the HMGA 
family, Hmga1 and Hmga2, have been identified in mammals (Reeves et al., 2001), each 
having distinct roles in oncogenesis (Jun et al., 2015; Meyer et al., 2007; Miyazawa et al., 
2004). As both genes share several common targets, they may compensate for each 
other where they overlap. Indeed, Hmga1/Hmga2 double knockout mice have severe 
embryonic lethality, compared to less-penetrant effects in individual knockouts (Federico 
et al., 2014). While both Hmga1 and Hmga2 genes are annotated in the chick genome, 
our scRNA-seq results show that a significant proportion of neural crest cells express 
Hmga1 but not Hmga2. Consistent with this, loss of Hmga1 resulted in neural crest-
related developmental defects, making it unlikely that there is redundancy and/or 
compensation by Hmga2 in chick embryos. Interestingly, only the hmga2 paralogue is 




knockdown of hmga2 did not affect the expression of neural plate border gene pax3/7. 
This contrasts with our results in chick embryos, where the loss of Hmga1 affected both 
Pax7 transcription and protein levels in the neural plate border. Together with the absence 
of Hmga2+ cells in our single-cell data, this raises the possibility that individual HMGA 
family members play discrete roles in neural crest development, similar to their distinct 
roles in tumorigenesis.  
In addition to Hmga1, other chromatin remodeling proteins serve similar functions 
in neural crest cell fate decisions. For example, both the ATP-dependent chromatin 
remodeler CHD7 and the histone demethylase Jumonji D2A (KDM4A/JmjD2A) are 
necessary for expression of neural crest specifier genes; notably, however, these 
chromatin modifiers appear to function at later developmental time points than Hmga1, 
as neither knockdown of KDM4A in chick embryos nor CHD7 in Xenopus embryos affect 
Pax3/7 expression levels (Bajpai et al., 2010; Strobl-Mazzulla et al., 2010). Furthermore, 
KDM4A influences Snai2 and Wnt1 levels, raising the possibility that Hmga1 may act in 
concert with KDM4A or other chromatin remodelers to restructure the accessibility of 
neural crest GRN circuits at different cell fate checkpoints.  
In summary, our data reveal a dual role for the chromatin remodeler Hmga1 during 
neural crest development. First, during specification at the neural plate border, Hmga1 
regulates the completion of neural crest induction as assayed by readout of Pax7 
expression at the neural plate border. Later, following neural crest specification, Hmga1 
plays a second role in modulating the levels of the canonical Wnt signaling pathway in 
the closing dorsal neural tube to influence neural crest EMT and delamination at the onset 
of their migration. Post-embryonically, neural-crest-derived cells are prone to metastasis 
and give rise to numerous cancers (Maguire et al., 2015). Furthermore, neural crest and 
cancer cells often employ similar mechanisms to drive EMT; in particular, the hallmarks 
of metastasis often involve disruption of the basement membrane, which may also be 
driven by canonical Wnt signaling (Ahsan et al., 2017; Powell et al., 2013). Interestingly, 
high expression levels of Hmga1 have been associated with premature EMT and 




et al., 2003), lung (Sarhadi et al., 2006), and ovaries (Masciullo et al., 2003). Therefore, 
it is interesting to note that Hmga1 may play parallel roles in neural crest development 
and cancer metastasis. Understanding how Hmga1, and chromatin remodeling in 
general, alters cell fate decisions and EMT through signaling and transcriptional 
regulation in neural crest cells will undoubtedly have important and broad implications in 
human development and disease. 
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 Chicken embryos (Gallus gallus) were commercially obtained from Sun Valley 
farms (CA), and developed to the specified Hamburger Hamilton (HH) (Hamburger and 
Hamilton, 1951) stage in a humidified 37°C incubator. For ex ovo electroporations, 
embryos were dissected from eggs at HH4, injected with specified reagents, then 
electroporated as described previously (Sauka-Spengler and Barembaum, 2008). 
Following electroporation, embryos were cultured in fresh albumin/1% penicillin-
streptomycin at 37°C and grown to specified HH stages. Once the embryos reached the 
desired stages, they were screened for transfection efficiency and overall health. 
Unhealthy and/or poorly transfected embryos were discarded and not included for 
downstream assays. 
6.7.3 Single-cell suspension  
HH4 embryos electroporated with FoxD3-NC2:eGFP were cultured until HH12 ex 
ovo at 37˚C, following which the hindbrain region spanning rhombomeres 6, 7, and 8 was 
dissected under a fluorescence microscope. For dissociation, several different conditions 
were tested (dissociation in a glass dish for 1h in Accumax (EMD Millipore), chemical 
dissociation on a nutator for 15, 30, and 45 minutes, and chemical dissociation with gentle 
pipetting for 15, 30, and 45 minutes). The quality of the single cell suspension obtained 
was tested by a trypan blue-based live-dead staining. Accordingly, we pooled dissected 
tissue washed in chilled 1X DPBS and incubated it in Accumax cell dissociation solution 
for 15 minutes at 37°C with gentle mixing every 5 minutes. Dissociation was terminated 
using Hanks Buffered Saline Solution (HBSS) (Corning) supplemented with BSA Fraction 
V (Sigma; 0.2% w/v). The suspension was centrifuged at 300g for 4 minutes to collect 
cells at the bottom, the supernatant was removed, and the pellet was resuspended in 
1mL HBSS-BSA. To remove cell debris and clumps, the 1mL suspension was passed 
through a 20µm filter in a clean hood. This suspension was loaded on a 10X Chromium 
chip A (v2) to generate GEMs. The library was prepared according to the manufacturer’s 




6.7.4 scRNA-seq data analysis 
The raw fastq files were aligned to the galgal6 (GRCg6a) genome assembly 
obtained from the ENSEMBL database using the cellranger pipeline downloaded from the 
10X Genomics website. For feature counts, a custom galgal6 GTF file, where all 
annotated 3’ UTRs were extended by 1kb, was used. This was done to compensate for 
improper gene annotations in the chick genome. The count matrices were then imported 
in R for analysis using Seurat (Butler et al., 2018). The initial filtering step discarded all 
cells with fewer than 200 and more than 10000 genes per cell. We also filtered out cells 
expressing more than 5% mitochondrial or less than 20% ribosomal genes. Next, we 
removed genes corresponding to small RNAs, micro RNAs, mitochondria, and general 
housekeeping from the count matrix. Following log normalization and Principal 
Component Analysis, the cells were clustered using the first 15 dimensions (calculated 
from the elbow plot). Different resolution parameter values were tested, and a value of 
0.45 was used to identify subpopulations within the data. Dimensional reductionality was 
performed using the UMAP (McInnes et al., 2018) algorithm. All plots were created in R, 
exported in SVG format, and assembled in Inkscape. All sequencing data has been 
deposited on NCBI under the accession number PRJNA624258.  
6.7.5 Hybridization Chain Reaction 
HCR v3 was performed using the protocol suggested by Molecular Technologies 
(Choi et al., 2018) with minor modifications. Briefly, the embryos were fixed in 4% 
paraformaldehyde (PFA) overnight at 4˚C or 2h at room temperature, washed in 0.1% 
PBS-Tween, dehydrated in a series of 25%, 50%, 75%, and 100% methanol washes, and 
incubated overnight at -20˚C in 100% methanol. The next day, the embryos were 
rehydrated, treated with proteinase-K for 2-2.5 minutes, and incubated with 10pmol of 
probes dissolved in hybridization buffer overnight at 37˚C. The next day, following several 
washes in “probe wash buffer,” embryos were incubated in 30pmol of hairpins H1 and H2 




were washed in 0.1% 5x-SSC-Tween and imaged. All probes were designed and ordered 
through Molecular Technologies. 
6.7.6 Molecular cloning 
 The coding sequence of Hmga1 was obtained from the UCSC genome browser 
(Karolchik et al., 2003). A V5 tag was cloned in-frame at the N-terminus using overlap 
PCR (Accuprime). The fusion product was cloned downstream of the CAGG promoter, 
upstream of the IRES-H2B-RFP segment of pCI-H2B-RFP (Betancur et al., 2010) to clone 
the final plasmid (CAGG>V5-HMGA1-IRES-H2B-RFP). The Cas9 and gRNA constructs 
(Gandhi et al., 2017), neural crest enhancer FoxD3-NC2:eGFP (Simões-Costa et al., 
2012), canonical Wnt reporter TCF/Lef:H2B-GFP (Ferrer-Vaquer et al., 2010), and neural 
crest-specific stabilized ß-catenin NC1-∆90ß-cat (Hutchins and Bronner, 2018) have all 
been previously described and validated. 
6.7.7 CRISPR-Cas9-mediated perturbations 
The genomic locus for Hmga1 was obtained from the UCSC genome browser 
(Karolchik et al., 2003). Two gRNAs targeting the coding sequence, the first targeting 
exon 3 (5’-CCAGGAAGAAACCGGAGgta-3’), and the second targeting exon 4 (5’-
GCCAGCTCCAAAGGCAGGgt-3’), were designed using CHOPCHOP (Labun et al., 
2019). The protospacers were cloned downstream of the chick U6.3 promoter as 
described in Gandhi et al., 2017. For control electroporations, the control gRNA 
described in (Gandhi et al., 2017) was used. CAGG>nls-Cas9-nls and CAGG>H2B-RFP 
were electroporated at a concentration of 2µg/µl, together with either 0.75µg/µl per 
Hmga1 gRNA on the right side or 1.5µg/µl of control gRNA on the left side.  
For Cas9/in vitro-transcribed gRNA RNP experiments, we generated single-guide 
RNAs (sgRNAs) as described previously (Hutchins and Bronner, 2018).   
2.6µl of recombinant Cas9 (M0646; New England Biolabs) was mixed with equal 




15 minutes. The solution was then incubated at room temperature for 15 minutes, mixed 
with 2µg/µl H2B-RFP and 1µl of sterilized 2% food dye, and injected in embryos for 
electroporation. 
6.7.8 In situ hybridization and immunohistochemistry  
Chromogenic in situ hybridization was performed as described previously for 
FoxD3, Sox10, and Tfap2b, c-Myc, and Wnt1 (Kerosuo and Bronner, 2016; Simões-Costa 
and Bronner, 2016; Simões-Costa et al., 2015).  
 Immunohistochemistry was performed as described previously (Gandhi et al., 
2017). Briefly, embryos were fixed for 20 minutes at room temperature, blocked in 10% 
goat or donkey serum in 0.5% PBS-Triton overnight at 4˚C, incubated overnight at 4˚C in 
primary antibodies diluted in blocking solution, washed at room temperature in 0.5% PBS-
Triton, incubated overnight at 4˚C in secondary antibodies diluted in blocking solution, 
washed at room temperature in 0.5% PBS-Triton, and processed for imaging and/or 
cryosectioning. The following primary antibodies and concentrations were used: Mouse 
IgM HNK1 (1:5; Developmental Studies Hybridoma Bank (3H5)); Mouse IgG1 Pax7 (1:10; 
Developmental Studies Hybridoma Bank (RRID:AB_528428)); Goat GFP (1:500; 
Rockland Cat# 600-101-215); Rabbit RFP (1:500; MBL Cat# PM005); Rabbit Snail2 
(1:200; Cell Signaling Technology (9585)); Rabbit Laminin (1:1000; Sigma-Aldrich 
(L9393)); Rabbit cleaved-Caspase 3 (1:500; R&D Systems Cat# AF835); Mouse 
phospho-histone H3 (1:500; Abcam Cat# Ab14955). The following species-specific 
secondary antibodies labeled with Alexa Fluor dyes (Invitrogen) were used: Goat/Donkey 
anti-mouse Alexa Fluor 647 (for Pax7 and pH3; 1:250), Goat/Donkey anti-mouse IgM 
Alexa Fluor 350/488 (for HNK1; 1:250), Goat/Donkey anti-rabbit Alexa Fluor 488 (for 
Snail2, cleaved-Caspase3, and Laminin; 1:250), Donkey anti-goat Alexa Fluor 488 (for 







Following whole mount imaging, embryos were washed in 5% and 15% sucrose 
overnight at 4˚C. The next day, embryos were transferred to molten gelatin for 3-5h at 
37˚C, embedded in molds at room temperature, frozen in liquid nitrogen, and stored at     
–80°C overnight. Embedded embryos were sectioned on a micron cryostat to obtain 
16µm sections through immunostained embryos and 20µm sections through in situ 
hybridized embryos. The sections were degelatinized at 42°C in 1x PBS for 5 minutes, 
washed in 1x PBS, soaked in 1x PBS containing 0.1µg/mL DAPI for 2 minutes, washed 
in 1x PBS and distilled water. Fluoromount mounting medium was used to mount 
coverslips on slides.  
6.7.10 Microscope image acquisition, analysis, and statistical tests 
Whole mount embryos and sections on slides were imaged on a Zeiss Imager M2 
with an ApoTome module and/or Zeiss LSM 880 confocal microscope at the Caltech 
Biological Imaging Facility. Images were post-processed using Fiji imaging software 
(Schindelin et al., 2012). To calculate corrected total cell fluorescence (CTCF), the 
following formula was used: 
𝐶𝑇𝐶𝐹 = 𝐼𝑛𝑡𝑒𝑔𝑟𝑎𝑡𝑒𝑑	𝐷𝑒𝑛𝑠𝑖𝑡𝑦 − (𝑆𝑒𝑙𝑒𝑐𝑡𝑒𝑑	𝑎𝑟𝑒𝑎 ∗ 𝑀𝑒𝑎𝑛	𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑	𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒). 
For cell counts, a median filter was applied to 8-bit images. A Bernsen-based auto 
local-thresholding method (Bernsen, 1986) followed by watershed segmentation was 
used to identify cell boundaries. The “Analyze particles” function was used to count the 
number of cells. All statistical analyses were performed in R. The Wilcoxon rank test was 
used on datasets that were not normally distributed. In cases where the underlying 
distribution was normal, Student’s t-test was used to calculate significance. In cases 
where multiple samples were compared, Analysis of Variance (ANOVA) test combined 
with Tukey HSD test was used. Post hoc power analysis was used to validate sample 
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6.9 Supplementary Figures 
 
  
Supplementary Figure 1. Quality of single-cell RNA-seq dataset. A. Scatter plot shows high correlation between 
the number of unique genes and the total number of molecules detected in each cell. B-C. The distribution of total 
number of molecules (B) and number of unique genes (C) detected per cell across the 8 cell types identified within 
the chick hindbrain. D. Increasing the resolution parameter in the single-cell analysis pipeline to calculate a cell’s 
“nearest neighbor” allowed identification of three subpopulations within the ‘mesoderm’ cluster displayed in Figure 1B. 
Based on marker gene expression, these subpopulations were identified as mesoderm (Twist1+), paraxial mesoderm 
(Prrx1+), and myocardium (Hand2+). E. The expression of the top 10 most abundant genes from each subcluster was 
used to plot a heatmap, which also grouped into 8 distinct categories, similar to (D). A subset of these abundant genes 







Supplementary Figure 2. Identification of novel genes expressed in the neural crest. A. Feature plots showing 
expression of marker genes in low-dimensional space used to identify all 8 sub-clusters within the chick hindbrain. B. 
Violin plots showing the distribution of expression of these marker genes (A) in surrounding cell types. C. Relative 
expression of all genes expressed in the neural crest cluster that share the GO terms “DNA binding,” “transcription 
factor,” and “regulation of transcription.” Several of these genes are transcriptional regulators and/or chromatin 
remodelers that are also expressed in surrounding tissues. The radius of each point reflects the proportion of cells 
within individual clusters that express a specific gene, whereas the relative expression is reflected by the color of the 






Supplementary Figure 3. Overlapping expression of Hmga1 and Pax7 in the neural crest visualized in 
individual channels. A-H. Transverse sections shown in Figure 2 stained with DAPI (A,C,E,G). The expression of 
Hmga1 and Pax7 overlapped in the neural plate border (B,B’; arrows), dorsal neural folds (D,D’; arrows), premigratory 





Supplementary Figure 5. Hmga1 knockout does not affect neural crest cell proliferation and apoptosis. A. 
Whole mount embryo shown in Figure 4F. Nuclear RFP was electroporated as a transfection control. B-G’. Adjacent 
transverse sections through embryo in A immunostained with antibodies against phospho-histone H3 (B,C’,D’) and 
cleaved-caspase-3 (E,F’,G’) as a readout for cell proliferation and apoptosis, respectively. While the levels of Pax7 
protein (C,D,F,G) were downregulated in the absence of Hmga1, no notable difference was observed in the rate of 
proliferation or cell death between the experimental (right; D’,G’) and control (left; C’,F’) sides. H. The relative 
fluorescence intensity for Pax7, cleaved-caspase-3, and phospho-histone H3 was measured as the ratio of corrected 
total cell fluorescence (C.T.C.F.) between the knockout versus the control side. The Pax7 fluorescence intensity was 
significantly reduced (** p<0.01, paired Student’s t-test) on the knockout side, whereas the difference between 
cleaved-caspase-3 and phospho-histone H3 relative intensities was not significant (n.s. p>0.05, paired Student’s t-
test). Dotted line represents unperturbed ratio. 
Supplementary Figure 4. Knocking out Hmga1 in gastrula stage embryos. A. The genomic locus of Hmga1 in 
the chick genome. Two gRNAs, one targeting the splice donor site of exon 3 and another one targeting the splice 
donor site of exon 4 were designed to knock it out using CRISPR-Cas9. The protospacer adjacent motifs for both 
gRNAs lie in the intronic regions (highlighted in blue). B. Electroporated embryos were allowed to develop until HH9+ 
and immunostained for the migratory neural crest marker HNK1. In the absence of Hmga1, neural crest cells failed to 
migrate properly on the experimental side. C. Hmga1 knockout results in reduced c-Myc expression in premigratory 
neural crest. D-E’’. Transverse section through a representative Hmga1-knockout embryo with FoxD3 mRNA labeled 
using in situ hybridization. Neural crest cells migrated normally on the control (arrow) compared to the knockout side 
(asterisk). While the thickness of the neural tube (E) was unaffected on the knockout side, the expression of Pax7 (E’) 






Supplementary Figure 6. Hmga1 regulates Wnt1 expression in premigratory cranial neural crest cells. A. 
Genomic locus of Wnt1 obtained from the UCSC genome browser (Karolchik et al., 2003). ATAC-seq profile of 
premigratory cranial neural crest cells (from Williams et al., 2019) shows a putative Wnt1 enhancer upstream of the 
gene (highlighted in red). B. Genomic sequence of the putative enhancer identified in (A) contains a predicted AT-rich 
Hmga1 binding motif (red box). C. A representative Hmga1-knockout embryo immunostained for Pax7 shows a 
migration defect on the experimental side (right) compared to the control side (left). D. The area covered by migratory 
cranial neural crest cells, marked by the position of the lateral-most leader cell, is reduced following Hmga1 knockout 
(green – control; 53.3 a.u.2, magenta – knockout; 40.5 a.u.2). An overlay of the two areas highlights this reduction. E. 
Transverse section through the embryo shown in (C). The number of dorsal neural tube cells positive for canonical 
Wnt activity, as indicated by the nuclear GFP reporter expression (E), was significantly decreased following the loss 
of Hmga1 (shown in Figure 6C). However, the number of Pax7+ cells (E’) on either side of the dorsal neural tube were 
relatively similar, despite the observed migration defect in (C). No difference in the thickness of the neural tube (E’’) 









Cardiac neural crest plasticity in heart development 
A modified version of this chapter was published as: 
Gandhi, S., Ezin, M., and Bronner, M.E. (2020). Reprogramming axial level identity to 













The vertebrate heart arises from cells in the lateral plate mesoderm that converge 
at the embryonic midline and fuse into a heart tube. In amniotes, cells from the second 
heart field are added after the heart tube loops, causing remodeling of the tube to form 
four heart chambers—two atria and two ventricles. The looped heart connects to the 
forming lungs by means of the truncus arteriosus, which initially is a single vessel destined 
to form the outflow tract of the heart. Cardiac neural crest cells make a critical contribution 
to the heart by septating the truncus arteriosus into the pulmonary trunk, through which 
deoxygenated blood flows to the lungs, and the aortic trunk, through which oxygenated 
blood is pumped throughout the body. In fact, abnormal cardiac crest development results 
in some of the most common human congenital heart defects (Grossfeld et al., 2004; 
Loffredo, 2000; Neeb et al., 2013), including Persistent Truncus Arteriosus (PTA), in 
which the aorticopulmonary septum fails to close, resulting in mixing of oxygenated and 
deoxygenated blood.  
Premigratory cardiac neural crest cells initially reside within the developing caudal 
hindbrain, from which they migrate to the forming pharyngeal arches 3, 4, and 6 (Phillips 
et al.,1987). While some cells remain in the arches, contributing to the carotid and other 
arteries (Waldo and Kirby,1993), others invade the heart to form the aorticopulmonary 
septum, cardiac cushions, part of the interventricular septum, and cardiac ganglia (Kirby 
and Stewart,1983). A small number of neural crest cells also move through arches 1 and 
2 to the right ventricle, where they adopt coronary smooth muscle fates (Arima et al., 
2012). 
Loss of genes important for cardiac neural crest development, such Pax3 or Edn1 
(endothelin-1), results in cardiac abnormalities (Franz,1989; Kurihara et al.,1999). 
Moreover, surgical ablation of the cardiac crest in chick (Kirby and Waldo,1990; Kirby et 
al.,1985) phenocopies human PTA (Besson et al.,1986; Kirby and Waldo,1995; 
Nishibatake et al.,1987). Importantly, grafting cranial or trunk neural crest in place of 




differences exist along the body axis in the neural crest’s ability to form cardiovascular 
derivatives. However, the mechanisms underlying the cardiac crest’s unique 
developmental potential remain unknown.  
Here, we tackle the molecular and cellular basis of cardiac crest-related birth 
defects by combining classical embryology with state-of-the-art genomics approaches. 
First, we reproduce and extend classical chick embryological experiments done over 30 
years ago and report laterality differences in cardiovascular defects resulting from 
unilateral cardiac neural fold ablations. Second, we identify new genes enriched in the 
cardiac neural crest by bulk and single-cell RNA-seq and demonstrate that migrating 
cardiac crest cells represent a heterogeneous population. Third, we establish regulatory 
relationships of cardiac neural crest genes and explore their role in heart development. 
Accordingly, we find that one of these genes, Tgif1, functions in a cardiac neural crest 
subcircuit important for specification and proper outflow tract septation. Finally, we show 
that ectopic expression of a cardiac crest-specific subcircuit, comprised of Sox8, Tgif1, 
and Ets1, is sufficient to reprogram trunk neural crest cells, enabling them to migrate to 
the heart and rescue the effects of a cardiac crest ablation, which they cannot normally 
do. Taken together, our results help elucidate the unique genetic properties of the cardiac 
neural crest in formation and function of the heart. Our results uncover potential target 
genes involved in cardiovascular birth defects and provide a molecular recipe for 
generating ectomesenchymal derivatives of the cardiac crest for the purposes of 
regenerative medicine.  
7.3 Results 
7.3.1 Ablation of the chick cardiac neural crest results in cardiovascular defects 
 The cardiac neural crest was described by Kirby and colleagues (Besson et 
al.,1986; Bookman et al.,1987; Harrison et al.,1995; Kirby et al.,1985; Nishibatake et 
al.,1987) as arising in the caudal hindbrain [Figure 1A,B]. Moreover, bilateral ablation of 
this region in chick embryos at a time corresponding to when the cardiac crest cell fate is 





To reproduce and extend cardiac neural crest ablation experiments, we ablated 
the chick dorsal neural tube adjacent to the caudal hindbrain [Figure 1C-D] at Hamburger 
Hamilton stage (HH) 9-10 (Hamburger and Hamilton,1951) and allowed embryos to 
develop until embryonic day (E) 3 or E6. In normal embryos, the primary heart tube 
exhibited proper elongation and looping dynamics at E3 [Figure 1E; Supplementary 
Figure 1A]. Staining sections of the heart tube for the myosin heavy chain marker MF20 
revealed uniform filamentous staining throughout the myocardial sleeve [Figure 1E’] of 
the distal outflow limb. At E6, the aorticopulmonary septum of control embryos developed 
normally [Figure 1I] with the aorta connected to the left ventricle and pulmonary trunk 
Figure 1. Chick cardiac neural crest ablation results in cardiovascular abnormalities. A. Dorsal view of a whole-
mount stage HH9+ embryo (inset). Cardiac domain stained with neural crest marker Pax7 (Magenta) and neural tube 
marker Sox2 (Green). Dotted line indicates level of sections in B-D. B. Transverse section through A shows cardiac 
neural crest residing in the dorsal neural tube in wild type embryo. C-D. Transverse section through embryos after 
unilateral (C) and bilateral (D) dorsal neural fold ablation. E-G. Ventral view of E3 control (E), unilaterally ablated (F), 
and bilaterally ablated (G) primary heart tubes. E’-G’. Transverse sections through E-G stained with the muscle 
marker MF20 show uniform MF20 labeling in wild type (E’) heart but patchy expression (arrows) in ablated embryos 
(F’-G’). H. Whole-mount image of an E6 chick embryo. Dotted line shows angle of sectioning in I-K. I. Cross-section 
through the outflow tract of a wild type E6 embryo shows complete septation, with the aorticopulmonary septum 
(AoP) separating the aorta (Ao) from pulmonary trunk (PT). J-K. Unilateral (J) and bilateral (K) cardiac crest ablation 
results in the failure of outflow tract septation, resulting in a single vessel emerging from the heart. (SMA; red, DAPI; 
blue) ot-otic placode, s-somites, At-atrium, V-ventricle, OFT-outflow tract, ect-ectoderm, nc-notochord, Hb-




connected to the right. In contrast, bilaterally ablated embryos had an uneven distribution 
of MF20 in the distal outflow limb at E3 [Figure 1G’] and a complete lack of septation of 
the outflow tract at E6, characteristic of severe PTA [Figure 1K].  
Next, we unilaterally ablated either the right (n=9) or left (n=8) dorsal neural tube, 
leaving the contralateral side intact [Figure 1C,D]. At E3, the primary heart tube appeared 
“bulbous” with a shortened and straighter outflow tract compared to the control group 
[Figure 1F,G]; no differences were noted between right or left cardiac neural fold 
ablations. At E6, removal of the cardiac neural folds from the right side caused PTA (n=4/9 
embryos) [Figure 1J], albeit not as severe as the phenotype observed following bilateral 
ablation. Notably, all embryos with an outflow tract septation defect following unilateral 
ablation had outflow tract cushions that failed to fuse in the middle, suggesting that a 
critical cardiac neural crest cell number is necessary to form the aorticopulmonary 
septum. In three cases, we observed Double Outlet Right Ventricle (DORV), another 
phenotype commonly associated with cardiac crest perturbations. In contrast to right side 
unilateral ablation, removal of the left dorsal neural tube resulted in DORV as the 
predominant phenotype (n=6/8) [Supplemental Figure 1B], with one embryo having PTA. 
These results raise the intriguing possibility that differences exist in the cardiovascular 
contributions of cardiac crest cells from different sides of the neural tube. Together, our 
results suggest that a bilateral cardiac neural crest contribution is necessary for proper 
outflow tract septation, and that unilateral extirpation of the caudal hindbrain is sufficient 
to cause cardiovascular anomalies. 
7.3.2 Population level transcriptome analysis reveals genes enriched in the 
cardiac neural crest  
To identify molecular mechanisms underlying the cardiac crest’s unique 
developmental potential to contribute to the cardiovascular system, we turned to a 
comparative transcriptomics approach to identify transcription factors enriched in the 
cardiac relative to trunk crest populations. To this end, we used the FoxD3-NC2 (Simões-




[Figure 2A] and later in the trunk neural crest [Figure 2B]. Dissecting embryos at different 
axial levels and developmental time points enabled isolation of pure migrating cardiac 
and trunk neural crest populations by Fluorescence-Activated Cell Sorting (FACS). 
Following library preparation, sequencing, and data analysis, we identified 474 genes 
upregulated in cardiac compared to trunk neural crest population [Figure 2C]. Quality 
control on the sequenced libraries showed that the data were good quality 
[Supplementary Figures S1C,D]. 
Next, we focused on transcription factors that were significantly upregulated in 
cardiac versus trunk crest [Figure 2C’]. We identified some transcription factors that were 
previously known to be expressed and/or functionally relevant in cardiac crest 
development, including V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog 1 
(Ets1) (Gao et al., 2010), MAF BZIP Transcription Factor B (MafB), and Transcription 
Factor AP-2 Beta (Tfap2b) (Tani-Matsuhana et al., 2018) [Figure 2D-F]. Others, such as 
TGFB-Induced Factor Homeobox 1 (Tgif1), SRY Box Transcription Factor 8 (Sox8), 
NACC family member 2 (Nacc2), and MAF BZIP Transcription Factor K (MafK), were 
transcription factors not previously ascribed to the cardiac neural crest. Their expression 
in the migrating cardiac crest was validated using in situ hybridization [Figure 2G-I]. Next, 
we compared genes enriched in cardiac crest to those previously shown to be enriched 
in cranial crest (Simões-Costa and Bronner, 2016). While some genes were shared with 
the cranial (e.g. Ets1, Sox8, Tfap2b), other genes were unique to the cardiac crest stream 
(e.g. Tgif1, MafK, Nacc2), thus identifying previously uncharacterized cardiac axial level-
selective transcription factors. 
7.3.3 Single-cell RNA-seq reveals heterogeneity in migrating cardiac crest  
Next, we turned to single-cell RNA-seq (scRNA-seq) to deeply profile individual 
cardiac neural crest cells. To this end, we labeled cardiac crest cells as described above 
and isolated 156 single cells using FACS. The libraries containing each barcoded cell 






Figure 2. Bulk and single cell transcriptional profiling of cardiac neural crest. A-B. Pure populations of cardiac 
or trunk neural crest cells labeled with the FoxD3-NC2 enhancer were isolated using FACS at HH12 (A) and HH18 
(B), respectively. C-C’. Volcano plot showing fold change and significance of genes enriched in cardiac and trunk 
neural crest (logFoldChange>1). Transcription factors examined for expression in migrating cardiac crest are 
highlighted in (C’). D-I. In situ hybridization of HH12 embryos shows expression of selected transcription factors in 
migratory cardiac crest (dorsal view; arrows). J. UMAP plot depicting clustering of 156 single cardiac neural crest 
cells that were profiled using smart-seq v2. J’-J’’. Cluster C1 and C2 exhibit high expression of neural crest markers 
Sox10 (J’) and FoxD3 (J’’) and differed subtly in the expression of proliferation genes. K. GO term analysis on 
differentially upregulated genes in each cluster confirmed the identity of each subpopulation within the migrating 
cardiac crest (Fisher’s exact test, adjusted-p<0.05). L. Heatmap illustrating hierarchical clustering of single cells that 
passed filtering parameters and expression levels of selected neural crest, ectomesenchymal, and neuronal genes. 
A few cells from the cardiac crest progenitor clusters C1 and C2 grouped together with cells from the 
ectomesenchymal cluster C3. M-N. Pseudotime analysis (M) on migratory cardiac crest cells. Cells are labeled 
according to their pseudotime values (N). ot-otic vesicle, cnc-cardiac neural crest, tnc-trunk neural crest, Hb-




Following alignment, filtering, and normalization, we recovered high quality data 
for 149 single cells [Supplementary Figure S1E-G]. Principal Component Analysis (PCA) 
followed by Uniform Manifold Approximation and Projection (UMAP) revealed the 
presence of 4 distinct clusters (C1, C2, C3, and C4) within the migrating cardiac crest 
population, suggesting heterogeneity between clusters [Figure 2J]. Bona fide migratory 
crest markers Sox10 and FoxD3 were less abundant in C3 compared to C1, C2, and C4 
[Figure 2J’-J’’], suggesting that a subset of migrating cardiac crest cells may already be 
down-regulating an early neural crest program, perhaps indicating fate restriction.  
To further explore these differences, we performed GO term enrichment analysis 
of genes that were differentially upregulated in each cluster [Figure 2K] and found that 
biological processes such as heart development and circulatory system development 
were primarily associated with C1 and C2 (p<0.05; Fisher’s exact test). C3 was 
associated with positive regulation of smooth muscle cell proliferation and muscle cell 
differentiation, consistent with reduced expression of bona fide neural crest markers. 
Similarly, C4 was associated with ephrin receptor signaling and central nervous system 
development, supporting a neuronal identity. C1 and C2 were transcriptionally similar to 
each other [Figure 2L] apart from a subtle increase in expression of cell proliferation 
genes such as Kpna2 and Cdc20 in C2.  
In contrast, we found a significant enrichment of ectomesenchymal cell state 
markers such as Twist1, Prrx1, and Acta2 in C3, suggesting that cells in this cluster have 
acquired a restricted ectomesenchymal cell state at the expense of a multipotent neural 
crest identity. Furthermore, C4 had increased expression of Schwann cell markers such 
as EphA4, Krox20, and Nrip3, along with bona fide crest markers such as Sox10, Ets1, 
and FoxD3. Based on marker genes, we ascribed the following identities to the single cell 
subclusters: progenitor cardiac crest (C1, C2), ectomesenchymal cardiac crest (C3) and 
Schwann cell-like (C4). Interestingly, hierarchical clustering with labeled UMAP cluster 
identity showed that a subset of progenitor cardiac crest cells was affiliated with the 
ectomesenchymal group, suggesting that we captured single cells that were transitioning 




potential relationships between subpopulations using Monocle [Figure 2M-N]. 
Unsupervised clustering along the pseudotime trajectory demonstrated a gradual 
transition from cells in cluster C1 (progenitor) to proliferating (C2), Schwann cell-like (C4), 
and ectomesenchymal (C3) cardiac crest [Figure 2M]. Taken together, these results 
suggest cellular heterogeneity within early migrating cardiac crest populations.  
To test whether our single-cell data, pooled together, recapitulated the cardiac 
neural crest transcriptomic profile obtained from bulk RNA sequencing, we compared the 
relative abundance of transcripts as measured by fragments per kilobase of exon per 
million fragments mapped (FPKM). The genes enriched in the two datasets were 
positively correlated, with a Pearson’s correlation coefficient of 0.85 [Supplementary 
Figure S1H]. Using markers identified and validated at the population level, we looked for 
their distribution of expression in the scRNA-seq data [Supplementary Figure S1I]. As 
expected, the expression of cardiac crest markers Ets1, MafB, Tfap2b, MafK, Nacc2, 
Sox8, and Tgif1 was uniformly distributed across C1, C2, and C4, with the latter four also 
similarly expressed in C3. Together, these results demonstrate that the four subclusters 
reflected the profile observed in the bulk cardiac crest dataset. 
7.3.4 Transcription factor Tgif1 is required for cardiac neural crest specification  
With an eye toward finding transcription factor(s) expressed at the onset of cardiac 
crest specification, we analyzed spatiotemporal expression patterns and were particularly 
intrigued by Tgif1 due to its selective expression in the delaminating cardiac crest at HH10 
[Figure 3A,B,E], the time at which cardiac crest fate is determined (Ezin et al., 2009). 
Tgif1 expression was first observed at stage HH9+ [Figure 3A] in the dorsal neural tube 
between the otic vesicle and the third somite, overlapping with the cardiac neural crest 
territory. After delamination at HH10 [Figure 3B,E], Tgif1 expression was retained in 
migrating cardiac crest cells co-expressing neural crest marker HNK-1 (Basch et al., 
2006) at HH12 [Figure 3C,D,F,F’].  
We next examined the role of Tgif1 in cardiac crest development. To this end, we 




chick embryos. We designed two gRNAs, one targeting the splice acceptor site of the 
second exon, and the second one targeting the third exon [Supplementary Figure S2A].  




To test if gRNAs targeting Tgif1 were sufficient to knock out its expression, we 
electroporated the right side of gastrula stage embryos with expression constructs for 
Cas9, Tgif1 gRNAs, and H2B-RFP, and the left side with control reagents and GFP 
[Figure 3G,H]. Embryos were cultured ex ovo until HH12 and assayed for expression of 
Tgif1 by in situ hybridization. As expected, these embryos exhibited nearly complete loss 
of Tgif1 [Figure 3I] on the experimental side, validating our approach. Furthermore, 
knockout of Tgif1 resulted in a notable reduction in expression of other cardiac crest 
markers like Tfap2B, MafB, Nacc2, Ret, and CXCR4 [Figure 3J-N]. Interestingly, while 
expression of the pan-neural crest markers Sox10 and FoxD3 was reduced on the Tgif1 
knockout side, the number of cells migrating away from the neural tube was similar, albeit 
in disorganized migration streams [Supplementary Figure 2B,C]. These data suggest that 
Tgif1 plays a pivotal role in the cardiac crest gene regulatory network. 
7.3.5 Tgif1 is necessary for proper outflow tract septation  
Given its importance in early cardiac crest development, we asked if Tgif1 is 
necessary for proper outflow tract septation using a grafting approach where the dorsal 
neural tube adjacent to the hindbrain of GFP+ control or Tgif1 knockout embryos was 
either unilaterally or bilaterally grafted into wild type embryos [Figure 3O]. As right 
unilateral cardiac neural fold ablation produces PTA [Figure 1H], we first asked whether 
unilateral knockout of Tgif1 was sufficient to cause septation defects. To this end, we 
Figure 3. Tgif1 is critical for cardiac neural crest specification and outflow tract septation. A-D. Spatiotemporal 
expression pattern of Tgif1 in cardiac neural crest between stages HH9+ and HH12 (dorsal view). E. Transverse 
section through (B) shows Tgif1 expression in delaminating cardiac crest cells in the dorsal neural tube. F-F’. 
Transverse section through (D) shows Tgif1 expression in migrating cardiac crest which overlaps with the expression 
of the neural crest marker HNK1 (F’). G. Diagram depicting ex ovo electroporation strategy for Tgif1 knockout in 
gastrula stage embryos. H. An embryo transfected with gRNAs targeting Tgif1 (magenta) and control gRNA (green) 
(dorsal view). I-N. Following CRISPR-Cas9-mediated knockout of Tgif1, expression of the indicated transcription 
factors was significantly reduced (dorsal view). Arrows indicate normal gene expression on control side. O. 
Experimental strategy to investigate the role of Tgif1 in outflow tract septation. Cardiac neural folds from a transgenic 
embryo where Tgif1 was bilaterally knocked out at the gastrula stage were grafted in place of the ablated cardiac 
crest in a stage-matched HH9 wildtype host. P. Cardiac crest cells from control gRNA-electroporated transgenic 
graft are observed within the condensed mesenchyme of the properly septated outflow tract. Q. The OFT of embryos 
grafted with the Tgif1 knockout cardiac neural fold failed to septate. Hb-hindbrain, ot-otic placode, ect-ectoderm, 
nt-neural tube, nc-notochord, cnc-cardiac neural crest, Ao-aorta, PT-pulmonary trunk, OFT-outflow tract. See also 




electroporated Cas9, Tgif1 gRNAs, and H2B-RFP on the right side of gastrula stage 
transgenic embryos and cultured them ex ovo until HH9+; control embryos were 
electroporated with expression constructs for Cas9, control gRNA, and H2B-RFP. 
Chimeras were developed until E6, the stage by which outflow tract septation in chick 
embryos is complete. Transverse sections through control chimeras confirmed that the 
outflow tract was properly septated, with GFP+ cardiac crest cells condensed in the 
septum [Figure 3P; n=2/2], replicating previous results of quail-chick chimeras 
(Kirby,1989; Kirby et al.,1985). Next, we repeated this experiment with unilateral grafting 
of the cardiac neural fold from a Tgif1 knockout transgenic embryo. The results show that 
this also results in a fully septated outflow tract, albeit with a significantly reduced number 
of GFP+ cells in the septum [Supplementary Figure S2D; n=4/4]. Thus, the presence of 
the contralateral host cardiac crest together with a reduced number of transgenic cells 
appears to be sufficient to compensate for the unilateral loss of Tgif1. 
As its unilateral loss was not sufficient to cause abnormalities, we tested the effects 
of bilateral Tgif1 loss of function using bilateral neural fold grafts from Tgif1 knockout 
transgenics. Remarkably, in E6 embryos, the outflow tract failed to septate, resulting in a 
single outflow vessel emerging from the heart [Figure 3Q; n=3/3], despite the migration 
of transgenic cells into the outflow tract. GFP+ cells were observed in other known 
derivatives of the cardiac crest, such as the left and right internal and external carotid 
arteries, demonstrating that outflow tract defects did not result from improper graft 
incorporation [Supplementary Figure S2E]. Taken together, the results show that Tgif1 
expression in cardiac neural crest cells is necessary for proper outflow tract septation. 
We confirmed that Tgif1 was not expressed in trunk neural crest by using Hybridization 
Chain Reaction (HCR) against Sox10, FoxD3, and Tgif1 in a HH15 chick embryo 
[Supplementary Figure S2F]. While Sox10, FoxD3, and Tgif1 expression overlapped in 
cardiac crest cells invading the circumpharyngeal ridge, Tgif1 transcripts were absent 
from migrating trunk neural crest cells [Supplementary Figure S2G-H]. We next asked if 
Tgif1 was sufficient to confer “cardiac-like” characteristics onto other axial levels, but 




neural crest enhancer (Betancur et al., 2010) in the trunk neural crest, used here as a 
readout for cardiac identity [Supplementary Figure S2I-K]. This suggested that other 
factors may work synergistically with Tgif1 for acquisition of cardiac crest fate. As we 
previously reported that  minimum of three transcription factors was required to reprogram 
trunk neural crest to a cranial crest identity (Simões-Costa and Bronner, 2016), we 
broadened our search to identify other putative cardiac neural crest subcircuit genes that 
might work in concert with Tgif1.  
7.3.6 HCR and scRNA-seq reveal coexpression of Tgif1 with Ets1 and Sox8  
We were able to eliminate several candidate genes that were not yet expressed in 
delaminating/early migrating cardiac crest cells [Supplementary Figure S3A]. However, 
Ets1 caught our attention as its loss causes ventricular septal defects, commonly 
associated with defects in cardiac crest development (Gao et al., 2010; Ye et al., 2009). 
In addition, SoxE transcription factors Sox8/9/10 are necessary for initiation of neural 
crest formation at all axial levels (O’Donnell et al., 2006). Amongst the family of SoxE 
factors, Sox8 was significantly enriched in cardiac relative to trunk neural crest. We first 
performed HCR using probes for Sox8, Tgif1, and Ets1 on HH12 chick embryos to test 
their coexpression [Figure 4A]. The results reveal overlapping expression of Ets1, Sox8 
and Tgif1 in migrating cardiac crest cells [Figure 4B-B’’] at single-cell resolution, with the 
three genes overlapping in the post-otic stream of migrating neural crest cells 
[Supplementary Figure S3B-E]. To further explore their co-expression at the single-cell 
level, we probed individual cells from our scRNA-seq dataset. Among the four 
subpopulations, subclusters C1 and C2 had signatures characteristic of progenitor 
cardiac crest cells. By visualizing the expression of the three genes on a UMAP plot 
[Figure 4C-E; Supplementary Figure S3F-K], we found overlapping expression of Tgif1, 
Sox8, and Ets1 in 93% of the cells in the two cardiac neural crest progenitor clusters 
[Figure 4F], suggesting that they could function as a cardiac crest-specific subcircuit. Of 
note, downstream cardiac crest transcription factors Tfap2B, MafB, Nacc2, and Ret were 





Figure 4. Tgif1 is coexpressed with Sox8 and Ets1 in migrating cardiac neural crest. A-B’’. HCR against Sox8 
(B), Tgif1 (B’), and Ets1 (B’’) shows their overlapping expression in the migrating cardiac crest cells. C-F. Expression 
levels of Sox8 (C), Tgif1 (D), and Ets1 (E) in individual cardiac crest cells following deep single-cell profiling. In 
progenitor cardiac crest clusters, the three genes had overlapping expression (orange) in 93% of the cells (F). G-I. 
Spatiotemporal expression pattern of Sox8 (G-G’’’), Tgif1 (H-H’’’), and Ets1 (I-I’’’) in the cardiac crest region between 
stages HH9+ and HH12 (dorsal view). J. Schematic diagram of HH12 embryo shows overlapping expression domains 
of Tgif1, Ets1, and Sox8 in the cardiac neural crest. K. The hierarchy of temporal expression dynamics of cardiac 
crest subcircuit genes from HH9 to 12. Ot-otic vesicle, Hb-hindbrain, nt-neural tube, cnc-cardiac neural crest, r4-




7.3.7 Sox8, Tgif1 and Ets1 comprise a transcriptional cascade important for 
cardiac neural crest  identity 
To explore regulatory relationships between Sox8, Tgif1, and Ets1, we first 
performed HCR  [Fig.4G-I] to establish their temporal order of expression in the cardiac 
crest. The results show that Sox8 turns on first at HH9, followed by Tgif1 at HH9+ and 
Ets1 at HH10+ [Fig.4J-K]. Given this putative hierarchy, we examined their functional 
relationships within a subcircuit by individually knocking out Sox8, Tgif1, or Ets1 using 
CRISPR-Cas9. To this end, we performed ex ovo electroporation of expression 
constructs for Cas9, gRNAs targeting Sox8, Tgif1 or Ets1 [Supplementary Figure S2A], 
and H2B-RFP on the right side of gastrula stage embryos; the left side was transfected 
with control reagents. Embryos were cultured ex ovo until HH11, then assayed for 
expression of the three factors using HCR.  
Sox8 knockout resulted in loss of both Tgif1 and Ets1 [Figure 5A,E,J], suggesting 
that Sox8 forms the uppermost node of this transcriptional subcircuit. On the other hand, 
knockout of Tgif1 resulted in reduction of Ets1 expression [Figure 5K] but no noticeable 
effect on Sox8 [Figure 5B]. Finally, loss of Ets1 had no effect on either Sox8 [Figure 5C] 
or Tgif1 [Figure 5G] in the premigratory neural crest, albeit Sox8 levels were reduced in 
the otic vesicle, suggesting that Ets1 might be a functional input into Sox8 in the ear but 
not cardiac crest. To further explore the epistatic nature of these regulatory relationships, 
we asked if Ets1 expression could be rescued after Sox8 knockout by exogenously 
expressing Tgif1. To test this, we removed Sox8 on the right side of gastrula stage 
embryos using CRISPR-Cas9 as described above, and concomitantly ectopically 
expressed Tgif1. Overexpression of Tgif1 was sufficient to partially rescue the levels of 
Ets1, even though the level of Sox8 was notably diminished [Figure 5D-D’]. Next, we 
asked if these regulatory linkages might result from direct interactions. To this end, we 
searched for putative transcription factor binding sites in enhancers that mediated 









For Ets1, we used a previously published enhancer that recapitulates Ets1 
expression in the cranial and cardiac neural crest (Barembaum and Bronner, 2013). For 
Tgif1, we identified an enhancer that was evolutionary conserved across several 
vertebrate species [Supplementary Figure S4A-C] and drove reporter expression in a 
manner that recapitulated that of Tgif1. We then identified and mutated putative binding 
sites for Sox8 in the Tgif1 enhancer (Tgif1-∆Sox8) and for Tgif1 in the Ets1 enhancer 
(Ets1-∆Tgif1). Mutant and wild type enhancers driving GFP were electroporated on the 
right or left side of gastrula stage embryos, respectively. H2B-RFP was electroporated on 
both sides as an electroporation control [Figure 5H,M].  
The results show that loss of Sox8 and Tgif1 binding sites was sufficient to reduce 
Tgif1 and Ets1 enhancer activity in the cardiac crest, respectively [Figure 5I,N]. 
Interestingly, the Ets1-∆Tgif1 mutant enhancer retained activity in cranial neural crest 
[Figure 5N], suggesting its differential regulation in cranial versus cardiac crest. Taken 
together, our results suggest a regulatory cascade consistent with the sequential 
expression pattern of Sox8, Tgif1 and Ets1, with the former two working together in the 
premigratory cardiac crest, and regulating the activity of Ets1 in the migratory neural crest 
[Figure 5O]. Using the pseudotime lineage trajectory defined earlier [Figure 5P], we 
plotted the relative expression pattern of our cardiac crest subcircuit genes on the 
Figure 5. Sox8, Tgif1 and Ets1 comprise a transcriptional cascade important for cardiac crest identity. A-N. 
Dorsal view of HH11 embryos where Sox8 (A, E, J), Tgif1 (B, F, K), or Ets1 (C, G, L) was knocked out on the right side 
at gastrula stage. Sox8 knockout resulted in loss of Tgif1 (E) and Ets1 (J), Tgif1 knockout resulted in reduced Ets1 
(K), but no noticeable change in Sox8 (B); Ets1 knockout had no effect on either Sox8 (C) or Tgif1 (G). Expression of 
Tgif1 on the right side in Sox8 knockout embryos (D’) was sufficient to partially rescue Ets1 expression (D). Mutation 
of Sox8 binding sites in a Tgif1 enhancer resulted in reduced enhancer activity on the right side (I). H2B-RFP (H, M) 
was used as a transfection control on both sides. Mutation of Tgif1 binding site in an Ets1 enhancer resulted in 
reduced enhancer activity in cardiac but not cranial neural crest (N). O. Functional relationships between Sox8, Tgif1, 
and Ets1 in a transcriptional subcircuit based on the results in A-N. P-S. Pseudotime lineage trajectory with each 
subcluster labeled (P) according to scRNA-seq analysis. Expression of cardiac neural crest subcircuit genes Sox8, 
Tgif1, and Ets1 was overlaid on the trajectory. T. Heatmap showing changes in gene expression profiles of 
reprogrammed trunk neural crest compared to wildtype cardiac and trunk crest. U-V. Dorsal view of an HH9+ embryo 
where Tgif1, Ets1, and Sox8 were overexpressed at gastrula stage on the right side (U). Ex ovo culturing of the 
embryos resulted in ectopic expression of cardiac crest gene Nacc2 in cranial neural crest (V) and surrounding naïve 
ectoderm. W-X. Dorsal view of the trunk neural crest of an HH18 embryo where cardiac crest subcircuit genes were 
transfected on the right side of the neural tube in ovo (W). Expression of trunk neural crest marker Hes6 was reduced 
in resident trunk neural crest cells (X). Ot-otic vesicle, Hb-hindbrain, tnc-trunk neural crest, rep-reprogrammed. See 




trajectory map [Figure 5Q-S]. While expression of all three genes was high in both 
progenitor and proliferative cardiac crest cells, both Sox8 [Figure 5Q] and Ets1 [Figure 
5S] were down-regulated as the cells transitioned into an ectomesenchymal state. The 
expression of Tgif1 [Figure 5R] was relatively unchanged, strengthening our hypothesis 
that Tgif1 is important for the formation of ectomesenchymal derivatives of cardiac crest.  
Based on these results, we hypothesized that these three genes may comprise a 
“cardiac neural crest subcircuit” that might confer cardiac-like identity onto other neural 
crest populations. To examine downstream genes associated with a “cardiac-like” crest 
identity, we ectopically expressed Sox8, Tgif1, and Ets1 along with the Sox10E2 reporter 
construct as “reprogramming readout” into the trunk neural crest of HH10 embryos 
[Supplementary Figure S4D-E]. After RNA-seq of enhancer-expressing sorted cells, we 
identified genes upregulated in the reprogrammed neural crest cells compared to 
unelectroporated trunk crest [Supplementary Figure S4F]. Examples of upregulated 
genes included “cardiac crest markers” like Nacc2, Ret, and Cdh11, that were otherwise 
absent from trunk crest cells. On the other hand, key trunk neural crest genes including 
HoxA6, Dll1, and Mitf were down-regulated in the reprogrammed population [Figure 5T].  
To validate the observed gene expression differences between reprogrammed and 
wild type trunk neural crest cells, we electroporated the right side of gastrula stage 
embryos with expression constructs for Sox8, Tgif1, and Ets1, and the left side with an 
equal concentration of H2B-RFP [Figure 5U]. As expected, expression of the cardiac crest 
subcircuit elicited ectopic expression of Nacc2 [Figure 5V] in both cranial neural crest and 
the naïve ectoderm. In contrast, overexpression of the three transcription factors in the 
trunk neural tube of HH10 [Figure 5W] led to reduction of the trunk neural crest gene 
Hes6 by HH18 on the experimental (right) compared with control side (left) [Figure 5X], 
suggesting that neural crest identity was altered to be cardiac-like at the expense of the 
original trunk-like signature. Taken together, these results suggest that the combination 
of Tgif1, Ets1, and Sox8 was sufficient to alter the character of neural crest cells from 




7.3.8 Reprogrammed trunk neural crest cells exhibit cardiac-crest-like migratory 
behavior 
Cardiac neural crest cells emerge in three distinct streams from the dorsal neural 
tube adjacent to rhombomeres 6, 7, and 8 and exhibit chain migration similar to cranial 
crest cells. The rostral-most stream of the cardiac crest follows a dorsolateral pathway of 
migration, forming a distinctive arc-like pattern, as shown by FoxD3-NC2 enhancer-driven 
GFP expression at HH12 [Figure 2A]. These cells eventually migrate into the 
circumpharyngeal ridge, where they pause while the branchial arches form. Once 
developed, the cardiac crest cells continue their migration and populate branchial arches 
III, IV, and VI, with some contributing to the satellite cells that surround neurons of the 
nodose and jugular ganglion of the vagus nerve after 2 days.  
Given that overexpression of the cardiac crest subcircuit resulted in altered neural 
crest molecular identity, we next examined the long-term effects of expressing this cardiac 
crest subcircuit in the trunk neural crest. To this end, we electroporated expression 
constructs for Sox8, Tgif1, and Ets1 into the trunk neural tube of HH10 transgenic GFP+ 
embryos in ovo. The Sox8 construct contains a cis-Internal Ribosome Entry Site (IRES) 
allowing the expression of the nuclear fluorescent protein H2B-RFP, used as a marker 
for electroporation efficiency. These “donors” were incubated at 37˚C for 12 hours, after 
which the dorsal neural tube caudal to somite 10 was surgically removed and grafted in 
place of the cardiac neural fold unilaterally in wild type HH9+ host embryos. As a control, 
unperturbed cardiac neural fold or trunk neural fold was grafted instead [Figure 6A]. To 
confirm that the homochronic, homotopic graft extracted from the donor embryo was 
successfully incorporated in the host embryo, we implanted the dorsal neural tube from 
the trunk of a GFP embryo electroporated with expression constructs for the cardiac crest 
subcircuit genes [Figure 6B]. Chimeras were given ten minutes to recover following 
surgery and incubated for 1h at 37˚C prior to fixation and sectioning. Transverse cross-
sections through the hindbrain [Figure 6B’-B’’’] confirmed that the graft healed efficiently 




To assess effects on cell migration, we allowed chimeras to develop for 2 days. 
We first analyzed the “control” group grafted with unperturbed GFP+ cardiac neural folds 
in whole mount and transverse section. Consistent with results from quail-chick chimeras, 
GFP+ cardiac crest cells that emerged adjacent to somite 1 and 2 migrated into branchial 
arch IV (Miyagawa‐Tomita et al., 1991) [Figure 6C; n=3/3] and formed satellite cells of 
Figure 6. Reprogrammed trunk neural crest cells exhibit cardiac-crest-like migratory behavior. A. Grafting 
strategy to test behavior of transplanted cells. Stage-matched cardiac neural fold, unperturbed trunk neural fold, or 
trunk neural fold reprogrammed by the ectopic expression of Sox8, Tgif1, and Ets1 was grafted in place of ablated 
cardiac neural folds in a wildtype host at HH9+. B. Embryo with a unilateral transgenic implant spanning the cardiac 
crest domain immediately after grafting (dorsal view). B’-B’’’. Transverse section through the hindbrain of a chimera 
showing successful incorporation of the GFP+ implant (B’’). The graft was electroporated with expression constructs 
for cardiac neural crest subcircuit genes Sox8, Tgif1, and Ets1 (B’’’). C-H. Whole-mount and cross-section images 
of chimeric embryos grafted with dorsal cardiac neural folds (C,F,F’), non-transfected dorsal trunk neural folds 
(D,G,G’), and “reprogrammed” dorsal trunk neural folds (E,H,H’) harvested 2 days post grafting. Transgenic cells from 
the cardiac neural fold graft migrated into branchial arches III-IV, whereas cells from the trunk neural fold graft 
exhibited restricted migration. Ectopic expression of the cardiac crest subcircuit was sufficient to change the 
migration behavior of these cells, with transgenic cells populating branchial arches III and IV. Hb-hindbrain, ot-otic 




the nodose vagal ganglia [Figure 6F,F’]. However, when unperturbed GFP+ trunk neural 
fold was grafted in place of the cardiac neural fold of wild type hosts, the grafted cells 
delaminated from the neural tube but exhibited restricted migration [Figure 6D; n=3/3], 
resulting in failure to invade branchial arch IV [Figure 6G,G’]. Moreover, the neurons of 
the nodose ganglion, otherwise derived from the post-otic placodal ectoderm (Narayanan 
and Narayanan, 1980), were malformed compared to those of control embryos, 
consistent with a previously reported cardiac crest ablation phenotype (Kuratani et al., 
1991). Thus, trunk neural crest cells failed to substitute for ablated cardiac neural folds 
as previously published (Harrison et al., 1995; Kirby, 1989).  
Importantly, unilaterally grafted “reprogrammed” trunk neural folds, electroporated 
with constructs encoding our cardiac subcircuit genes Sox8, Tgif1, and Ets1, exhibited 
cardiac-crest-like behavior. These cells migrated into branchial arch IV [Figure 6E; n=3/3] 
to form satellite cells of the jugular ganglion of the vagus nerve [Figure 6H,H’], similar to 
normal cardiac crest cells at the 2 day time point. The placodally-derived neurons were 
also evenly distributed. Taken together, these results show that the combined expression 
of Tgif1, Ets1, and Sox8 was sufficient to reprogram trunk neural crest cells to exhibit 
migration patterns and morphogenesis similar to cardiac crest cells.  
7.3.9 Reprogrammed trunk neural crest acquires cardiac ectomesenchymal 
potential  
Once cardiac crest cells have migrated into the caudal pharynx, a subset condense 
around the pharyngeal arch arteries, contributing to the smooth muscle tunica media 
surrounding these vessels (Bergwerff et al., 1998). While the endothelial cells lining these 
arteries are mesoderm-derived and hence not dependent on cardiac crest for initial 
development, the cardiac crest plays a vital role in the remodeling of the pharyngeal arch 
arteries (Bookman et al., 1987), resulting in the formation of the aortic arch, 
brachiocephalic artery, the carotid arteries and the subclavian arteries (Hiruma and 




where they will condense to form the aorticopulmonary septum. Some of these cells also 
contribute to the proximal segment of the interventricular septum.  
To test whether reprogrammed trunk neural crest cells acquired a developmental 
potential normally confined to cardiac crest, we analyzed their ability to differentiate into 
ectomesenchymal derivatives such as the condensed mesenchyme of the 
aorticopulmonary septum, tunica media of the branchial arch arteries, and the nodose 
Figure 7. Reprogrammed trunk neural crest acquires cardiac ectomesenchymal potential. A-C. Transverse 
sections through embryos grafted with GFP+ cardiac neural folds show cardiac crest-derived cells in the 
aorticopulmonary septum (A, arrowheads in A’), tunica media surrounding the branchial arch arteries (B, arrowheads 
in B’), and neurons and satellite cells of the jugular ganglion of the vagus nerve (C,C’; orange arrowhead–satellite 
cells, yellow arrowhead–neurons). D-F. Embryos grafted with non-transfected trunk neural fold cells exhibit PTA 
(D,asterisk), abnormally constricted right-fourth branchial arch artery (E,asterisk; arrowhead in E’), and improper 
gangliogenesis (F,asterisk). Transplanted cells were found associated with ectopic cervical nerves (F’, orange 
arrowheads). G-I. GFP+ cells from the reprogrammed trunk implant migrate into the outflow tract and contribute to 
the aorticopulmonary septum (G, arrowheads G’). GFP+ cells were found surrounding vessels (H, arrowheads H’), 
and in neurons and satellite cells of the jugular ganglion (I,I’; orange arrowhead-satellite cells, yellow arrowhead-





ganglia (Kirby, 1989; Kirby and Stewart, 1983) [Figure 7A-C,7A’-C’], in comparison to wild 
type cardiac and trunk neural fold grafts. First, to validate the contribution of cardiac crest 
to these different tissues, we grafted unperturbed GFP+ neural folds spanning the entire 
cardiac crest region from a transgenic embryo into a wildtype host and allowed the 
embryos to develop to E6. Consistent with results obtained with quail-chick chimeras, 
cardiac crest cells were found in the aorticopulmonary septum [Figure 7A,A’], the tunica 
media surrounding the branchial arch arteries [Figure 7B,B’], and neurons and glial cells 
of the jugular ganglion of the vagus nerve [Figure 7C,C’].  
In contrast to GFP+ cardiac implants, when unperturbed GFP+ transgenic trunk 
neural folds were grafted into the cardiac crest region, the host embryos exhibited 
cardiovascular defects at E6, most notably septation defects of the outflow tract (Kirby, 
1989; Nishibatake et al., 1987) [n=4/5; Figure 7D]. Interestingly, the phenotype looked 
similar to what we observed after unilateral ablations, where the outflow tract cushions 
had developed but failed to fuse, resulting in PTA [Figure 1H]. This suggests that the 
endogenous cardiac crest from the contralateral side failed to compensate for complete 
unilateral loss of cardiac neural folds. One embryo exhibited DORV, another similarity 
observed to that occurring after unilateral cardiac crest ablation. We also noticed defects 
in remodeling of the pharyngeal arch arteries (Hiruma and Nakajima, 2002), as 
demonstrated by an abnormally constricted fourth arch artery [Figure 7E, E’], and lack of 
proper gangliogenesis [Fig.7F] in the hindbrain. To confirm that the phenotypes we 
observed were not artifacts of improper graft incorporation, we looked for known 
derivatives of resident trunk neural crest cells in the chimeras. As expected, some GFP+ 
melanocytes (Serbedzija et al., 1994) were identified [white arrow, Figure 7F], suggesting 
that trunk crest cells retained their developmental potential to contribute to melanocyte 
precursors. Surprisingly, we found ectopic cervical nerves in proximity to the trachea in 
these chimeras, with GFP+ satellite cells surrounding the ganglionic neurons [Figure 7F’]. 
Taken together, these results confirmed that trunk neural crest was unable to rescue the 




However, when we grafted trunk neural tube that was “reprogrammed” by ectopic 
expression of Sox8, Tgif1, and Ets1, the chimeras exhibited proper septation of the 
outflow tract [Figure 7G,G’’; n=4/6], with GFP+ cells present in the aorticopulmonary 
septum. Moreover, these embryos showed signs of proper remodeling of the pharyngeal 
arch arteries, as demonstrated by the presence of unconstricted arteries III, IV, and VI 
leading to the outflow tract, as well as a developed jugular ganglion of the vagus nerve. 
We found reprogrammed cells in the tunica media of these vessels [Figure 7H,H’], and 
neurons and glia of the jugular ganglia [Figure 7I,I’]. Taken together, our results show that 
expression of a transcriptional program comprised of Tgif1, Ets1, and Sox8 can confer 
cardiac ectomesenchymal differentiation potential onto trunk neural crest cells, 
essentially altering their developmental potential such that they are interchangeable with 
the cardiac crest.  
7.4 Discussion 
The neural crest is a versatile cell population with great promise in regenerative 
medicine due to its ability to form diverse progeny ranging from neurons to facial cartilage 
and portions of the heart (Gandhi and Bronner, 2018). However, different neural crest 
subpopulations with distinct developmental potential exist along the body axis. Over 30 
years ago, Kirby et al. (1985) defined the “cardiac neural crest” based on quail-chick 
chimeras as the region arising from the caudal hindbrain with the potential to form 
ectomesenchymal derivatives of the heart. The heart of amniotes is divided into separate 
systemic and pulmonary circulations such that deoxygenated blood flows from the heart 
to the lungs and oxygenated blood returns to the heart to be pumped through the rest of 
the body. The cardiac crest is critical in separating the aortic and pulmonary arteries by 
dividing the outflow tract via formation of the aorticopulmonary septum. Importantly, 
ablation of this cell population in chick embryos resulted in developmental defects of the 
outflow tract highly reminiscent of the human congenital birth defect PTA (Hutson and 
Kirby, 2003), highlighting the critical role of the cardiac crest. The cardiac crest is unique 
amongst neural crest subpopulations, since those from other axial levels are unable to 




classical studies from a modern genomics perspective to identify molecular mechanisms 
that define the ectomesenchymal differentiation potential of the cardiac neural crest.  
Our results suggest that there is left-right asymmetry with respect to contributions 
of the cardiac crest to the heart. While both left and right cardiac crest ablations resulted 
in heart defects, they differed in type and severity. Whereas removal of the left neural 
folds predominantly caused Double Outlet Right Ventricle (DORV) defects (n = 6/8), 
ablation of the right side caused PTA (n=4/9) and DORV (n=3/9). These differences likely 
reflect left-right asymmetry in the heart itself, which undergoes dextral looping. Crest 
ablation also affects heart tube looping and elongation, as ablated hearts appeared 
bulbous with shortened and straighter outflow tract compared to controls. Remodeling of 
aortic arches is also asymmetric (Snider et al., 2007; Waldo et al., 1998), with selective 
regression of the left 4th artery in birds and unequal contribution of the left-right cardiac 
crest to the vagus nerve’s heart innervation (Verberne et al., 2000).  
Our results uncover a transcriptional program necessary for normal cardiac crest 
development that is sufficient to reprogram trunk neural crest cells to take on a cardiac-
crest-like fate. We identify Tgif1 as a critical factor for normal development of the cardiac 
crest. Tgif1 encodes a transcriptional repressor that limits TGFß signaling by interacting 
with SMADs and/or binding directly to DNA and also regulates processes like 
proliferation, specification, and differentiation (Bartholin et al., 2008; Hamid and Brandt, 
2009). In cancer, Tgif1 promotes the migration and growth of non-small cell lung cancer 
cells (Xiang et al., 2015), consistent with our findings where loss of Tgif1 in chick caused 
impaired cardiac neural crest migration and reduced activity of several cardiac crest-
specific genes.  
While Tgif1 mutant mice have severe holoprosencephaly (Taniguchi et al., 2012), 
no apparent heart defects have been reported, possibly due to the presence of its 
functionally redundant paralog Tgif2 in the murine heart (Imoto et al., 2000; Jin et al., 
2005). However, Tgif2 was not differentially enriched in migrating chick cardiac crest. The 




from central nervous system to cardiovascular development. In sea urchin embryos, tgif 
has been associated with epithelial to mesenchymal transition (EMT) (Saunders and 
McClay, 2014), an important process in neural crest development. However, in the 
cardiac crest, Tgif1 appears to function in specification rather than EMT.  
Our data show that Sox8 functions upstream of Tgif1, which in turn regulates 
activity of Ets1 in the migratory cardiac neural crest. We postulated that these three 
factors work together in a cardiac crest specific regulatory subcircuit. To test this, we 
“reprogrammed” trunk neural crest by ectopically expressing subcircuit genes and found 
that this is sufficient to alter their character to behave in a cardiac-crest-like manner. 
Transcriptional profiling of reprogrammed trunk neural crest cells confirmed that they 
became more cardiac crest-like. Furthermore, grafting reprogrammed trunk neural crest 
cells in place of the cardiac neural folds changed their migratory and differentiative 
behavior such that they not only migrated into the heart but also restored septation of the 
outflow tract. Thus, these data show that the combination of these three factors was 
sufficient to imbue the transfected cells with cardiac crest-like identity.  
Of note, a relatively small number of reprogrammed trunk neural crest cells in the 
outflow tract appears sufficient for its septation. As crest-derived cells are relatively short 
lived in the outflow tract, undergoing apoptosis at later stages, one possibility is that an 
early interaction between cardiac crest cells and neighboring cells, likely derived from the 
second heart field, is sufficient for proper septation without the need for a large neural 
crest contribution to the septum itself. On the other hand, perhaps only small numbers of 
neural crest cells are required, as is true in other contexts; e.g. Barlow et al. (2008) 
showed that a small number of enteric neural crest cells is sufficient to populate the entire 
digestive tract. In mice, reprogramming a small contingent of smooth muscle cells into 
melanocytes results in patent ductus arteriosus (Yajima et al., 2013). 
The cardiac neural crest is specified just prior to emigration from the hindbrain. Our 
findings raise the intriguing possibility that these cells may be biased very early toward 




Twist1 in a single cardiac crest cluster suggests these cells may have already acquired 
ectomesenchymal characteristics, as these genes are associated with the cardiac crest’s 
ability to form the smooth muscle lining of the pulmonary arteries and the outflow tract 
septum. Thus, cardiac neural crest cells may acquire an ectomesenchymal identity well 
before they migrate into the branchial arches. Given that cells from the trunk neural crest 
graft delaminated from the neural tube but failed to migrate any further, it is likely that the 
transcriptional state of cardiac crest cells governs their ability to migrate into the 
corresponding branchial arches.  
Together with a previously described cranial crest-specific subcircuit important for 
the formation of craniofacial cartilage (Simões-Costa and Bronner, 2016), our results 
suggest that small transcriptional changes can alter neural crest identity and resultant 
differentiative behavior along the body axis. It is interesting to note that two of the three 
transcription factors (Sox8 and Ets1) are shared between the cardiac and cranial crest 
subcircuits, though Tgif1 is unique to the cardiac region. Moreover, mutation of the Tgif1 
binding site in the Ets1 enhancer had drastic effects on the activity of the enhancer in the 
cardiac but not cranial crest. This suggests that a small shift in regulatory subcircuitry can 
have profound effects in conferring axial level identity, since grafting of the cranial neural 
folds in place of cardiac neural folds also resulted in PTA (Kirby, 1989). Our results not 
only validate the reproducibility of experiments done by Kirby and colleagues over 30 
years ago (Besson et al., 1986; Kirby and Stewart, 1983; Kirby and Waldo, 1995; Kirby 
et al., 1985; Nishibatake et al., 1987; Phillips et al., 1987; Waldo and Kirby, 1993), but 
also shed light on the underlying molecular mechanisms that distinguish the cardiac 
neural crest from other axial levels. We posit that identification of axial-level-specific 
transcription factors and subcircuits holds the promise of identifying potentially important 
genes involved in proper formation of the cardiovascular system and may provide targets 
for identification of human genetic mutations in coding or regulatory regions. Moreover, 
elucidation of the gene regulatory subcircuits that underlie axial level identity will be useful 
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7.8 Materials and methods 
7.8.1 Key Resource Table 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Mouse IgG1 anti-Pax7 Developmental Studies 
Hybridoma Bank at 




Rabbit anti-Sox2 Abcam Cat#ab97959; 
RRID: 
AB_2341193 
Mouse IgG2b anti-MF20 Developmental Studies 
Hybridoma Bank at 
University of Iowa 
RRID: 
AB_2147781 
Mouse IgM anti-HNK1 Developmental Studies 
Hybridoma Bank at 




Mouse IgG2a anti-SMA Sigma Cat#3879S; 
RRID: 
AB_2255011 
Mouse IgG2b anti-HuC/D Invitrogen Cat# A21271; 
RRID: 
AB_221448 
Goat IgG anti-GFP Rockland Cat# 600-101-
215; RRID: 
AB_218182 
Mouse IgG2a anti-V5 Invitrogen Cat#R960-25; 
RRID: 
AB_2556564 
Rabbit anti-RFP MBL Cat#PM005; 
RRID: 
AB_591279 
Critical Commercial Assays 






SmartSeq2 V4 kit Takara Clontech Cat#634889 




Qubit High sensitivity DNA kit ThermoFisher Scientific Cat#Q32854 
NEB Next High-Fidelity 2X PCR 
Master Mix 
New England Biolabs Cat#M0543S 




Endofree maxi prep kit Macharey Nagel Cat#740426.50 
Agencourt AMPure XP beads Beckman Coulter Cat#A63880 
illustra MicroSpin G-50 Columns GE Healthcare Life 
Sciences 
Cat#27533001 
Hybridization Chain Reaction Molecular Technologies NA 
Deposited Data 
Raw and analyzed data This paper BioProject ID 
PRJNA515142 
Software and Algorithms 
Fiji/ImageJ (Schindelin et al., 2012) https://imagej.nih
.gov/ij/ 












Seurat (Butler et al., 2018) https://satijalab.o
rg/seurat/ 
Oligonucleotides 
GCAGGTGTAGTTGCAATATC This paper Tgif1.1.gRNA 
GTTGGTCCCCCGCCGTGAGA This paper Tgif1.2.gRNA 
GGGTCATGTTGAGCATTTGG This paper Sox8.1.gRNA 
GTCCACCTTAGCGCCCAGCG This paper Sox8.2.gRNA 




GGCCTCAACCATGAAGGCGG This paper Ets1.1.gRNA 
GACCTTCAGTGGCTTCGCAA This paper Ets1.2.gRNA 
GAGAGACGCACGTGCGGGAC This paper Ets1.3.gRNA 
GAAAGTCAGGCGCTAGCTCC This paper Ets1.4.gRNA 
7.8.2 Experimental model 
Fertilized chicken eggs were purchased from Sun State Valley farm (CA) and incubated 
at 37°C for 33-36h to get HH9+ embryos for ablation and reprogramming experiments. 
All experiments were performed on chick embryos younger than E10 and were therefore 
not subjected to IACUC regulations. 
7.8.3 Cardiac neural crest ablation 
Windows were made in the eggs and 2% blue food dye solution was injected under 
the embryo to provide contrast. Unilateral and bilateral ablations were performed using 
glass needles by surgically removing the dorsal neural tube the level of the mid-otic 
vesicle to the caudal edge of somite 3 as previously described (Kirby, 1989). The embryos 
were sealed with surgical tape and incubated at 37˚C in ovo for 3 or 6-6.5 days.  
7.8.4 Embryo electroporation 
Ex ovo electroporations were performed as previously described (Sauka‐Spengler 
and Barembaum, 2008) by passing 5 electric pulses every 50ms at an interval of 100ms 
at 5.2V. The electroporated embryos were cultured in sterile petri dishes in 1mL albumin 
supplemented with penicillin/streptomycin at 37°C until HH9+ or HH12. pCAG>H2B-RFP 
was electroporated as a marker for transfection efficiency and was used to discard 
embryos with poor transfection. For in ovo electroporations, fertilized eggs were 
incubated for 33-36h to get HH9 embryos. The DNA solution was injected into the lumen 
of the neural tube and the right side transfected by passing 5 electric pulses every 30ms 
at an interval of 100ms at 18V. The egg shell was sealed with surgical tape and the eggs 




under a Leica epifluorescence scope and embryos with improper morphology and/or poor 
transfection were discarded.  
7.8.5 Cell sorting and library preparation 
To sort cardiac and trunk neural crest cells, HH4 and HH9 embryos were 
electroporated with FoxD3-NC2>mCherry (Simões-Costa et al., 2012) ex ovo and in ovo, 
respectively. To sort reprogrammed trunk neural crest cells, HH9 embryos were 
electroporated with expression constructs for Sox8, Tgif1, and Ets1 along with 
Sox10e2>GFP. The embryos were cultured until HH12 to isolate cardiac neural crest and 
HH18 to isolate wild-type and reprogrammed trunk neural crest. The embryos were 
dissected between the otic vesicle and somite 3 and between somite 18 and 25 for cardiac 
and trunk neural crest, respectively. For cell dissociation, the dissected tissue was 
collected in chilled 1X DPBS, washed thrice, and incubated in Accumax cell dissociation 
solution (EMD Millipore) for 15 minutes at 37°C, with gentle pipetting every 5 minutes. 
Once the tissue appeared dissociated, Hanks Buffered Saline Solution (HBSS) (Corning) 
supplemented with 25mM HEPES (pH 7), BSA Fraction V (Sigma; 0.2% w/v), and 10mM 
MgCl2 was used to terminate dissociation. Cells were collected at the bottom by spinning 
the solution at 300g for 4 minutes and resuspended in 1mL HANKS-MgCl2. The cells were 
then passed through a 40µm filter to remove debris and undissociated clumps. mCherry+ 
cells were sorted on a Sony Synergy 3200 cell sorter equipped with a 561nm laser at the 
Caltech Flow Cytometry Facility. Sytox Blue staining was used to label dead cells during 
the sorting run. 
 For bulk RNA-seq, the SMART-Seq v4 Ultra Low Input RNA Kit for sequencing was 
used by following the manufacturer’s protocol (Takara Bio). Briefly, the sorted cells were 
washed thrice in chilled sterile 1x PBS. cDNA was synthesized using the 3’ SMART-Seq 
CDS Primer II A (followed by template switching with the SMART-Seq v4 Oliognucleotide 
primer) and amplified using the following program: 95°C for 1min, 15 cycles of 98°C for 
10s, 65°C for 30s, and 68°C for 3min, and a final extension at 72°C for 10min. The 




confirmed on the Agilent 2100 Bioanalyzer using a high sensitivity DNA chip. The library 
was prepared by Igor Antoshechkin at the Caltech Genomics Facility and sequenced on 
a HiSeq 2500 to obtain 50 million single end reads.  
For single-cell RNA-seq, individual neural crest cells were collected in 96-well plates 
by FACS. Sequencing libraries were prepared as previously described (Picelli et al., 
2014). Libraries were sequenced on the Illumina NextSeq500 platform using single end 
75bp sequencing chemistry.  
7.8.6 Molecular cloning and in situ hybridization 
Overexpression constructs for Ets1 and Sox8 were generously provided by Marcos 
Simões-Costa and Meyer Barembaum, respectively. The coding sequence for Tgif1 was 
obtained from the UCSC genome browser (Karolchik et al., 2003) and amplified using 
Accuprime polymerase (ThermoFisher). A V5 epitope tag was fused to the N-terminus to 
allow for construct validation using immunohistochemistry. This fusion gene was then 
cloned under the regulation of the CAGG promoter. Tgif1 and Ets1 enhancers were 
amplified from genomic DNA using Accuprime polymerase (ThermoFisher). 
RNA was extracted from HH12 embryos using an optimized TRIzol-chloroform 
extraction protocol. SuperScript III Reverse Transcriptase was used to synthesize cDNA 
using oligo dT primers and PCR program recommended by the manufacturer. Cardiac 
crest genes were amplified from this cDNA and cloned in pBluescript plasmid. All RNA 
probes were synthesized using Digoxigenin-labeled UTPs and diluted in Hybridization 
buffer containing 50% formamide, 5mM EDTA, 1.3x SSC, 200µg/mL tRNA, 0.2% Tween-
20, 0.5% CHAPS, and 100µg/mL heparin. All probes were used at a final concentration 
ranging between 2-5ng/µL. In situ hybridization was performed using a previously 






7.8.7 Hybridization Chain Reaction 
HCR v3 was performed using the protocol suggested by Molecular Technologies 
(Choi et al., 2018). Briefly, the embryos were cultured to desired stages and fixed in 4% 
paraformaldehyde overnight at 4˚C. On day 2, the fixed embryos were washed in 0.1% 
PBS-Tween and dehydrated using a series of 25%, 50%, 75%, and 100% methanol. 
Following an overnight incubation at -20˚C in 100% methanol, the embryos were 
rehydrated, treated with proteinase-K for 2.5 minutes, and incubated with 5-10pmol of 
probe mixture overnight at 37˚C. On day 3, excess probe was washed off and the 
embryos were incubated with 30pmol of both hairpins H1 and H2 at room temperature 
overnight. On day 4, the embryos were washed in 0.1% 5x-SSC-Tween and imaged on 
a Zeiss Imager M2 with an ApoTome module and/or Zeiss LSM 880 confocal microscope 
at the Caltech Biological Imaging Facility. 
7.8.8 CRISPR-Cas9-mediated knockouts 
The genomic loci for Tgif1, Sox8, and Ets1 were obtained from the UCSC genome 
browser (Karolchik et al., 2003). Two gRNA targets were generated to knockout Tgif1: 
Tgif1.1 (5’- GCAGGTGTAGTTGCAATATC -3’) and Tgif1.2 (5’- 
GTTGGTCCCCCGCCGTGAGA -3’), three gRNA targets were generated to knockout 
Sox8: Sox8.1 (5’ – GGGTCATGTTGAGCATTTGG -3’), Sox8.2 (5’- 
gTCCACCTTAGCGCCCAGCG -3’), and Sox8.3 (5’- GACGCGACGCCCATCCTCAA -
3’), and four gRNA targets were generated to knock out Ets1: Ets1.1 (5’- 
GGCCTCAACCATGAAGGCGG -3’), Ets1.2 (5’- GACCTTCAGTGGCTTCGCAA -3’), 
Ets1.3 (5’- GAGAGACGCACGTGCGGGAC -3’), and Ets1.4 (5’- 
GAAAGTCAGGCGCTAGCTCC -3’) using CHOPCHOP (Labun et al., 2019). For 
contralateral control electroporations, we used the control gRNA described in (Gandhi et 
al., 2017). Gastrula HH4 embryos were bilaterally electroporated with CAGG>nls-Cas9-
nls (2µg/µl) and CAGG>H2B-RFP (2µg/µl) together with either U6.3>Tgif1.1.gRNAf+e 
and U6.3>Tgif1.2.gRNAf+e (0.75µg/µl each) on the right side 




ovo until HH12, assayed for good transfection efficiency and morphology, and processed 
for whole mount in situ hybridization and HCR. 
7.8.9 Reprogramming resident trunk and cranial neural crest cells 
Enhancer element governing the expression of Sox10 (e2) (Betancur et al., 2010) 
was cloned under the regulation of a constitutive HSV thymidine kinase promoter driving 
GFP expression. To test whether Tgif1 alone can reprogram trunk neural crest cells, 
HH9+ embryos were unilaterally co-electroporated with overexpression constructs 
CAGG>V5-Tgif1 (2.5µg/µl each) and the enhancer construct pTK-Sox10e2>GFP (2µg/µl) 
in ovo as described above. The eggs were sealed and incubated at 37°C until HH14 to 
look for enhancer activity. The embryos were screened for the expression of H2B-RFP 
and fixed for antibody staining against GFP. To test the effect of reprogramming on 
resident trunk neural crest cells, HH9+ embryos were electroporated with CAGG>V5-
Tgif1, CAGG>Ets1, and CAGG>Sox8-IRES-H2B-RFP (2µg/µl each) on the right side in 
ovo. The embryos were developed to until HH18 and fixed for HCR. To test the effect of 
reprogramming on resident cranial neural crest cells, HH4 embryos were electroporated 
with the three expression constructs (2µg/µl each) on the right side. The left side was 
electroporated with CAGG>H2B-RFP (2.5µg/µl) and served as our internal control. The 
embryos were cultured ex ovo until HH9+, after which they were fixed for in situ 
hybridization against the cardiac neural crest marker Nacc2. 
7.8.10 Grafting experiments  
Wild-type chicken embryos served as hosts in our transplants and were incubated at 
37°C until HH9+/HH10 (8-10 somite stage). Donor transgenic Roslin Green GFP eggs, in 
which CAGGS (CMV enhancer/beta actin promoter/first intron) drives eGFP expression 
(McGrew et al., 2008) were obtained from Clemson University through Dr. Susan 
Chapman and incubated to HH14 or to the same stage as their wild-type counterparts. 
Precautions taken to ensure a high survival rate post-surgery consisted of maintaining 
high humidity levels (80-100%) in an environment free of fungal contamination. All eggs 




trays and water tanks were treated with methylene blue to avoid any fungal infection. Host 
embryos were prepared by removing, unilaterally, the dorsal neural tube of wild-type 
stage 9+/10 host embryos from the level of the mid-otic vesicle to the caudal edge of 
somite 3. For positive controls (cardiac to cardiac), a similar microsurgical procedure was 
carried out on a stage-matched donor transgenic embryo. A homochronic, homotopic 
graft was completed, with the transgenic dorsal neural tube used as donor tissue to 
replace the section of dorsal neural tube removed from the wild-type host. Negative 
controls embryos (trunk to cardiac) were generated similarly, with the difference that the 
donor tissue originated from the trunk level of a stage 14 donor transgenic embryo, 
specifically from somite 18 to approximately somite 24. In our experimental group 
(reprogrammed trunk to cardiac), the reprogrammed transgenic dorsal neural tube 
originated from a stage 14 transgenic donor, previously electroporated with the regulatory 
subcircuit (Tgif1, Ets1 and Sox8) at HH9. The reprogrammed dorsal neural tube was 
inserted in place of the host dorsal neural tube. Post-surgery, the host eggs were sealed 
with surgical tape and incubated until HH18-20 (E4) and stage 31-34 (E6).  
7.8.11 Sectioning and histology 
E4 and E6 chimeric embryos were washed in 5% (room temperature, 30min) and 
15% sucrose (4˚C, overnight) and incubated overnight in gelatin at 37°C. The next day, 
they were embedded in plastic molds, frozen in liquid nitrogen, and stored at -80°C for at 
least 4 hours. The embedded embryos were then sectioned on a micron cryostat to obtain 
16µm sections. Immunohistochemistry on sections was performed using a previously 
described protocol (Ezin et al., 2009). Briefly, the sections were degelatinized at 42°C in 
1x PBS for 5 minutes and blocked in PBS-0.3%Triton supplemented with 10% goat or 
donkey serum. The sections were incubated in primary antibodies overnight at 4°C. The 
next day, slides were washed thrice in 1x PBS, and the sections were incubated in 
secondary antibodies for 1h at room temperature. Following 2 washes in 1x PBS, the 
slides were soaked in 1x PBS containing 0.1µg/mL DAPI for 5 minutes. The slides were 
then washed once each in 1x PBS and distilled water. Transverse sections were imaged 




at the Caltech Biological Imaging Facility. All post-processing was done using FIJI 
imaging software (Schindelin et al., 2012). Early stage embryos (HH10-12) were 
sectioned using the same protocol as described but with a 6h instead of overnight 
incubation in gelatin at 37°C.  
The following primary antibodies were used: Mouse IgG1 anti-Pax7 (DSHB; 1:10), 
Rabbit anti-Sox2 (Abcam ab97959; 1:500), Mouse IgG2b anti-MF20 (DSHB; 1:100), 
Mouse IgM anti-HNK1 (DSHB; 1:5), Mouse IgG2a anti-SMA (Sigma Cat# A5228; 1:500), 
Mouse IgG2b anti-HuC/D (Invitrogen – Cat# A21271; 1:500), Goat anti-GFP (Rockland 
Cat# 600-101-215; 1:500), Mouse IgG2a anti-V5 (Invitrogen Cat# R96025; 1:200), and 
Rabbit anti-RFP (MBL Cat# PM005; 1:500). The signal was detected using the following 
secondary antibodies: Goat anti-mouse Alexa Fluor 647 (for Pax7; 1:250), Goat anti-
mouse IgM Alexa Fluor 350 (for HNK1; 1:250), Goat anti-rabbit Alexa Fluor 488 (for Sox2; 
1:500), Donkey anti-goat Alexa Fluor 488 (for GFP; 1:500), Goat anti-mouse IgG2a Alexa 
Fluor 568 (for SMA and V5; 1:500), Goat anti-mouse IgG2b Alexa Fluor 633 (for HuC/D 
and MF20: 1:250), and Goat anti-rabbit IgG1 Alexa Fluor 568 (for RFP; 1:500).  
7.8.12 Differential gene expression analysis for bulk RNA-seq data 
The reads obtained from the HiSeq run were demultiplexed and filtered using custom 
scripts. The filtered reads were checked for quality using fastqc (Andrews and Babraham 
Bioinformatics, 2010). Based on the traces, the reads were trimmed by 10bp at the 3’ end 
and overrepresented sequences (adapter and poly A tail) were removed using cutadapt 
(Martin, 2011). These 40bp reads were then mapped to the chicken genome (galgal6.0 
assembly) obtained from Ensembl using Bowtie2 (Langmead and Salzberg, 2012). 
Transcript counts were calculated using HTseq-count (Anders et al., 2015), and 
differential gene expression analysis was performed using DESeq2 (Love et al., 2014). 
For our analysis, cardiac neural crest genes were directly compared with trunk neural 
crest genes. Genes with fold change ³ 2 and adjusted p-value £ 0.05 were considered 
“enriched and significant” and were included in subsequent analysis. For reprogrammed 




described in (Martik et al., 2019) and plotted relative values for top genes that have 
previously been shown to be required for neural crest development at cardiac and trunk 
axial levels as a heatmap. 
7.8.13 Bioinformatics analysis for SMART-Seq data 
The raw fastq data of 75-bp single-end sequencing reads were aligned to the chicken 
galgal6 reference genome using STAR-2.7.0 software (Dobin et al., 2013). The mapped 
reads were further processed by Cufflinks 2.2 (Trapnell et al., 2012) using the chick gene 
annotation file obtained from Ensembl to estimate transcript abundance. Relative 
abundance of transcripts was measured by fragments per kilobase of exon per million 
fragments mapped (FPKM). For each library, we computed total number of sequencing 
reads, number of uniquely mapped reads, mapping rate and number of genes detected. 
We selected cells with more than 100K total reads for downstream analysis. The data 
was filtered, normalized, and scaled using Seurat v3 (Butler et al., 2018), and all plots 
were generated using the in-built functions. For GO term analysis, the Bioconductor 
package topGO (Alexa and Rahnenführer, 2019) was used using default parameters. 
Adjusted p-values were calculated using Fisher’s exact test. The heatmap showing 
relative expression values for different genes was generated using a normalized matrix 
as described above. Representative genes for each population (progenitor, proliferative, 
ectomesenchymal, and Schwann cell-like) were selected for the heatmap. Pseudotime 
trajectories were generated using Monocle v2 (Trapnell et al., 2014) by following standard 
instructions from the authors. 
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7.10 Supplementary Figures 
Supplementary Figure S1 (related to figure 1, 2). Effect of ablations on cardiovascular development, and 
quality control on bulk and single cell RNA-seq data. A. (left to right) Primary heart tubes of E3 embryos where 
the cardiac neural folds were left intact, unilaterally ablated on the left, unilaterally ablated on the right, and bilaterally 
ablated. No difference was observed on the effect of left and right unilateral ablation on primary heart tube looping 
and elongation. B. Transverse cross-section through an E6 outflow tract of an embryo where the cardiac neural crest 
was unilaterally ablated on the left side exhibits Double Outlet Right Ventricle (DORV). C-D. Hierarchical clustering 
(C) and Principal Component Analysis (D) done on the two cardiac and three trunk neural crest libraries prepared for 
population-level transcriptional profiling shows high correlation between replicates. E-G. Quality control on SMART-
seq sequencing data showing the number of genes identified per cell (E, G) and high correlation between mapped 
and sequencing reads (F). H. Scatter plot comparing genes enriched in the bulk and single cell RNA-seq datasets. I. 
Genes validated in main figure 2 using in situ hybridization were highly expressed across C1, C2, and C4, with lower 





Supplementary Figure S2 (related to figure 3, 4). Role of Tgif1 in cardiac neural crest. A. Loci for Tgif1, Sox8, 
and Ets1 with gRNA target sites highlighted in red. 2 gRNAs for Tgif1, 3 gRNAs for Sox8, and 4 gRNAs for Ets1 were 
designed. B-C. Loss of Tgif1 resulted in reduced expression of pan-neural crest markers Sox10 (B) and FoxD3 (C), 
but little difference was observed in the number of cells. D. The outflow tract of embryos that were unilaterally grafted 
with a Tgif1 knockout dorsal cardiac neural fold septated properly. E. Cross-section through the neck of a chimera 
where Tgif1 knockout dorsal cardiac neural folds were bilaterally grafted in the embryo. Cardiac neural crest cells 
surrounded in the internal and external carotid artery, but failed to form the outflow tract septum. F-H. Hybridization 
Chain Reaction in a HH15 embryo shows expression of Sox10 (G,H) and FoxD3 (G’,H’) in both cardiac and trunk 
neural crest cells. Tgif1 was expressed in the cardiac region (G’’), but absent from the trunk neural crest (H’’). I-K. 
Electroporation strategy (I) to check the effect of ectopic expression of Tgif1 on resident trunk neural crest cells. DNA 
solutions containing expression constructs for Tgif1, Sox10-e2>GFP, and H2B-RFP were injected in the lumen of 
the neural tube of an HH9+ embryo. The electroporation efficiency was checked using H2B-RFP expression (J). 






Supplementary Figure S3 (related to figure 5). Identification of cardiac neural crest subcircuit genes. A. in situ 
hybridization against genes enriched in the cardiac compared to trunk neural crest that are expressed in migratory 
(HH12) but not premigratory (HH10) cardiac neural crest.  B-E. Transverse cross-sections through a HH12 embryo 
where Tgif1, Sox8, and Ets1 transcripts were labeled using Hybridization Chain Reaction. Cardiac neural crest cells 
from the post-otic r6 stream showed overlapping expression of the three genes. F-K. Coexpression analysis of Tgif1 
with Sox8 and Ets1 using the SMART-seq data. Both genes were abundant in a high proportion of cardiac neural 





Supplementary Figure S4. Investigation of functional relationships between cardiac neural crest subcircuit 
genes and identification of downstream targets (related to figure 5). A. UCSC genome browser track shows an 
evolutionary conserved region in the second intron of Tgif1. B-C. The Tgif1 (B) and Ets1 (C) enhancer sequence that 
recapitulated expression of the respective genes in the cardiac neural crest at HH12. Sox8 binding sites in the Tgif1 
enhancer and Tgif1 binding site in the Ets1 enhancer are labeled. D. Electroporation strategy for isolating 
reprogrammed trunk neural crest cells for transcriptional profiling. E. Dorsal view of trunk neural crest from a 
representative HH14 embryo transfected with expression constructs for Sox8, Tgif1, and Ets1 together with Sox10-
e2 enhancer-mediated GFP expression (Scale bar = 100µm). F. Volcano plot showing genes differentially expressed 
in resident trunk (blue) and reprogrammed trunk (orange) neural crest cells. Inset – genes included in the heatmap in 











A modified version of this chapter is currently in press as:  
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During early embryonic development, multipotent precursors, capable of giving 
rise to most cell types found in the adult organism, are gradually committed to discrete 
lineages. Classically, this restriction was thought to be a binary fate choice, with onset of 
expression of a “master” regulator (Davidson, 1991) biasing a bipotent cell towards one 
fate or the other (Huang et al., 2007; Laslo et al., 2006). Recently, the application of 
single-cell technologies has greatly enhanced our understanding of how cells become 
committed to different fates. Surprisingly, current data suggest that multipotent progenitor 
cells express several lineage markers concomitantly and can exist in an uncommitted 
state just prior to their differentiation (Brunskill et al., 2014; Gouti et al., 2014; Hanchate 
et al., 2015; Treutlein et al., 2014). Thus, rather than being influenced by a single factor, 
it seems more likely that modulating the relative levels of lineage determinants may lead 
to a cell’s decision to adopt a particular cell fate. 
The neural crest (Le Douarin, 1982) is an important example of a cell population 
in vertebrate embryos that serves as an excellent model system for addressing how cell 
fate decisions are made (Dupin et al., 2006; Powell et al., 2013; Smith, 1990; Tucker, 
2004). Arising from the junction of the neural plate (future central nervous system) and 
non-neural ectoderm (future epidermis), presumptive neural crest cell progenitors first 
arise at the neural plate border (Streit and Stern, 1999) [Figure 1A-C], which elevates 
during neurulation to become the closing neural folds [Figure 1D-F] that will then 
transform into the dorsal neural tube (Gammill and Bronner-Fraser, 2003). After neural 
tube closure in most species, these cells undergo an epithelial-to-mesenchymal 
transition, losing their cell-cell adhesion and transforming into a migratory and 
mesenchymal state (Sauka-Spengler and Bronner-Fraser, 2008) [Figure 1G-I]. Motile 
neural crest cells then migrate throughout the embryo to form a wide range of derivatives, 
including craniofacial bone and cartilage, ganglia of the peripheral nervous system, and 
pigment cells of the epidermis (reviewed in (Gandhi and Bronner, 2018; Martik and 




In my graduate studies, I have addressed questions pertaining to neural crest 
plasticity and cell fate determination in avian embryos. I particularly focused on the cranial 
neural crest, which contributes to craniofacial structures including the facial skeleton, and 
the cardiac neural crest, which emerges from the caudal hindbrain and has the unique 
developmental potential to contribute to the heart.  
 
Figure 1. Early stages of neural crest development. A-C. Neural crest cells are induced at the neural plate border 
(A), a strip of ectoderm that lies at the juxtaposition of the neural plate and the non-neural ectoderm (B). Lineage-
specific markers are expressed in neural plate border precursors as the embryo develops. Pax7 transcripts label the 
presumptive neural crest, whereas Tfap2a transcripts label the developing ectoderm. However, a subset of the neural 
plate border cells express both Pax7 and Tfap2a, supporting the hypothesis that the neural plate border represents a 
heterogeneous mixture of multipotent progenitors with the capacity to contribute cells to the neural, neural crest, 
ectoderm, and the placodal lineages. D-F. During neurulation, the neural plate border elevates to form neural folds 
(D,E), and a battery of transcription factors known as the neural crest specifier genes are expressed in the dorsal 
aspect of the developing neural tube. Eventually, as the neural folds fuse to form the neural tube, premigratory neural 
crest cells in the dorsal midline of the neural tube undergo an epithelial to mesenchymal transition, losing expression 
of cell junction proteins and gaining mesenchymal characteristics. Pax7 protein continues to be expressed in 
emigrating neural crest cells (F). G-I. Following their emigration (G), neural crest cells migrate extensively throughout 
the embryo (H) to give rise to diverse array of cell types, including neurons, glia, smooth muscle, cartilage and bone, 




8.2 The neural crest 
The neural crest is a uniquely vertebrate cell type (Bronner and LeDouarin, 2012). 
On this basis, Gans and Northcutt (Gans and Northcutt, 1983), in their seminal paper from 
1983, proposed that the advent of the neural crest at the base of vertebrates played a 
critical role in vertebrate evolution. By giving rise to bone and cartilage of the lower jaw 
as well as contributing to sensory structures of the head, they proposed that innovation 
of this new cell type facilitated a behavioral shift in vertebrates towards active predation 
(Glenn Northcutt, 2005). Moreover, despite their ectodermal origin, the fact that neural 
crest cells were capable of giving rise to critical mesenchymal derivatives challenged 
existing hypotheses regarding germ layer contributions (Green et al., 2015; Hall, 2000).  
In Chapter 2, I discussed the early principles of neural crest development and 
provided a summary of research that addressed a long-standing question of whether 
individual premigratory neural crest cells that reside within the dorsal neural tube are 
multipotent or a mixture of predetermined progenitors each with the ability to give rise to 
a particular cell type. Through a combination of in vitro and in vivo techniques, the 
multipotency of the neural crest has been established. The experimental techniques used 
to address the question of multipotency have been recently reviewed in detail (Tang and 
Bronner, 2020). I also discussed how neural crest cells move in a highly patterned fashion 
through neighboring tissues and how their patterns of migration and types of derivatives 
formed depend upon their axial level of origin (Le Douarin, 1982; Noden, 1975). Four 
distinct axial levels were noted, designated as cranial, vagal, trunk and lumbosacral 
neural crest [Figure 2]. While neural crest cells at all axial levels contribute to some 
common derivatives such as skin melanocytes, glia and Schwann cells (Le Douarin, 
1982), there are also neural crest-derived cell types that are unique to particular axial 
levels (Le Douarin and Teillet, 1974). Cranial and vagal neural crest cells, that originate 
in the rostral half of the embryo, follow different patterns of migration compared to the 
trunk and sacral neural crest and differentiate into some unique cell types. For example, 
neural crest cells originating in the midbrain migrate primarily as a broad, unsegmented 




skeleton to the ciliary and trigeminal ganglia (D’amico‐Martel and Noden, 1983; Le 
Douarin and Kalcheim, 1982). Neural crest cells originating in the rostral hindbrain enter 
the branchial arches and form many of the cartilaginous elements of the facial skeleton, 
including the quadrate, Meckel’s cartilage and surrounding membrane bones, and the 
basihyoid cartilage in the tongue (Couly et al., 1992, 1993; Noden, 1978).  
Another neural crest population, developmentally unique from the cranial neural 
crest, originates in the caudal hindbrain and is called the “cardiac” neural crest, originally 
Figure 2. Rostrocaudal arrangement of neural crest populations. Neural crest derivatives are segregated based 
on their axial levels of origin. Cranial neural crest cells have the unique ability to contribute bone and cartilage of the 
craniofacial skeleton and odontoblasts to the developing dental pulp. The cardiac neural crest, which is considered a 
subset of the vagal neural crest, is also the only neural crest subpopulation that can contribute smooth muscle cells 
to the developing heart. Embryos in which the cardiac neural crest was surgically ablated suffer from persistent truncus 
arteriosus, a condition where the outflow tract fails to septate, resulting in a single vessel emerging from the heart that 
carries both oxygenated and deoxygenated blood. Recent work has highlighted the contribution of the cardiac neural 
crest to the ventricular myocardium (Tang et al., 2019b). The rest of the vagal neural crest gives rise to the enteric 
ganglia. Trunk neural crest is the largest neural crest population in the early embryo. While lacking the ability to form 
specialized ectomesenchymal derivatives such as cartilage and smooth muscle, these cells give rise to the dorsal root 
ganglia, the adrenal medulla, sympathetic ganglia, and melanocytes. Finally, the sacral neural crest contributes to the 




designated by Le Douarin and colleagues as a subset of the vagal neural crest (Le 
Douarin and Teillet, 1973). These cells arise adjacent to the mid-otic to somite 3 level and 
are the only neural crest subpopulation that contributes to the cardiovascular system 
(Kirby et al., 1983). Following delamination from the dorsal hindbrain, they migrate into 
the pharyngeal arches 3, 4, and 6, from which a subset of cardiac crest cells migrates 
into the cardiac outflow tract, within which they condense to form the aorticopulmonary 
septum (Hutson and Kirby, 2007; Kirby et al., 1983; Neeb et al., 2013; Snider et al., 2007; 
Stoller and Epstein, 2005). Some cells migrate still further into the ventricles and form 
cardiomyocytes (Tang et al., 2019b). Other vagal neural crest cells enter the foregut and 
contribute to the neurons and glia of the enteric nervous system (Epstein et al., 1994), 
which also receives a contribution from the sacral neural crest (Burns et al., 2000). The 
largest neural crest population is the “trunk” neural crest which arises at spinal cord levels 
[Sidebar 3] and forms sympathetic and sensory ganglia of the peripheral nervous system 
as well as to the adrenal medulla (Bronner-Fraser, 1986; Kuo and Erickson, 2010; Osorio 
et al., 2009; Rickmann et al., 1985; Vega-Lopez et al., 2017).  
In Chapter 3, we investigated the evolutionary origin of the neural crest population 
in vertebrates (Martik et al., 2019) by comparing cranial and trunk neural crest gene 
expression from the sea lamprey, which are parasitic, eel-shaped fish without jaws, with 
those of jawed vertebrates embryos at different positions on the vertebrate tree of life 
(skate, zebrafish, chick). While the chick possess a cranial neural crest subcircuit that is 
transcriptionally unique from its trunk neural crest, lamprey cranial neural crest lacks this 
subcircuit and more closely resembles chick trunk neural crest. Interestingly, cranial crest 
subcircuit genes appear to have been progressively added as the vertebrates continued 
to evolve. Based on these results, we proposed that ancestral neural crest of jawless 
vertebrates exists in a primitive “trunk-like” state, and that progressive addition of new 
genes during the course of vertebrate evolution gradually conferred onto neural crest the 
ability to form bone and cartilage of the lower jaw.  
In Chapters 4 and 5, I described our work on developing molecular tools for genetic 




embryos. My graduate thesis work has helped expand the experimental toolkit available 
to understand the development of the neural crest and other embryonic cell types, making 
this an opportune time to delve deeply into the molecular mechanisms underlying 
specification, migration and differentiation of this cell population.  
8.3 Plasticity at the neural plate border 
All neural crest subpopulations are induced at the neural plate border (Streit and 
Stern, 1999), a broad stripe of ectoderm immediately adjacent to the future neural plate. 
Neural crest induction precedes the onset of expression of early neural marker genes 
such as Otx2, Sox3, and ERNI (Rex et al., 1997; Streit et al., 2000) in the presumptive 
neural plate of a pre-gastrula stage embryo. Expression of these markers relies on 
activating FGF signaling and inhibiting Wnt and BMP signaling to establish the neural 
lineage from the underlying ectoderm (Albazerchi and Stern, 2007; Rogers et al., 2011; 
Stern and Downs, 2012; Streit et al., 2000). On the other hand, in the lateral edges of the 
embryo, the absence of antagonistic Wnt and BMP signals triggers the expression of 
genes that mark the non-neural ectoderm, such as those belonging to the transcription 
factor families Tfap2, Dlx, Foxi, and Msx (reviewed in Thawani and Groves, 2020). While 
the neural and non-neural lineages are segregating, a battery of genes belonging to the 
neural crest gene regulatory network, termed neural plate border specifiers (Simões-
Costa and Bronner, 2015), are transcribed in the early gastrula, including Pax3/7, Zic1, 
and Msx1, thereby establishing the boundaries of the neural plate border. The expression 
of these genes is maintained in the neural plate border through a series of positive-
feedback cross-regulatory interactions (Martik and Bronner, 2017).  
The classical view of the neural plate border region was that it was comprised of 
separate zones containing cells with different prospective fates, with placodal precursors 
found more laterally and neural crest precursors more medially (Ahrens and Schlosser, 
2005; Pieper et al., 2012). In contrast, Roellig et al. (2017) proposed that neural plate 
border cells initially may be naïve and capable of giving rise to several possible 




located within the neural plate border, they showed that neural plate border cells are 
heterogeneous based on their protein expression profiles and often co-express two or 
three markers characteristic of neural (Sox2) (Fernández-Garre et al., 2002), neural crest 
(Pax7) (Basch et al., 2006), ectodermal (Tfap2a) (Knight et al., 2005), or placodal (Six1) 
(Ahrens and Schlosser, 2005) lineages. They further demonstrated that expression of the 
neural plate marker Sox2 extends throughout the whole neural plate border when 
compared to Msx1/2 and Pax7, which suggests that numerous cells at the neural plate 
border simultaneously express a subset of markers of definitive neural, neural crest, 
placodal and epidermal progenitors. Consistent with these observations, modulation of 
Sox2 and Pax7 expression level was sufficient to shift the balance between neural and 
neural crest fates. Moreover, when small groups of neural plate border (Schoenwolf and 
Sheard, 1990) or presumptive placodal precursors (Streit, 2002) were labeled using focal 
DiI injections in the neural plate border region of gastrula-stage chick embryos, DiI-
labeled cells were found in the epidermis, neural tube, neural crest and placodal tissues, 
also supporting the idea of shared lineages. 
While Roellig et al. (2017) characterized the molecular switch that controls the fate 
switch between neural and neural crest lineages, the role of epigenetic modifiers in 
regulating these cell fate decisions was previously unclear. In Chapter 6, I delved deeper 
into this question (Gandhi et al., 2020a) by profiling the chick embryonic hindbrain at a 
single-cell resolution using scRNA-seq, looking for genes that were expressed in neural 
(hindbrain), neural crest (cardiac neural crest), and epidermis (non-neural ectoderm), 
three lineages derived from the neural plate border. This allowed us to identify the 
chromatin remodeler gene Hmga1 (Fedele et al., 2006; Xian et al., 2017) as broadly 
expressed across the three cell populations. Extensively studied for its role in several 
types of cancers (Resar et al., 2018; Shah and Resar, 2012), Hmga1 increases the 
accessibility for transcriptional complexes to bind in proximity and regulate the expression 
of target genes (Reeves and Beckerbauer, 2001). However, little was known about its 
role in early neural crest development. In avian embryos, Hybridization Chain Reaction 




neural plate and the presumptive neural plate border (Gandhi et al., 2020a). Its 
expression preceded that of Pax7 in neural plate border precursors, such that CRISPR-
Cas9-mediated knockout of Hmga1 resulted in a specific loss of Pax7 in the neural plate 
border without affecting the expression of other neural plate border specifier genes, such 
as Msx1 and Tfap2a. These experiments established Hmga1 as an upstream regulator 
of Pax7-dependent neural crest specification at the neural plate border. Following the loss 
of Hmga1 in neural crest precursors, the expression of Sox2 was elevated at the expense 
of Pax7, suggesting that cells acquired a neural fate at the expense of neural crest fate. 
My work further illuminates the importance of proper nucleosomal remodeling as an 
additional regulatory mechanism for governing cell fate choices at the neural plate border. 
8.4 Specification of the cardiac neural crest in the dorsal hindbrain 
One of the neural crest populations along the body axis about which the least is 
known is the cardiac neural crest (Hutson and Kirby, 2003). The axial level of origin for 
the cardiac neural crest was identified as the hindbrain over 30 years ago by Margaret 
Kirby and colleagues, using ablation experiments and quail-chick chimeric grafts (Kirby 
et al., 1985). They showed that bilateral ablation of the dorsal neural tube adjacent to mid-
otic vesicle to somite 3 caused a broad range of defects, including persistent truncus 
arteriosus (PTA), double outlet right ventricle (DORV), abnormal myocardium function, 
and misalignment of the arch arteries (Bockman et al., 1987). Conversely, quail-chick 
grafts showed that hindbrain neural crest cells contribute to the cardiac outflow tract, 
pharyngeal arch arteries and some valves of the heart (Kirby and Stewart, 1983; Waldo 
and Kirby, 1993; Waldo et al., 1998). More recently, retroviral lineage tracing (Tang et al., 
2019b) has confirmed these cardiac crest derivatives and additionally revealed a 
contribution of the cardiac neural crest to cardiomyocytes in the ventricles in both birds 
and mice similar to that previously noted in zebrafish (zebrafish contribution reviewed in 
George et al., 2020). Moreover, after resection of the adult heart of zebrafish, a neural 
crest gene regulatory program is redeployed and heart regeneration fails upon ablation 




The specification of cardiac neural crest cells is similar to but temporally follows 
that of the cranial neural crest. Expression of neural plate border specifier genes is swiftly 
followed by the expression of a set of transcription factors known as neural crest specifiers 
(Rothstein et al., 2018; Simões-Costa and Bronner, 2015; Simões-Costa et al., 2014). 
The onset of specification is a Wnt signaling dependent process, where the neural plate 
border specifier genes Pax7 and Msx1 interact with the Wnt effector Axud1 to directly 
regulate the levels of FoxD3 in specified neural crest cells (Simões-Costa et al., 2015). 
Tfap2a, which is expressed in the neural plate border and non-neural ectoderm lineages, 
is also essential for proper specification of neural crest cells (De Crozé et al., 2011; Knight 
et al., 2003; Luo et al., 2003; Rothstein and Simões-Costa, 2020), and acts in a manner 
independent of its role in the non-neural ectoderm.  
Upon completion of specification, neural crest specifier genes appear in the 
cardiac neural crest population that are similar to those expressed in cranial neural crest, 
including Sox10 (Betancur et al., 2010a), Tfap2b (Rothstein and Simões-Costa, 2020), 
Snai2 (Nieto et al., 1994), FoxD3 (Barembaum and Bronner-Fraser, 2005), Ets1 
(Théveneau et al., 2007) and cMyc (Kerosuo and Bronner, 2016). However, unlike 
midbrain level neural crest cells which lack Hox gene expression, a number of different 
Hox genes are expressed in the cardiac neural crest including Hoxa1, Hoxb1, and Hoxb5 
(Gandhi et al., 2020b; Tani-Matsuhana et al., 2018). As is the case with neural plate 
border specifier genes, the expression of neural crest specifier genes is maintained in 
premigratory and migratory neural crest cells through a series of positive feedback/feed-
forward loops. For example, Ets1 is necessary for maintaining the expression of FoxD3 
(Simões-Costa et al., 2012).  
A cardiac neural crest specific program appears to be superimposed upon a more 
general neural crest specification program. In Chapter 7, I showed that the cardiac crest 
subcircuit includes the transcription factor Tgif1 (Gandhi et al., 2020b), which is 
specifically expressed in premigratory and migrating cardiac neural crest cells. When 
Tgif1 was knocked out from the cardiac neural crest using CRISPR-Cas9, the expression 




2018) was downregulated, without affecting the levels of other pan-neural crest specifier 
genes such as FoxD3. Moreover, Tgif1 acted downstream of the transcription factor Sox8, 
which is required for induction of neural crest cells (O’Donnell et al., 2006), and upstream 
of Ets1, which has been implicated in their proper specification and delamination (Gao et 
al., 2010). The expression of Ets1 is also regulated by the neural plate border specifier 
genes Pax7 and Msx1 in specified neural crest cells (gene circuitry reviewed in Martik 
and Bronner, 2017; Simões-Costa and Bronner, 2015), suggesting that members of the 
neural plate border specifier gene circuits continue to play a crucial role in the 
establishment of neural crest identity.  
Following specification, the cardiac crest migrates to the body wall and settles in 
the circumpharyngeal area of forming pharyngeal arches 3, 4, and 6, known as the 
circumpharyngeal ridge. From there, some of these cells will continue migration into the 
cardiac outflow tract where they condense and form the outflow tract septum, which 
septates the outflow tract into the aorta and the pulmonary trunk (Creazzo et al., 1998). 
Other cardiac neural crest cells remain in these arches and contribute to the aortic arch 
arteries (precursors to the brachiocephalic arteries, medial common carotid artery, aorta 
and ductus arteriosus), as well as the thymus, thyroid, and parathyroid glands (Hutson 
and Kirby, 2007; Jiang et al., 2000). These cells also play a critical role in remodeling of 
the aortic arch arteries. Cardiac neural crest cells also populate the cardiac cushions 
(future semilunar valves), interventricular septum, and form the nerves of the cardiac 
parasympathetic nervous system including the cardiac ganglia. My graduate work has 
raised important outstanding questions, including whether individual cardiac neural crest 
cells contribute to all derivatives of the heart, or whether precursors are set aside that are 
already committed to particular lineages. 
8.5 Molecular recipe for neural crest cell fate 
Within the last decade, genome sequences of a broad spectrum of species (e.g. 
chick (Hillier et al., 2004), opossum (Mikkelsen et al., 2007), armadillo (Lindblad-Toh et 




vertebrates, considerably increasing the fidelity with which conserved regions across 
species can be predicted. Detailed cis-regulatory analysis, through a combination of 
phylogenomics and high-throughput sequencing-based approaches, has enabled the 
identification and dissection of active tissue-specific enhancers. Using genomic alignment 
between multiple vertebrate species, conserved non-coding regions at the loci of neural 
crest specifier genes Sox10 (Betancur et al., 2011), FoxD3 (Simões-Costa et al., 2012), 
and Ets1 (Barembaum and Bronner, 2013) have been identified. Not only have these 
enhancers provided the means of establishing positive and negative links between 
downstream factors and their direct transcriptional inputs, but in genetically intractable 
systems such as the chick, they have allowed the isolation of pure populations of neural 
crest cells. In Chapters 6 and 7, I demonstrated how these cis-regulatory elements can 
be applied to elaborate our understanding of the regulatory differences between different 
neural crest populations originating at distinct axial levels. 
8.5.1 Cranial neural crest 
Following induction of the neural crest at the neural plate border, the cranial neural 
crest is the first population that undergoes delamination from the dorsal neural tube. 
These cells will give rise to diverse cell types in the developing head, including much of 
the craniofacial cartilage and bone, and neurons and glia of the cranial ganglia (Le 
Douarin, 1982). Their ability to form cartilage is unique amongst neural crest populations, 
such that the trunk neural crest lacks the ability to form ectomesenchymal derivatives 
(Nakamura and Ayer-Le Lievre, 1982). This raised the possibility that inherent 
transcriptional differences exist between cranial and trunk neural crest cells.  
Simões-Costa and Bronner took advantage of cranial versus trunk neural crest 
specific enhancers to isolate pure neural crest populations for transcriptional profiling 
(Simões-Costa and Bronner, 2016). Accordingly, they identified transcription factors 
enriched in the cranial neural crest compared to the trunk neural crest: Brn3c, Lhx5, 





Figure 3. Transcriptional subcircuits and neural crest identity. A. Slight changes in transcriptional circuitry can 
alter neural crest identity. The ectopic expression of a cranial “subcircuit” comprising of the transcription factors Sox8, 
Tfap2b, and Ets1 can confer onto trunk neural crest cells the ability to form cartilage. However, the ectopic expression 
of a cardiac “subcircuit” where Sox8 and Ets1 work with Tgif1 instead of Tfap2b imbues cardiac-like migration and 
differentiation ability onto trunk neural crest cells. B-D. Normalized expression for the cardiac subcircuit genes Sox8, 
Tgif1, and Ets1 (B), genes enriched in wildtype cardiac neural crest cells HoxA2, Nrip2, and Nr6a1 (C), and genes 
enriched in wildtype trunk neural crest cells (D) following expression of the cardiac subcircuit in the trunk neural crest. 
The expression of cardiac markers was upregulated in “reprogrammed” trunk neural crest, while the expression of the 
trunk neural crest markers was downregulated. Data from Gandhi et al. (2020). Shaded area in B, C, and D represents 




These factors comprised a “cranial-specific” subcircuit, with Brn3c, Lhx5, and 
Dmbx1 expressed in the neural plate border and Sox8, Tfap2b, and Ets1 expressed in 
the premigratory and emigrating cranial neural crest [Figure 3A]. Through a series of loss-
of-function and promoter-ChIP experiments, they established regulatory linkages 
between these factors. Importantly, ectopic expression of the downstream factors Ets1, 
Sox8, and Tfap2b in the trunk neural crest resulted in upregulation of genes associated 
with the chondrogenic potential of cranial neural crest cells, such as Alx1 and Runx2, and 
concomitant downregulation of trunk neural crest genes, such as Dbx2 and Hes6. When 
“reprogrammed” trunk neural crest tissue was transplanted into the cranial region, the 
cells gave rise to ectopic cartilage nodules, as identified by the expression of COL9A. 
This was the first direct demonstration of how neural crest cells from other axial levels 
can be successfully reprogrammed into a cranial-like fate (Simões-Costa and Bronner, 
2016). 
8.5.2 Cardiac neural crest 
Like cranial neural crest, the cardiac neural crest also has a unique developmental 
potential—the ability to form the ectomesenchymal derivatives of the developing heart, 
most notably the aorticopulmonary septum that septates the outflow tract into the 
pulmonary and aortic trunks (Kirby et al., 1983). When trunk neural crest from a quail 
embryo was grafted in place of the cardiac neural crest in a chick embryo, the neural crest 
cells failed to migrate into the heart, resulting in cardiovascular anomalies consistent 
similar to cardiac neural crest ablation (Kirby, 1989).  
In Chapter 7, I used specific neural crest enhancers to isolate pure neural crest 
populations for bulk RNA-seq to identify transcription factors that were enriched in the 
cardiac neural crest compared to the trunk neural crest (Gandhi et al., 2020b). While 
many of the enriched transcription factors were shared with the cranial neural crest 
(Simões-Costa et al., 2014), one transcription factor, Tgif1, was specifically expressed in 
the delaminating cardiac neural crest in the dorsal hindbrain. This was particularly 




level become restricted to a cardiac fate (Ezin et al., 2011). Loss of Tgif1 resulted in a 
downregulation of cardiac neural crest markers, without affecting the expression of pan 
neural crest genes. We posited that Tgif1 may cooperate with other transcription factors, 
and found that it worked together with Sox8 and Ets1 in a cardiac-crest-specific subcircuit. 
Sox8 is a member of the SoxE family of genes and Ets1, a member of the ETS-domain 
transcription factor family, has been implicated in Jacobsen syndrome (11q-), a disease 
often associated with ventricular septal defects (Grossfeld et al., 2004; Ye et al., 2009). 
In addition, Sox10 expression is lost in Ets1-/- mutant mice, and embryos suffer from large 
membranous interventricular septal defects in the absence of other structural heart 
defects (Ye et al., 2016).  
CRISPR-Cas9-mediated knockouts of Sox8, Ets1, and Tgif1 allowed us to 
assemble the cardiac crest gene regulatory subcircuit where Sox8 and Tgif1 were 
expressed in premigratory cardiac neural crest cells, and regulated the expression of Ets1 
in migratory cardiac neural crest cells [Figure 3A]. Through transcription factor motif 
mutational analysis, we found that the interactions between Sox8 and Tgif1, and between 
Tgif1 and Ets1, were direct. Ectopic expression of this circuit [Figure 3B] in the trunk 
resulted in “reprogramming” of the trunk neural crest as assayed by upregulation of 
cardiac neural crest genes [Figure 3C] and downregulation of endogenous trunk neural 
crest markers [Figure 3D]. Transplantation of these reprogrammed trunk neural crest cells 
in place of ablated cardiac neural crest, resulted in neural crest cells following cardiac-
like migration pathways and populated branchial arches 3 and 4. Moreover, when the 
grafted embryos developed to stages of normal outflow tract septation, the reprogrammed 
trunk neural crest cells populated the aorticopulmonary septum. This shows that 
expression of the cardiac subcircuit imbued a “cardiac-like” identify onto the trunk neural 
crest (Gandhi et al., 2020b).  
8.5.3 Vagal neural crest 
Vagal neural crest, of which cardiac neural crest is a subset, originates in the dorsal 




Douarin and Teillet, 1973; Epstein et al., 1994) [Figure 2]. Errors in their development can 
lead to severe birth defects, including Hirschsprung disease, which presents with a lack 
of enteric neurons in the distal portion of the gut (Iwashita et al., 2003). In spite of its 
importance for proper human gut development, the genetic circuitry underlying vagal 
neural crest fate specification was not well known previously. Ling and Sauka-Spengler 
performed a comprehensive genome-wide study to identify the genetic and epigenetic 
mechanisms that orchestrate the diversification of vagal neural crest cells into enteric 
derivatives (Ling and Sauka-Spengler, 2019). By profiling the vagal population at a single-
cell resolution using scRNA-seq, they uncovered three distinct lineages derived from 
these precursors: neural, neuronal, and mesenchymal. Each of these lineages expressed 
distinct set of molecular markers, including Sox10 and FoxD3 for neural, Sox3 and Elavl4 
for neuronal, and Prrx1 and Twist1 for mesenchymal. The chromatin accessibility data 
collected across different time points revealed that the Tfap2, Sox, Hbox, and bHLH 
families of transcription factors were involved in diversification of vagal crest derivatives. 
These results, together with their single-cell data, provided a unique perspective on vagal 
neural crest colonization of the gut, with a migrating heterogenous population of vagal 
crest cells epigenetically predetermined to form enteric glia, neurons, and a previously 
overlooked mesenchymal population within the gut. Ling and Sauka-Spengler’s proposed 
model that vagal neural crest cells, regardless of their axial level of origin, are predestined 
to form derivatives of the gut, runs contrary to the results observed by  Barlow et al., 
(2008), who found that while cells adjacent to somite 3 are capable of giving rise to enteric 
neurons, cells adjacent to somite 1 primarily migrate into the heart. 
8.6 To go with your heart or your gut? 
While cardiac neural crest cells migrate into the developing heart where they 
assume a mesodermal-like identity, vagal neural crest cells migrate into the developing 
enteric nervous system where they give rise to the sympathetic, parasympathetic, and 
enteric neurons. The mechanisms of these cell fate choices have long been debated. 
While some groups have proposed that cardiac neural crest cells are bipotent precursors 




proposed that heart-specific and gut-specific precursors are intermingled within the vagal 
neural crest domain (Espinosa-Medina et al., 2017; Kuo and Erickson, 2011). 
Tang et al. (2021) approached this question using replication incompetent avian 
retroviruses that have been established as a versatile tool for lineage tracing (Tang et al., 
2019a), gene editing, and clonal analysis in chick embryos. Using a combination of 
different retroviruses encoding unique combinations of fluorescent proteins and 
subcellular localization signals, they demonstrated that cardiac neural crest cells are 
indeed multipotent, with individual cardiac neural crest cells having a broad 
developmental potential to give rise to smooth muscle cells, neurons and glia. To address 
the possibility that premigratory neural crest cells residing in the caudal hindbrain are 
multipotent and able to migrate to both the heart and the gut, they performed single-cell 
photoconversion of sparsely labeled premigratory cardiac neural crest cells. Following 
photoconversion, daughter cells migrated extensively towards both the pharyngeal 
pouches and the developing gut. Not only were clonally-related cells found within the 
dorsal neural tube, glossopharyngeal nerve complex, pharyngeal arch arteries, and the 
outflow tract, tissues that are derived from the cardiac neural crest, but several clonally 
derived cells were also found in the developing gut. The neural tube adjacent to somites 
4-7 was not found to be retrovirally labeled, suggesting that the clones found in the gut 
originated within the cardiac axial level. Slice culture-based live imaging of virally-labeled 
cardiac neural crest cells revealed that following delamination from the dorsal neural tube, 
neural crest cells intermixed in the circumpharyngeal ridge. Interestingly, a subset of the 
cells migrating into the sixth pharyngeal pouch instead migrated caudally to colonize the 
gut. Tang et al. further characterized the molecular cues that controls migration into the 
heart versus the gut. When they expressed a dominant negative form of the receptor 
CXCR4, cardiac neural crest cells failed to migrate into the outflow tract. However, the 
proportion of cells that migrated into the gut remained unchanged, suggesting that 
CXCR4-SDF1-based chemoattraction is necessary to bias a cardiac crest precursor 
towards the heart. On the other hand, when a dominant negative form of Ret was 




outflow tract, but failed to colonize the gut. Overall, these results are complementary to 
phenotypes observed in mice that lack proper CXCR4-SDF1 (Escot et al., 2013) or RET-
GDNF (Bogni et al., 2008) signaling. The former resulted in DiGeorge Syndrome-like 
malformations, whereas the latter resulted in a significant reduction in the number of 
enteric neurons.  
While Tang et al. uncovered the signaling cues that attract cardiac neural crest 
cells in the heart or the gut, their work did not explore possible intrinsic parameters that 
might control this fate switch. Vincentz et al. (2013) employed Wnt1Cre mice to target the 
bHLH transcription factor Twist1 from cardiac neural crest cells, in an effort to dissect the 
principles that drive a mesodermal identity in cardiac neural crest derivatives as 
compared to an ectodermal identity in the vagal neural crest. Conditional deletion of 
Twist1 in premigratory cardiac neural crest cells resulted in the formation of unusual cell 
aggregates within the outflow tract at the expense of the aorticopulmonary septum, 
resulting in completely penetrant persistent truncus arteriosus. These aggregates were 
cardiac-neural-crest-derived and expressed Sox10 and the pan-neuronal marker Tubb3, 
as well as bona fide sympathetic ganglion neuronal markers such as Phox2a, Phox2b, 
and Ascl1. These data demonstrated that in the absence of Twist1, cardiac neural crest 
cells in the outflow tract turned on a neuronal at the expense of a smooth muscle program. 
Vincentz et al. then inactivated Twist1 using the Hand1Cre knock in allele. While the 
Wnt1Cre driver line ablated Twist1 in premigratory cardiac neural crest cells, the Hand1Cre 
driver line deleted Twist1 in post-migratory cardiac crest cells. In contrast to the highly 
penetrant OFT defect in the Twist1;Wnt1Cre conditional knockouts, the Twist1;Hand1Cre 
conditional knockouts were less penetrant, even though neuronal aggregates still formed 
in the outflow tract. Further investigation into the mechanism revealed that the ectopic 
neurogenesis in the outflow tract in a Twist1 conditional knockout background was 
dependent on the paired-like homeobox gene Phox2b. In Phox2b null homozygotes mice, 
vagal neural crest cells migrate into the gut but fail to turn on neuronal markers, eventually 
undergoing premature apoptosis (Pattyn et al., 1999). When Phox2b gene was deleted 




suggesting that in cardiac neural crest cells, Twist1 represses the activity of Phox2b to 
bias cardiac neural crest cells towards a smooth muscle fate. Consistent with this, 
Soldatov et al. (2019) examined the transcriptional profile of neural crest cells in the 
mouse embryo at a single cell resolution and found that Twist1 was an important 
determinant of mesenchymal identity. Accordingly, Twist1 overexpression in the trunk 
neural crest altered cell fate from neuronal to mesenchymal. 
8.7 Epigenomic regulation of neural crest cell fate  
Over the last decade, there has been interest in deciphering the gene regulatory 
network underlying neural crest development (Betancur et al., 2010b; Gammill and 
Bronner-Fraser, 2002; Martik and Bronner, 2017; Sauka-Spengler and Bronner-Fraser, 
2008; Simões-Costa and Bronner, 2015). In addition to transcriptional circuitry, neural 
crest formation also relies on an ever changing epigenetic landscape that culminates in 
alterations in gene expression. This is achieved by chromatin remodeling complexes and 
chromatin-modifying enzymes such as DNA and histone methylases, demethylases, and 
acetylases, which orchestrate changes in gene expression (reviewed in (Hu et al., 2014)). 
Histone methylation has been associated with both transcriptional activation and 
repression. Whereas methylation of H3 lysines 4 and 36 (H3K4me2/me3 and 
H3K36me2/3) are enriched in transcriptionally active euchromatic regions, H3 lysines 9 
and 27 (H3K9me3 and H3K27me3) are located in repressed sites as well as associated 
with heterochromatin. Chromatin remodeler proteins, such as CHD7 and HMGA1, are 
critical for proper neural crest development. CHD7, an ATP-dependent helicase, has 
been shown to activate the expression of neural crest specifier genes like Sox9 and 
Twist1 through direct regulation of their enhancers (Bajpai et al., 2010). Mutations in the 
CHD7 locus have been associated with CHARGE syndrome, a rare congenital disorder 
that causes defects in neural crest development. As I discussed in Chapter 6, HMGA1, 
which acts upstream of Pax7 and regulates a neural versus neural crest fate switch in 
neural plate border precursors, functions as a Wnt-activator in the dorsal neural tube 




emigration of neural crest cells from the neuroepithelium (Burstyn-Cohen et al., 2004; 
Rabadán et al., 2016).  
8.7.1 Non-coding RNAs  
The post-transcriptional circuitry that governs neural crest fate determination has 
remained poorly understood. Recent evidence suggests potential roles for non-coding 
RNAs and, in particular, microRNAs (miRNAs), small non-coding RNA molecules that 
post-transcriptionally regulate gene expression by binding to the 3’ UTR and/or the coding 
sequence of their target genes. Neural crest-specific knockout of Dicer in mice results in 
craniofacial (Nie et al., 2011) and cardiovascular defects (Huang et al., 2010), including 
ventricular septal defects. Interestingly, there are distinct effects of losing Dicer on neural 
crest cells originating from different axial levels; loss of Dicer caused premature cell death 
in cranial neural crest cells, whereas its loss in the cardiac neural crest altered their 
migration and patterning of the aortic arch arteries and the outflow tract.  
To examine the possible role of miRNAs in establishing the neural crest formation, 
Xi et al. (2017) took advantage of an in vitro embryonic stem cell model to characterize 
the function of miRNAs in the fate switch between neural and neural crest. They 
discovered that the miRNA-29b was upregulated in differentiated neural tube cells 
compared to differentiated neural crest cells. Using a miRNA sponge strategy to reduce 
miRNA-29b-mediated repression of its target genes, they demonstrated its necessity for 
neural tube differentiation. The expression of neural tube markers such as Pax6, Nestin, 
and Tubb3 were downregulated, with no change in the levels of pluripotency marker 
genes such as Oct4 and Nanog. Conversely, overexpression of miRNA-29b resulted in 
an increased proportion of neural tube cells derived from mESCs at the expense of the 
neural crest lineage. It was previously known that miRNA-29b targeted the DNMT family 
members Dnmt3a and Dnmt3b. Consequently, they assayed for DNMT3A/3B protein 
levels in miRNA-29b sponge and overexpression backgrounds and observed that 
DNMT3A but not DNMT3B protein was increased and reduced, respectively. Indeed, 




tube differentiation whereas overexpression rescued neural crest differentiation. The 
transcription factor POU3F1, which has been previously shown to activate neural lineage 
genes resulting in fate commitment towards the neural lineage (Zhu et al., 2014), was 
found to act upstream of miRNA-29b in both mouse and human cells.  
While the results of this study were entirely in vitro, they are consistent with 
previous in vivo literature. For example, in avian embryos, Dnmt3a has been shown to be 
important for the cell fate decision between neural versus neural crest lineages, where it 
actively represses the levels of Sox2 and Sox3, priming the cells towards a neural crest 
fate (Hu et al., 2012). Loss of DICER prior to neural crest specification also results in a 
fate switch of neural crest precursors into neural plate cells (Copeland and Simões-Costa, 
2021), likely due to an accumulation of SOX2 protein. These results suggest post-
transcriptional regulators function synergistically with the molecular circuitry to control 
bifurcation of the neural and neural crest lineages from neural plate border precursors. 
8.7.2 RNA-binding proteins 
In addition to chromatin modifiers, RNA binding protein partners of non-coding 
RNAs play central regulatory roles in modulating transcriptional and post-transcriptional 
gene expression. Hutchins et al. recently demonstrated that the RNA-binding protein HuR 
is required for proper neural crest specification (Hutchins et al., 2020). Loss of HuR 
resulted in a downregulation of FoxD3, its activator Axud1 (Simões-Costa et al., 2015), 
and the secreted molecule Draxin (Hutchins and Bronner, 2018, 2019), without affecting 
the relative proportions of neural crest precursors in the neural plate border. The authors 
suggest that HuR associates with and stabilizes Draxin mRNA, as evidenced by the 
enrichment of Draxin transcripts bound to the HuR ribonucleoprotein complex. Moreover, 
overexpression of Draxin in a HuR knockdown background rescued neural crest 
specification, suggesting a direct mechanism by which RNA-binding proteins can regulate 





8.8 Genomics and neural crest cell fate 
The advent of sequencing technologies that permit characterization of the 
transcriptional (RNA-seq) and epigenetic (ATAC-seq) landscape at the single-cell level 
has opened up the possibility to glean a near complete transcriptional program of 
individual cells at unprecedented resolution. Moreover, computational approaches that 
enable comparison of cell profiles over time provide a window into understanding cell 
trajectories as they move from an undifferentiated to a differentiated state. In this manner, 
genomic approaches can help understand cell fate choices. In this section, we discuss 
how the advent of new sequencing technologies has facilitated our understanding of how 
multipotent neural crest precursors may acquire a unique ectomesenchymal identity, and 
also revealed heterogeneity that may be inherent within the population. 
8.8.1 Acquisition of neural crest identity 
Historically, gene regulatory interactions in the neural crest were studied using a 
bottom-up approach, where individual candidate genes were targeted and their effect on 
downstream effector genes was assayed in an effort to establish regulatory linkages 
between them (Betancur et al., 2010b; Gammill and Bronner-Fraser, 2003; Sauka-
Spengler and Bronner-Fraser, 2008). Moreover, identification of cis-regulatory elements 
was restricted to intergenic regions that were highly conserved between related species 
(Barembaum and Bronner, 2013; Betancur et al., 2011; Simões-Costa et al., 2012). The 
advent of ATAC-seq at the bulk and single-cell level has greatly expanded identification 
and dissection of cis-regulatory elements that are critical for normal neural crest 
development. 
Using a combination of epigenomic and transcriptional profiling coupled with 
perturbations, Williams et al. (2019) provided the first comprehensive global gene 
regulatory network underlying the avian cranial neural crest development. They identified 




[Figure 4A] that contribute to neural crest cell fate decisions to provide a thorough analysis 
of the regulatory interactions that help shape cranial neural crest identity.  
Chromatin-modifying enzymes and remodelers are not the only class of genes that 
can modulate chromatin accessibility. A class of transcription factors, referred to as 
pioneer factors, has recently gained attention (Iwafuchi-Doi and Zaret, 2016). Pioneer 
factors are proteins that bimodally function as transcriptional activators as well as 
chromatin modifiers within a given genetic context. More importantly, they can selectively 
bind to condensed chromatin prior to the occupation of these cis-regulatory elements by 
other transactivation complexes. FoxA and GATA factors were among the first group of 
gene families that were identified as “pioneer factors” in the context of liver development 
(reviewed in (Zaret and Carroll, 2011)). In the neural crest, Lukoseviciute et al. (2018) 
Figure 4. Application of high-throughput sequencing technologies to decipher gene regulatory networks. A. 
The genomic locus of the avian neural crest specifier gene Sox10. Cranial neural crest cells isolated by Fluorescence-
activated cell sorting (FACS) at premigratory and migratory stages for characterization of their chromatin accessibility 
using ATAC-seq. The cis-regulatory landscape surrounding Sox10 contained a super-enhancer-like cluster proximal 
to the Sox10 promoter. This super-enhancer region was upstream of the Sox10 enhancer element E2, which was 
identified by (Betancur et al., 2010) using sequence conservation between vertebrates. B-D’. An example of an intronic 
enhancer for the gene Pax7. This enhancer element recapitulates endogenous PAX7 expression in the dorsal neural 
folds during neural crest specification and emigration, as well as in migratory cranial neural crest cells. Raw data for 




established the role of the neural crest specifier gene foxd3 as a pioneer factor. Using 
zebrafish as a model, they demonstrated that loss of foxd3 in premigratory neural crest 
cells resulted in a broad downregulation of neural crest specification markers, including 
sox10, snai1b, sox9b, and twist1b. However, at migratory stages, they observed 
upregulation of genes associated with neural crest differentiation into ectomesenchymal 
(bmp5/6, col2a1b) and neuronal (robo4, slit1a/b) derivatives. These genes were absent 
in wild type migratory neural crest cells, suggesting that foxd3 functionally represses a 
premature differentiation program in migrating neural crest cells. Enhancers in the vicinity 
of several genes that were differentially up- or down-regulated in foxd3 mutant embryos 
were directly occupied by foxd3. Moreover, in contrast to the depleted accessibility of 
these enhancers in the absence of foxd3, ectopic expression of foxd3 resulted in an 
increase in chromatin accessibility. Together, the results suggest that activation of the 
neural crest program and repression of the differentiation program occurs simultaneously 
in a foxd3-dependent mechanism. 
As another example of pioneer transcription factor activity in neural crest 
development, Rothstein and Simões-Costa (2020) explored the heterodimerization of 
TFAP2 family of transcription factors as a regulatory mechanism for neural crest 
specification. One of five paralogs, Tfap2a is important for both neural crest induction and 
neural crest specification (De Crozé et al., 2011; Knight et al., 2003; Luo et al., 2003), first 
expressed in neural crest precursors in gastrula stage embryos as a member of the neural 
plate border specification gene regulatory network. There, its expression overlaps with 
Tfap2c. As neurulation proceeds and presumptive neural crest cells are localized within 
the dorsal neural tube, the expression of Tfap2b comes on in the neural crest, while 
Tfap2c is downregulated. By mapping the regulatory targets of Tfap2a, Tfap2b, and 
Tfap2c using Cut&Run (Skene and Henikoff, 2017), Rothstein and Simões-Costa 
proposed a model whereby Tfap2a associates with Tfap2c to first control neural crest 
induction. Once neural crest induction is complete, Tfap2a switches its dimerizing partner 
to interact with Tfap2b to drive neural crest specification. As a case in point, when the 




specifically functions in the neural crest, the timing of neural crest specification was 
altered, resulting in premature activation of neural crest specifier genes Sox9 and Snai2. 
These results demonstrate that pioneer transcription factors can add additional layers of 
regulation over cell state transitions during neural crest development. 
Identification of open enhancers that regulate expression of important cell fate 
determinants and may be critical for tissue morphogenesis is particularly important given 
that mutations in non-coding regions can result in their inactivation. In fact, several 
congenital birth defect-causing mutations, including neurocristopathies, exist in the non-
coding regions of the genome, which accounts for more than 98% of the human genome. 
For example, deletions in the non-coding regions of the SRY-related HMG box 
transcription factor Sox9, an important member of the neural crest specification gene 
regulatory network, have been associated with Pierre Robin Sequence (PRS), which 
results in an underdevelopment of the lower jaw.  
Long et al. (2020) used a combination of in vitro and in vivo methods to classify 
clusters of enhancers within the Sox9 topologically-associating domain (TAD). These 
enhancers were selectively accessible within cranial-neural-crest-derived human 
craniofacial tissues, and their activity coincided with the onset of Sox9 expression that 
resulted in the transition of Human embryonic stem cells into cranial neural crest cells. 
Using Capture-C, they presented evidence for long-range interactions between the Sox9 
promoter and the clusters of Sox9 enhancers. Using a luciferase reporter gene assay, 
they demonstrated selective activity of these enhancers in neural crest cells, as compared 
to undifferentiated hESCs or even neural crest cells differentiated into chondrocytes. At 
E9.5 and E11.5, the enhancers recapitulated the expression of Sox9 within the 
mandibular branchial arch. One of these enhancers was evolutionarily conserved across 
several vertebrate species, and ChiP-seq experiments revealed that the bHLH 
transcription factor Twist1 regulated its activity in a sequence-dependent manner. Finally, 
using the Wnt1Cre2 mice for selective knockout of Sox9 and/or the mouse orthologous 
enhancer, they showed that loss of the enhancer exacerbated defects in mandibular arch 




8.8.2 Acquisition of a broad developmental potential 
The early blastula segregates into the three germ layers designated ectoderm, 
mesoderm, and endoderm. While neural crest cells are derived from the ectodermal layer, 
they have the unique ability to form both ectodermal (e.g. neurons, glia) and mesodermal 
(e.g. cartilage, bone, smooth muscle of the cardiac outflow tract) type derivatives (Le 
Douarin, 1982). For this reason, the neural crest is sometimes referred to as the “fourth 
germ layer” (Le Douarin and Dupin, 2014; Glenn Northcutt, 2005). What underlies this 
broad developmental potential [Sidebar 2]? Two possible hypotheses have been 
proposed: 1) retention of developmental programs active in the early blastula, hereby 
referred to as the “retention model,” or 2) redeployment of pluripotency programs after 
neural crest induction, hereby referred to as the “reacquisition model.”  
8.8.2.1 The retention model 
Buitrago-Delgado et al. (2015) argued in favor of the retention model hypothesis, 
positing that neural crest cells retain a subset of genetic programs that are otherwise 
active in blastula cells of the early Xenopus embryo. Through in situ hybridization, they 
found that the neural crest gene regulatory network factors such as Tfap2, Ets1, and 
FoxD3 were co-expressed with the core pluripotency markers Oct60 (Pou5F3.3), Sox3, 
and Vent2. As the embryo developed, the expression of Vent2 was retained in gastrula 
stages, whereas Oct60 and Sox3 were downregulated. When they knocked down the 
neural crest gene Snai1 in the animal pole of blastula embryos, the expression of other 
neural crest markers as well as pluripotency genes was lost, suggesting that neural crest 
genes are required to maintain expression of pluripotency factors in the inducing neural 
crest. Loss of Snai1 also resulted in reduced developmental potential of the animal pole, 
such that Snai1 mutant cells failed to express markers associated with either the 
mesoderm derivatives (Brachyury and MyoD) or endodermal derivatives (Endodermin 
and Sox17). Snail proteins are absent from the endodermal lineage, therefore linking the 
loss of Snai1 to a general lack of potency. Conferring a neural plate border identity 




developmental potential at gastrula stages, in contrast to untreated animal pole cells, 
which lost the ability to form mesodermal and endodermal derivatives at gastrula stages. 
Finally, the treatment of neural plate border cells isolated from neurula stage embryos 
with high concentrations of activin was sufficient to induce expression of endodermal 
markers Endodermin and Sox17, despite the fact that neural crest cells do not 
endogenously form endodermal derivatives. Through this work, Buitrago-Delgado et al. 
(2015) demonstrated that neural crest cells maintain their broad developmental potential 
by retaining programs normally active at blastula stages. 
In order to interrogate the lineage relationships between early embryonic 
precursors and their progeny, Briggs et al. (2018) took advantage of their optimized 
microfluidics method to profile 136,966 single-cell transcriptomes obtained from 10 
individual timepoints representing early Xenopus development, with stages ranging from 
zygotic genome activation to early organogenesis. Using a computational approach, they 
demonstrated that the fate choices can be mapped as a tree-like model. Rather than step-
wise transitions to distinct cell states, they found several transitions occurring as a 
transcriptional continuum. Their dataset uncovered 87 distinct cellular identities, out of 
which 69 corresponded to known anatomical states. This dataset also allowed them to 
investigate the correlation between computational occurrence of a cell state and 
experimental evidence for when the state is first observed. As a consequence, they 
identified several cell states that appeared in their dataset much earlier than previously 
recognized. For example, an endothelial/hemangioblast progenitor appeared at stage 18, 
as compared to previously published work, which suggested that the hemangioblast cell 
first appeared at stage 26 (Walmsley et al., 2002). By contrast, experimental evidence 
suggested that endothelial cells only appeared at stage 31 (Liu et al., 2008). They also 
provided insights into the concept of multi-lineage priming (Laslo et al., 2006), where 
uncommitted cells co-express transcription factors associated with multiple terminal cell 
fates, similar to the co-expression of neural (Sox2) and neural crest (Pax7) markers at 
the neural plate border. Interestingly, the depth of their data allowed them to revisit the 




supplemented their whole-organism data with cells dissected from the neural plate border 
to enrich neural crest precursors.  
In contrast to the results of Buitrago-Delgado et al. (2015), Briggs et al. (2018) 
failed to uncover a cluster of cells with enriched expression of pluripotency markers. 
Instead, their data suggested that the transition from a blastula to gastrula stage embryo 
follows conventional trajectories, with the pluripotent blastula transitioning through 
intermediate neuroectodermal states before committing to the neural crest lineage. 
Interestingly, they found that the pluripotency genes were not specifically expressed in 
the neural plate border but were broadly present across all three germ layers. While this 
goes against the retention model, one caveat remains the reliance on transcriptional data 
to understand cell fate choices and developmental trajectories. It is possible that 
additional layers of non-transcriptional regulation, such as epigenetic modifications of 
enhancers regulating the expression of pluripotency genes, or post-translational 
modifications of pluripotency proteins, could still allow blastula cells to retain a 
pluripotency state following induction of the neural crest. However, as far as a 
transcriptional program underlying the retention model is concerned, they found little 
evidence to support it. 
8.8.2.2  The reacquisition model 
In a recent study, Zalc et al. (2021) revisited the “acquisition model” of neural crest 
cells’ broad developmental potential. Using Wnt1Cre;Rosa26TdTomato mice, they collected 
neural crest cells at four distinct timepoints of development ranging from four to ten 
somites stage, corresponding to cranial neural crest precursors in the dorsal neural folds 
(four somites), and delaminating (six somites), migrating (eight somites), and 
differentiating (ten somites) cranial neural crest. As expected, cells isolated from the 
dorsal neural folds expressed markers characteristic of specified neural plate border cells, 
with high expression of neural markers such as Sox2, Otx2, and Gbx2. Six somite stage 
was marked by the onset of neural crest specifier genes FoxD3, Sox10, Ets1, and Twist1. 




markers, and segregated into committed lineages, including ectomesenchymal, glial, and 
neural progenitors. While cells from the four-somite stage further segregated into anterior 
and posterior populations, this segregation was lost once the cells delaminated, 
suggesting that following their epithelial to mesenchymal transition, the cells represent a 
homogenous population of migrating neural crest cells that diversify into distinct lineages 
in response to specific environment cues.  
Interestingly, cells within the earliest Wnt1Cre+ cranial neural crest precursor cluster 
expressed pluripotency genes Oct4, Sox2, Nanog, and Klf4. Oct4 levels were distinctively 
higher than the other three factors, although the expression of Nanog and Klf4 was 
restricted to this cell cluster. At the six-somite stage, Oct4 was notably downregulated 
within the Wnt1Cre/Otx2+ cells, which mark the anterior boundary of the neural plate 
border. On the other hand, Oct4 expression was increased within the Wnt1Cre/Gbx2+ 
cells, which mark the posterior boundary of the neural plate border. This dynamic 
regulation of Oct4 within the dorsal neural folds occurred in an anterior-posterior wave, 
coinciding with the timing of cranial neural crest delamination. Spatiotemporal expression 
of Oct4 was assayed using Oct4-GFP embryos, which revealed that while Oct4 was 
expressed in the whole epiblast at E7.5, it was absent in the developing head fold. 
Following somitogenesis, Oct4 expression re-appeared in the most anterior part of the 
embryo. They also performed lineage tracing using an inducible Oct4CreER/+;Rosa26TdT/+ 
line and showed that the proportion of cranial neural crest derivatives labeled directly 
correlated with the stage at which tamoxifen was administered, such that induction at one-
somite stage positively labeled cells in the frontonasal mass and branchial arch 1, 
whereas induction at six-somite stage only labeled cells within the branchial arches 1, 2, 
and the glossopharyngeal nerve complex. Diphtheria toxin-mediated ablation of Oct4 
between E7.5 and E8 resulted in a complete absence of the frontonasal mass, even 
though neural folds were present in the embryos, mimicking the phenotype observed in 
avian embryos following the extirpation of the cranial neural crest (D’amico‐Martel and 
Noden, 1983; Noden, 1975). Consistent with the transient shift of Oct4 expression along 




however, the posterior derivatives, such as the nasal processes, were absent. Loss of 
Oct4 mainly resulted in a downregulation of genes associated with the ectomesenchymal 
potential of the cranial neural crest, such as Sox9 and Alx4, with no effect on Sox10 
expression. ATAC-seq of Oct4+ cells revealed that the non-coding regions surrounding 
cranial neural crest-specific cis-regulatory elements were accessible at six-somite stage, 
even though the expression of those genes peaked at ten-somite stage, as would be 
expected if the enhancers regulating the expression of these genes were primed to drive 
gene expression prior to when the genes were functionally relevant. Cis-regulatory 
priming has been observed across several systems (Huang et al., 2007; Laslo et al., 
2006), and demonstrates the importance of following a multimodal approach to 
understand how transcriptional activation coordinates with chromatin accessibility to drive 
cell fate decisions.  
The finding that the premigratory neural crest domain in mice expresses 
pluripotency factors is consistent with reports in the chick that reveal a neural crest stem 
cell niche in the dorsal midbrain with high expression of neural crest genes, pluripotency 
factors, and lineage markers (Lignell et al., 2017). Similarly, profiling of zebrafish foxd3 
positive cells revealed an early pluripotency signature that is down-regulated and then re-
expressed in neural crest precursors prior to migration (Lukoseviciute et al., 2018). These 
results may suggest that the reacquisition model may reflect a pan-vertebrate trait.  
8.9 Conclusions 
 This is an exciting time in developmental biology, when new methodologies have 
opened up the possibility to explore developmental cell fate choices at unprecedented 
resolution and across numerous species. The neural crest represents an interesting cell 
type for this type of analysis due to its broad developmental potential, extensive migratory 
ability and importance from a clinical perspective. In particular, the cranial and 
cardiac/vagal neural crest give rise to numerous cell types that are prone to mistakes 
leading to debilitating birth defects. The use of modern genomic approaches has allowed 




has opened up the possibilities to dig deeper into some of the fundamental questions in 
neural crest biology: What triggers the cell-fate decision at the neural plate border? What 
mechanistic differences govern collective versus individual cell migration of the neural 
crest? Are there molecular signatures that govern neural crest migration across different 
species? What triggers the compensatory response of neural crest cells? Can their stem 
cell-like properties play a role in tissue replacement therapy? With 150 years of neural 
crest research behind us and exciting emerging technologies in front of us, the next 
century promises to help unravel the answers to these enduring questions. 
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Authors’ recommendations for gRNA design for chicken embryos:  
Ideal targets for knock out: early in gene, mutations near the start codon and/or mutations 
in an early splice acceptor site 
 Splice sites: NNNN<exon>NNNNgt --- <intron> – agNNNN<exon>NNNN 
PAM sequence: NGG 
PAMs with C and T at the N position are better that A or G. 
 CGG or TGG > AGG or GGG 
The authors recommend using an online tool to identify all possible protospacers within 
a 250nt target region. These tools can rank gRNA protospacers based on their potential 
off-target activity with the chicken genome. 
To design targets manually:  
Open target sequence in your favorite sequence visualizing software (such as ApE or 
SnapGene).  
Search the genomic locus for the sequence “NNNNNNNNNNNNNNNNNNNNNGG.” 
Allow the sequence software to search the reverse complement sequence for “CCN” 
targets.  
Locate the PAM sequence. The 6 nucleotides in the protospacer immediately adjacent to 
the PAM are the PAM-proximal nucleotides (PAM-PNs). The GC% for PAM-PNs should 
be as high as possible, preferably at least 66%. 
G[19nt]NGG  Avoid TTT-Tn 
CCN[19nt]C  Avoid AAA-An 




Look for off-target sites in the genome by doing a BLAST search for the first 13nt of the 
protospacer (from the PAM) sequence against the chicken genome. If you use an online 
tool to design gRNAs, this is already done by the algorithm, so select one of the top hits 
if possible. 
The U6 promoter requires a G at the 5’ end of the protospacer for RNA Pol-III-mediated 
transcription. If the protospacer sequence selected does not have a G in the front, just 
replace the first nucleotide with a ‘G.’    
Step 1: Order the following oligos: 
Primers: Target: 5’ [CGAGAAGGTTGGCTGGGTG]CGG 3’ 
Forward: ggatg[19nt] 
  Reverse: aaac[revcomp19nt]c 
  Order:  For:  5’-  ggatg[CGAGAAGGTTGGCTGGGTG] -3’ 
    Rev:  5’-  aaac[CACCCAGCCAACCTTCTCG]c -3’ 
For CCN PAMs, take the reverse complement of the protospacer+PAM and paste in a 
new window. Now use the above-mentioned strategy to design the oligos. 
Step 2: Set up the following annealing reaction: 
5 µl 100 µM Forward Primer 
5 µl  100 µM Reverse Primer 
5 µl NEB 10x T4 DNA Ligase Buffer 
35 µl  dH2O 
50 µl 
Heat to 95°C for 5 minutes. Bring to room temperature on your bench for 30-45 minutes.  
Annealed:  For: 5’- ggatgCGAGAAGGTTGGCTGGGTG   -3’ 
       |||||||||||||||||||| 
 Rev: 3’-     cGCTCTTCCAACCGACCCACcaaa  -5’ 




Step 3: Set up the following digestion: 
Digest U6.3>empty gRNA overnight with BsaI-HF.  
x µl  Empty gRNA plasmid 
2 µl   Bsa-I HF 
6 µl  10x Cutsmart Buffer 
(52-x) µl  dH2O 
60 µl 
Gel extract the vector. 5’-GGAT-3’ and 3’-CAAA-5’ overhangs will allow you to clone this 
annealed oligo in your linearized vector using this recipe: 
Step 4: Set up the following ligation: 
1 µl  BsaI-digested vector 
2.5 µl   1:1000 diluted annealed oligos 
2 µl  NEB 10x T4 DNA Ligase Buffer 
1 µl  T4 DNA Ligase 
13.5 µl  dH2O 
20 µl 
Incubate at room temperature for 20 minutes, then transform 25 µl competent cells using 
5 µl ligation reaction [Maintain 1:5 ratio of ligation reaction to competent cells]. 
Add 37.5 µl SOC media [1.5x transformation volume] for 15 minute recovery at 37˚C. 
Plate full volume on LB+Amp plates. For first use after digesting vector, perform a “vector 
only” control to test for digestion efficiency. After transformation, test for successful inserts 
by colony PCR using U6 sequencing primer + gRNA reverse primer. 
ex ovo electroporations: 
Its ideal to electroporate multiple gRNAs, but ensure that the targets are no closer than 
108nt to one another in the genome. 
Electroporation recipe: 2 µg/µl Cas9 + 1.5 µg/µl (gRNA1 + gRNA2 + … + gRNAn) + 2 µg/µl 
















Step 1: Order the following oligos:  
Example target: 5’ ...CCGAGAAGGTTGGCTGGGTGCGG... 3’  
Forward primer: cgtc[20nt protospacer]  
Reverse primer: aaac[reverse complement of 20nt 
protospacer] 
Order:  
gRNA-TOP:  5’- cgtcCCGAGAAGGTTGGCTGGGTG - 3’  
gRNA-BOT:  5’- aaacCACCCAGCCAACCTTCTCGG - 3’  
EcoRI-HH-<Gene>-Fwd: 5’–aaaGAATTC<NNNNNN>CTGATGAGTCCGTGAGGACG–3’ 
This primer will be specific to each gRNA. <NNNNNN> is the reverse complement of the 
first 6 nucleotides of the gRNA protospacer. For the CCGAGAAGGTTGGCTGGGTG gRNA, 
this sequence will be <TCTCGG>, and the ‘EcoRI-HH-<Gene>-Fwd’ primer will be  
5’-aaaGAATTCtctcggCTGATGAGTCCGTGAGGACG-3’. 
The following primers are common for all constructs: 
HDV-NotI-Rev: 5’ – aaagcggccgcGTCCCATTCGCCATGCCGAA – 3’ 
Citrine-ColonyPCR-Fwd: 5’ – CACAAGCTGGAGTACAACTA – 3’ 
T7-seq-Rev: 5’ – taatacgactcactataggg – 3’ 






Step 2: Set up the gRNA protospacer annealing reaction:  
5 µL 100 μM gRNA TOP 
5 µL 100 μM gRNA BOT 
5 µL NEB 10x T4 DNA Ligase Buffer 
35 µL Water 
50 µL Total volume 
Heat to 95°C for 5 minutes. Bring to room temperature on the bench for 30-45 minutes.  
Annealed oligos: 5’- cgtcCCGAGAAGGTTGGCTGGGTG     - 3’  
       |||||||||||||||||||| 
   3’-    GGCTCTTCCAACCGACCCACcaaa - 5’  
Dilute this reaction 1:1000. This is your insert.  
Step 3: Digest the shuttle vector plasmid:  
x µL 6µg of DNA 
6 µL 10x Cutsmart Buffer 
2 µL BsaI-HF enzyme 
(52-x) µL Water 
60µL Total volume 
Digest at 37˚C overnight (16-18 hours at least). Gel extract to obtain your shuttle vector. 
Do not CIP-treat. Ensure the vector concentration after elution is less than 50ng/µL (dilute 
if necessary). 
Step 4: Ligate annealed oligos into the Shuttle vector: 
1 µL Linearized Shuttle vector 
2.5 µL gRNA annealed primers (1:1000 dilution from above) 
2 µL NEB 10x T4 DNA Ligase Buffer 
1 µL T4 DNA Ligase 
13.5 µL Water 
20 µL Total Volume 
Incubate at room temperature for 20 minutes, then transform 25µL competent cells (our 
lab uses homegrown competent cells) with 5µL of ligation reaction (This can be changed 




volume of competent cells used) and recover for 15 minutes at 37˚C. Plate full volume on 
LB+Amp plates. Incubate plates at 37˚C overnight. 
(For first use after digesting the Shuttle vector, perform a “Shuttle vector only” negative 
control to test for digestion efficiency. Make sure you don’t get any colonies. Repeat 
digestion if necessary.)  
Step 5: Amplification of HH-gRNAf+e-HDV precursor: 
Pick individual colonies and swirl in 10µL of SOC (in a PCR strip tube). Set up the 
following reactions: 
Reaction 1 
2.5 µL Swirled Culture 
5 µL EcoRI-HH-<Gene>-Fwd 
5 µL HDV-NotI-Rev 
2.5 µL Taq Buffer 
1 µL dNTPs 
1.5 µL DMSO 
0.5 µL Taq Polymerase 
32 µL Water 
50 µL Total Volume 
In parallel, set up the following colony PCR to verify successful integration of the 
protospacer: 
Reaction 2 
1 µL Swirled Culture 
2 µL gRNA-TOP (10µM dilution) 
2 µL T7 seq Reverse 
1 µL Taq Buffer 
0.4 µL dNTPs 
0.6 µL DMSO 
0.2 µL Taq Polymerase 
12.8 µL Water 




Run 2µL of Reaction 1 and 20µL of Reaction 2 on a gel. Reaction 1 should yield a ~215bp 
product, while Reaction 2 should yield a 690bp product (if the protospacer was 
successfully integrated into the shuttle vector). PCR purify the remaining 48µL of Reaction 
1 (for colonies that have a positive band for Reaction 2) and elute in 52µL.  Set up the 
following digestion reaction: 
52 µL PCR-purified product 
6 µL 10x Cutsmart Buffer 
1 µL EcoRI-HF enzyme 
1 µL NotI-HF enzyme 
60µL Total volume 
Digest for 2 hours at 37˚C. Gel extract. This is your “EcoRI-HH-gRNA-HDV-NotI” insert.  
Step 6: Clone HH-gRNAf+e-HDV precursor into single CRISPR plasmid:  
Set up the following digestion reaction: 
x µL 6µg of single CRISPR plasmid 
6 µL 10x Cutsmart Buffer 
1 µL EcoRI-HF enzyme 
1 µL NotI-HF enzyme 
(52-x) µL Water 
60µL Total volume 
Digest at 37˚C overnight. Gel extract to obtain the CRISPR destination vector. Set up 
ligation at 1:3 molar ratio using this vector and the insert obtained in Step 5.  
x µL Linearized CRISPR destination vector 
y µL Digested and purified HH-gRNA-HDV insert (from Step 5) 
2 µL NEB 10x T4 DNA Ligase Buffer 
1 µL T4 DNA Ligase 
(20-x-y) µL Water 
20 µL Total Volume 
Ligate for 2 hours at room temperature. Transform 25µL competent cells (our lab uses 
homegrown competent cells) with 5µL of ligation reaction (This can be changed to 




volume of competent cells used) and recover for 1 hour at 37˚C. Plate and incubate at 
37˚C overnight.  
The next day, validate colonies by colony PCR using Citrine-ColonyPCR-Fwd and 10µM 
dilution of gRNA-BOT primers. Validate insert by sequencing and electroporate chick 

















1. Coat 15cm plates with 0.1% gelatin solution before use. DF1 cells are maintained 
in DMEM with 10% FBS supplemented with 1% Penstrep.  
2. On the day of transfection, cells should reach 80% confluency for optimal 
transfection.  
(In our experience, this density permits cells to attach with each other in order to 
survive, but still have space to divide.) 
3. Remove old media and replace with 15ml fresh DMEM with 10% FBS.  
4. Prepare ‘Tube 1’ by mixing 96µL of PEI with 1.2mL of OPTI-MEM prewarmed to 
room temperature. Vortex.  
(To make working stock of PEI, dissolve PEI in water at 1mg/mL and filter-sterilize. 
The solution can be stored at 4°C for up to 3 months. Keep on ice when it is being 
used.) 
5. Prepare ‘Tube 2’ by mixing 20µg of RIA-CRISPR plasmid and 5µg of VSVG 
plasmid with 1.2mL of room-temperature OPTI-MEM. Vortex.  
6. Transfer all solution from ‘Tube 1’ to ‘Tube 2.’ Vortex. Let the mixture sit at room 
temperature for 30 mins.  
7. Add the DNA/PEI mixture (2.4mL) into DF1 cells by dripping uniformly onto the 
plate. Gently swirl the plate to mix. Place the plate back in the incubator.  
8. 2-3 hours later, replace the old media with 24mL fresh DMEM with 10% FBS. Place 







1. 16 hours later, add 240µL of sodium butyrate and mix by gently swirling the plate. 
Incubate the cells for 6 hours.  
(Make sodium butyrate by mixing 0.1g sodium butyrate in 1ml 1xPBS. Filter-
sterilize before use.) 
Note: make sure that the transfected cells are healthy and growing; otherwise, redo 
the transfection by adjusting the amounts of RIA-CRISPR and VSVG plasmids 
used. The optimal concentration will be variable for different recombinant RIA 
plasmids. 
2. Remove the old media, wash twice with 10mL 1XPBS. Add 16mL fresh DMEM 
with 10% FBS. Place the cells back in the incubator overnight.  
(Now, the cells will start producing the virus. Since sodium butyrate affects normal 
cell growth, it is expected that some cells will die. If too many cells die, then 
readjust the concentration of and/or treatment duration with sodium butyrate.) 
Day 3-7 
1. Collect 12ml media (supernatant contains the viral particles) in 15ml conical tube. 
Replenish the plate by adding 12mL fresh DMEM with 10% FBS. Freeze the 
supernatant at -80˚C immediately.  
2. Repeat this collection step every 12 hours for 4 days if possible, or every 24 hours 
for 4 days.  
(In total, this will yield about 96mL or 48mL supernatant containing viral particles 
for concentration. Some media will be lost to evaporation during the 12-hour 
incubation, so adjust the media volume accordingly. Caution: Do not add excess 




3. Monitor the cells during collection. If the cells look extremely healthy, the 
transfection may not have been successful. Some deterioration in health is 
expected. If the cells are very confluent, switch to DMEM with 1% FBS to prevent 
the cells from falling off.  
Day of injection 
1. Take out 4 tubes of supernatant collected from transfection (48mL) and thaw at 
37˚C in a water bath. Invert the tube frequently to ensure proper mixing, and put 
immediately on ice when thawed.  
(The virus is extremely sensitive and should not be subjected to room 
temperature.)  
2. Centrifuge the tubes at 6000g for 10 minutes to clean up cell debris.  
3. In the Tissue Culture hood, gently pour the supernatant into a 45µm filter. Collect 
the filtered solution. 
4. Pipet the filtered solution into ultracentrifuge tubes. Be careful to avoid making 
bubbles. Balance with DMEM if necessary.  
5. Centrifuge at 26000rpm for 1.5 hours at 4°C.  
(~75500g for a 10cm rotor. Using a swinging bucket is critical to collect the pellet 
at the bottom.)  
6. Decant the supernatant.  
(At the bottom of the tube, there should be a yellowish-white pellet which contains 
the viral particles).  
7. Use an autoclaved glass pipet and aspirate to remove the residual media in the 
tube. Leave around 30µL. Seal the centrifuge tube with parafilm and tin foil. Nutate 




(The virus is sensitive to light, so protect it by wrapping the tube in foil.) 
8. Remove the parafilm and foil. Pipet up and down 100 times to resuspend the virus. 
(Do not make bubbles at this step, since the virus can die when in contact with air.) 
9. Make 2µL aliquots. Use the virus the same day or store at -80˚C. Only take out 
when ready to use. The viral titer drops after a few weeks.  
(During the injection, add a small volume of 2% food dye so as to not dilute the 
virus too much. Only load 1µL in the injection needle at a time. Keep the rest of 
















This protocol has been optimized for chicken embryos and is designed for Fluorescence-
activated cell sorting. For each experiment, you will need to take the following solutions 
to the sorting facility: 
1. Single-cell suspension of cells of interest. 
2. Single-cell suspension of cells with individual fluorophores you are sorting for (Do not 
use RFP as a control for mCherry). 
3. Single-cell suspension of wild-type cells (preferably from the same anatomical area as 
your cells of interest). 
4. Live-dead cell staining dye (Sytox Blue if sorting mCherry+ cells, 7AAD if sorting 
GFP+ cells). 
5. Low-binding microcentrifuge tubes with 100µL of Hank's-EDTA. 
6. Falcon tube with Hank's-MgCl2 (Hank's-BSA for scRNA-seq). 
For single-cell RNA-sequencing without FACS, use variations of the protocol as highlighted 
wherever appropriate. 
Materials 
• 1X DPBS – Make 50mL aliquots and store on bench. Stock bottles at stored 4˚C. 
• 10X Hank's Balanced Salt Solution (HBSS) – no calcium, no magnesium, no 
phenol red. Make 50mL aliquots and store at room temperature. Stock bottles 
stored at 4˚C. 
• Accumax – Stored at -20˚C. Make 750µL aliquots and store them in the freezer. 
Avoid multiple freeze-thaw cycles. Activity of the enzyme-mix declines with more 
than 2-3 freeze-thaw cycles. 




• 1M HEPES (pH 7.0) – Filter (0.22um) sterilized and stored at room temperature. 
• 0.5M EDTA – Autoclaved and stored at room temperature. 
• Bovine Serum Albumin (Sigma Aldrich) – Stored at 4˚C. 
• 40um cell strainers 
• RQ1 DNase-I – RNase-free, stored at -20˚C. 
• Sytox blue – Live-dead stain for sorting red FP, stored at -20˚C. Cover aliquots 
in foil. 
• 20µm nylon strainer (for single-cell RNA-seq suspension) – Millipore.  
• Low-binding 1.7mL Eppendorf tubes. 
• 15mL falcon tubes – One tube per sample you are dissociating. 
• 50mL falcon tubes – One tube per sample you are dissociating. 
• 5mL polystyrene round bottom tubes – One tube per sample you are dissociating. 
Procedure 
Embryo dissection and pre-dissociation washes 
1. Have an ice bucket with 1X DPBS, 10X HBSS, low-binding microcentrifuge tubes 
with 500µL ringers for each tissue type, and Accumax. 
Thaw Accumax on ice while dissecting the tissue, then at room temperature during 
PBS washes. 





The longer the tissue stays at room temperature, the more cell debris you will get 
later on. 
3. Remove Ringer’s solution from the tube and replace with 1mL of chilled 1X DPBS. 
Allow the dissected tissues to settle at the bottom of the tube. 
4. Wash with 1X DPBS thrice. At this point, keep Accumax in your hands to facilitate 
thawing. Once thawed, pipette up and down a couple of times and spin down to collect. 
Tissue dissociation 
5. Carefully remove as much 1X DPBS as possible and replace it with 750µL of 
Accumax. Transfer tubes to 37˚C heat block. Start your timer counting up. The goal is to 
dissociate cells for no longer than 15 minutes.  
If you have several tubes, then add Accumax to each tube and keep the tube on 
ice. The enzymatic activity starts at 37˚C, so your cells are safe on ice. 
6. Check dissociation by pipetting up and down every 5 minutes. Be gentle. 
Use blue filter tips since they have a wider opening. My rule of thumb is to pipette 
15 times against the wall of the tube. 
7. While the cells are dissociating, prepare Hank's buffers using the following recipes: 
Hank's- MgCl2 (for 40mL)  Hank's-EDTA (for 10mL) 
10X HBSS 4 mL  10X HBSS 1 mL 
HEPES (pH=7) 1 mL  HEPES (pH=7) 250 µL 
BSA 100 mg  BSA 25 mg 
1M MgCl2 400 µL  EDTA 20 µL 
Water 34.6 mL  Water 8.75 mL 
Add BSA at the very end and nutate for 5 minutes to ensure proper mixing. Hank's- 




in which you will collect cells at the sorting facility. EDTA chelates divalent ions and hence 
inhibits the activity of DNase-I. 
8. If you are dissociating cells to directly load them on the 10X Genomics controller, 
use this recipe instead: 
Hank's recipe for scRNA-seq 
Hank's-BSA      (for 40mL)  for 10mL 
10X HBSS 4mL      1mL 
HEPES (pH=7) 1mL      250µL 
BSA 100mg      25mg 
Water 35mL      8.75mL 
MgCl2 interferes with the reverse transcription step of the scRNA-seq protocol by 
10X Genomics, so it is important not to use Hank's-MgCl2. 
9. After 15 minutes, load 10µL of the suspension on a microscope slide and check 
under the cell-culture microscope. 
If your dissected tissue contains the neural tube, be extremely careful. Cells at the 
periphery (including neural crest cells) are already in a single-cell suspension, while parts 
of the neural tube might be visible as threads floating in the sample. Over-dissociating 
can potentially lyse cells of interest. While checking the cells under the microscope, 
transfer tubes on ice. 
10. Keep Hank's-MgCl2 (Hank's-BSA for scRNA-seq) and Hank's-EDTA on ice. 
Transfer 5mL Hank's-MgCl2 (Hank's- BSA for scRNA-seq) in a 15mL conical tube per 
sample and keep on ice. 
Post-dissociation washes 
11. Once the tissue is dissociated as required, transfer the suspension to chilled 15ml 




Wash original Eppendorf with some Hank's-MgCl2 (Hank's-BSA for scRNA-seq) 
from the conical to ensure all cells are in the 15mL falcon tube. 
12. Spin down at 4˚C at 300 rcf for 4 mins in 15mL falcons. 
While the cells are in the centrifuge, get 40um cell strainers (20µm filters for 
scRNA-seq) and 50mL falcons for each dissociated sample. Label the tubes and put them 
on ice. 
13. Carefully remove supernatant and resuspend pellet in 1mL Hank's-MgCl2 (Hank's-
BSA for scRNA-seq). Be extremely gentle. 
The cells at this point have (theoretically) clumped at the bottom of the falcon. It is 
important to release the cells back into a single-cell suspension before passing it through 
the filter in the next step. My rule of thumb is to pipette 10 times very gently against the 
wall of the tube. 
14. Filter the 1mL suspension through the 40µm cell strainer (20µm filter for scRNA-
seq) into the 50ml conical tube on ice. 
Pipette the solution into a P1000 filter tip. Place the pipette such that the tip touches 
the strainer. Release the solution in one smooth motion without stopping. Use the 20µm 
filter in the TC hood. 
15. Centrifuge the 50mL falcons at 4˚C for 3 mins at 300 rcf. Leave the cell strainer on 
the top of the falcon. 
For scRNA-seq, when using the 20µm nylon filters from Millipore, discard the filter 
after passing the cell suspension through it. 
16. Remove the supernatant as much as possible without disturbing the pellet and 
replace with 50-250µl Hank's-MgCl2 (Hank's-BSA for scRNA-seq) depending on how 




A good rule of thumb is to pipette up and down 10 times extremely gently against 
the wall of the tube. Keep additional Hank's-MgCl2 buffer (Hank's-BSA for scRNA-seq) 
on ice in case cell density is very high. Sometimes, the pellet might be too small to be 
seen. If that's the case, just be very careful when removing the supernatant. 
17. Transfer the cells to a 5mL culture tube. Label and keep on ice. Check cell viability 
using Trypan Blue and count live cells. 
Add 10µL cells (or a 1:10 dilution depending on the size of pellet observed at the 
beginning of step 15) to 10µL trypan blue. Load 10µL of this mixture on chamber-slide in 
the tissue-culture room. Cell viability should be at least 85% if not more. 
18. Add 15µL of RQ1 DNase-I to each tube. Pipette up and down gently. To collect 
sorted cells, transfer 100µL of Hank's-EDTA to low-bind Eppendorf tubes (one per 
replicate) and keep them on ice. 
19. For scRNA-seq applications, skip steps 17 and 18. Instead, transfer your single-
cell suspension in Hank's-BSA to a low-bind Eppendorf tube. Spin at 300g for 5 
minutes at 4˚C and resuspend in ~38µL of Hank's-BSA buffer. You are ready to 
load your cells on the 10X controller chip. 
This volume is variable. Please check the volume of cells you would load on the 
controller chip in the scRNA-seq protocol by 10X Genomics. 
